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The interplay of genes and nutrition during early development profoundly impacts fetal
outcome. Copper is an essential nutrient required for the redox activity of many enzymes,
and recent work in our laboratory has elucidated the phenotype of copper deficiency in
zebrafish, which includes a strikingly distorted notochord. The studies described here
establish the specific genetic etiology of this distortion and reveal a number of gene-gene
and gene-nutrient interactions critical to notochord morphogenesis.
We first demonstrate that the notochord distortion observed in copper-deficient
zebrafish results from lysyl oxidase cuproenzyme inhibition. Four lysyl oxidase family
members are expressed throughout the developing zebrafish notochord, including loxl1
and loxl5b. Morpholino antisense experiments reveal that knockdown of loxl1 results in
notochord distortion and also demonstrate overlapping roles for loxl1 and loxl5b in
notochord formation. Furthermore, partial knockdown of either loxl1 or loxl5b sensitizes
embryos to notochord distortion when combined with reduced copper availability, and
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any of these treatments alone sensitizes embryos to notochord distortion after partial
disruption of the gene encoding a lysyl oxidase substrate, col2a1.
To elucidate additional gene-nutrient interactions involved in notochord
formation, we conducted a forward genetic screen for mutants that exhibit increased
notochord distortion after partial lysyl oxidase inhibition. This screen was facilitated by
the identification of a novel, highly potent lysyl oxidase inhibitor, 2-mercaptopyridine-Noxide, and yielded a mutant with defects in notochord and vascular morphogenesis, puff
daddygw1. Subsequent work demonstrated that the puff daddygw1 phenotype results from
loss of zebrafish fibrillin-2. Importantly, the notochords of puff daddygw1 mutants are
strikingly sensitized to distortion under conditions of suboptimal copper nutrition that do
not affect wild-type embryos. This sensitization is also observed in a published notochord
mutant, gulliverm208, and we demonstrate that the gulliverm208 phenotype arises from a
missense mutation in the alpha 1 chain of type VIII collagen.
Taken together, these studies demonstrate essential roles for copper and multiple
extracellular matrix components in late notochord formation and suggest that nutritional
status should be interpreted within the polymorphic genetic context of the developing
embryo.
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CHAPTER 1

Introduction
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Gene-nutrient interactions in early development
Adequate nutrition during embryogenesis is critical for preventing adverse developmental
outcomes, and what is “adequate” is determined partly by genetic context. In the agouti
mouse strain, dietary supplementation of female mice with vitamin B12 or other methyldonors during pregnancy permanently alters gene expression and results in fewer
offspring with obesity and an abnormal yellow coat color (1). Furthermore, different
genetic breeds of ewes grazed on the same copper-deficient pasture give birth to
offspring with strikingly dissimilar incidences of enzootic ataxia, a disease resulting from
copper deficiency (2). In humans, a role for genetic susceptibility loci in the pathogenesis
of fetal iodine deficiency disorder – the leading cause of preventable mental retardation
in newborns – was likewise suggested by observations that not everyone born to an
iodine-deficient mother is affected (3-5). A few of these genetic susceptibility loci have
recently been identified (4, 6), and perinatal iodine supplementation should be
particularly advantageous for mothers with these or other undiscovered genetic risk
factors for iodine deficiency. Similarly, genetic susceptibility loci may determine the
need for folate supplementation in the prevention of neural tube defects. Indeed, perinatal
folate supplementation has been shown epidemiologically to reduce the risk of fetal
neural tube defects by 50-70% and genetic risk factors have been described (7).
A great deal of evidence from animal models and epidemiologic studies supports
the importance of diverse gene-nutrient interactions in determining developmental
outcome (2, 8, 9). In essence, nutrient deprivation provides a stress that can result in the
expression of congenital birth defects or other adverse fetal outcomes depending on
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genetic background. The elucidation of gene-nutrient interactions during development is
thus of particular relevance, since it can provide insight into the molecular pathways of
organogenesis and may also allow for targeted therapeutic interventions designed to
prevent disease.
Cuproenzymes in development
Copper is an essential nutrient required by many proteins as a cofactor for catalyzing
electron transfer reactions (10). Cuproenzymes perform a number of functions critical to
normal human development (Table 1), and these functions appear to be substantially
conserved across species (10). Copper deficiency can result from insufficient dietary
intake or from genetic factors (2). In humans, Menkes disease results from loss of
function mutations in the intracellular copper transporter ATP7A, which delivers copper
to the secretory pathway for incorporation into cuproenzymes or export from the cell
(11). Children with Menkes disease appear normal at birth but soon exhibit many features
attributable to loss of cuproenzyme activity, including skin hypopigmentation, kinky hair,
cerebral and cerebellar degenerative symptoms such as hypotonia and seizures, lax skin,
arterial tortuosity, emphysema, osteoporosis, and bladder diverticuli (11, 12).
Subcutaneous copper injections fail to clinically reverse disease progression unless a
small amount of residual ATP7A activity remains (12), as would be expected from a
defect in copper delivery to the secretory pathway. Death generally occurs by three years
of age, although survival is better in an allelic form of the disease known as Occipital
Horn Syndrome where a greater degree of ATP7A activity is present (12, 13). In patients
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with Occipital Horn Syndrome, scoliosis or kyphosis of the vertebral column are
common and developmental delay is less profound (10).
Our laboratory has recently delineated the phenotype of copper deficiency in the
zebrafish embryo, which can be induced either pharmacologically through incubation in
copper chelators such as neocuproine or through genetic disruption of atp7a, as in the
mutant calamity (14). Copper deficiency in zebrafish results in a pleiotropic phenotype
including loss of melanin pigmentation, midbrain/hindbrain degeneration, and striking
notochord distortion. The role for copper in notochord formation was previously
unappreciated, and notochord distortion thus provides a new, highly visible phenotype
that can be utilized for further study of copper homeostasis during embryonic
development.

Enzyme
Function
Chemical crosslinking of collagens and elastin
Lysyl oxidase
Melanin pigment biogenesis
Tyrosinase
Ferroxidase
Ceruloplasmin
Peptide hormone activation
Peptidylglycine -amidating
monooxygenase
Electron transport and cellular respiration
Cytochrome c oxidase
Antioxidant defense
Copper-zinc superoxide
dismutase
Chemical cross-linking of keratin
Sulfhydryl oxidase
Table 1. Select human cuproenzymes and functions.
Notochord formation
The notochord is a midline axial organ that specifies left-right asymmetry and provides
structural support to the growing embryo. It also plays a critical role in patterning nearby
ectodermal, mesodermal, and endodermal tissues including the neural tube, somites,
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pancreas, heart, and dorsal aorta (15, 16). The notochord facilitates locomotion in lower
chordates and is required for vertebral column formation. Indeed, defects in notochord
formation have been linked to abnormalities in vertebral bone structure and other
congenital birth defects in humans (15).
The notochord is specified early in embryogenesis and originates from the dorsal
organizer. Notochord progenitors in this anatomic structure differentiate first into
chordamesoderm and then into mature notochord. The transition from chordamesoderm
to mature notochord involves the formation of an extracellular matrix sheath that
constrains a single row of notochord vacuolar cells as their vacuoles inflate. This
transition also correlates with the extinction of an embryonic gene program expressed by
chordamesoderm (16). In zebrafish, a number of mutants with defects in different stages
of notochord morphogenesis have been described (17-19). Of interest, defects in late
notochord formation can arise from extracellular matrix abnormalities that impair the
integrity of the notochord sheath (20).
Zebrafish as a model for studying gene-nutrient interactions in early development
Zebrafish provide a useful model for interrogating the relationship between genes and
nutrition during early development. This vertebrate is genetically tractable and completes
embryogenesis rapidly ex utero where organogenesis can be directly observed;
furthermore, nutrient concentrations can be precisely controlled in the zebrafish
embryonic milieu via pharmacologic manipulation.
Many phenotypes relevant to human development can be studied in zebrafish, and
a number of zebrafish mutants identified in forward genetic screens have already
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increased our understanding of the cell biologic mechanisms underlying human disease
(21-23). Zebrafish are amenable to chemical mutagenesis, and phenotypic screening of
mutant carriers can be conducted using haploid offspring, which complete the first few
days of embryonic development relatively normally despite having half the normal
complement of chromosomes (24). A major advantage of the haploid method is that F1
females (derived by fertilizing wild-type clutches with sperm from mutagenized males)
can be utilized, eliminating the need to generate and maintain large families of F2 fish,
which requires time and space (24). Once a mutant is identified, polymorphic strains of
fish and large clutch sizes permit meiotic mapping of the lesion to a limited region of the
genome for subsequent cloning of the affected gene (25, 26). Morpholino antisense
oligonucleotides can be used to recapitulate the mutant phenotype in wild-type fish by
altering splicing or inhibiting translation, resulting in transient knockdown of specific
gene expression (27). Conversely, microinjection of wild-type mRNA into one-cell
embryos will usually rescue the mutant phenotype. Importantly, forward genetic screens
in zebrafish can be carried out in the presence of pharmacologic agents at doses just
below what is required to elicit a phenotype in wild-type embryos. This permits the
identification of hypomorphic alleles that might go undetected without pharmacologic
stress, and focuses the screen on a biologic pathway of interest. When the pharmacologic
agent alters nutrient metabolism, gene-nutrient interactions can be detected.
Summary
At present, zebrafish are the vertebrates most closely related to humans that are amenable
to the application of powerful genetic techniques and also allow embryogenesis to be
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observed in real-time. The studies in this thesis describe several gene-gene and genenutrient interactions critical to normal notochord morphogenesis. Chapter 2 demonstrates
that the notochord distortion observed in copper-deficient zebrafish embryos results from
inhibition of specific lysyl oxidase cuproenzymes. Chapter 3 describes the identification
and characterization of 2-mercaptopyridine-N-oxide, a novel, highly potent lysyl oxidase
inhibitor. Chapter 4 reports the use of this inhibitor in a forward genetic screen for
mutants that exhibit increased notochord distortion after partial lysyl oxidase inhibition,
and discusses the characterization of a mutant identified in the screen. Chapter 5
demonstrates that the phenotype of a published notochord mutant, gulliver, results from a
missense mutation in the gene encoding the alpha 1 chain of type VIII collagen. Taken
together, the data in this thesis contribute to an understanding of notochord formation and
lysyl oxidase function, and elucidate some of the complex gene-nutrient interactions that
shape development.
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CHAPTER 2

Essential role of lysyl oxidases in notochord development

John M. Gansner,1 Bryce A. Mendelsohn,1 Keith A. Hultman,2
Stephen L. Johnson,2 and Jonathan D. Gitlin1,2
Departments of Pediatrics1 and Genetics2
Washington University School of Medicine
St. Louis, Missouri 63110
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Abstract
Recent studies reveal a critical role for copper in the development of the zebrafish
notochord, suggesting that specific cuproenzymes are required for the structural integrity
of the notochord sheath. We now demonstrate that β-aminopropionitrile, a known
inhibitor of the copper-dependent lysyl oxidases, causes notochord distortion in the
zebrafish embryo identical to that seen in copper deficiency. Characterization of the
zebrafish lysyl oxidase genes reveals eight unique sequences, several of which are
expressed in the developing notochord. Specific gene knockdown demonstrates that loss
of loxl1 results in notochord distortion, and that loxl1 and loxl5b have overlapping roles
in notochord formation. Interestingly, while notochord abnormalities are not observed
following partial knockdown of loxl1 or loxl5b alone, in each case this markedly
sensitizes developing embryos to notochord distortion if copper availability is
diminished. Likewise, partial knockdown of the lysyl oxidase substrate col2a1 results in
notochord distortion when combined with reduced copper availability or partial
knockdown of loxl1 or loxl5b. These data reveal a complex interplay of gene expression
and nutrient availability critical to notochord development. They also provide insight into
specific genetic and nutritional factors that may play a role in the pathogenesis of
structural birth defects of the axial skeleton.

9

Introduction
Structural birth defects are a leading cause of morbidity and mortality in humans. Despite
recent advances identifying the molecular genetic basis of several such disorders, the
genetic and environmental determinants of most structural birth defects remain unknown
(28). One of the most important environmental factors influencing the outcome of fetal
development is nutrition, and epidemiologic data, twin studies, and phenotype-genotype
correlations all suggest that specific nutritional influences in combination with genetic
susceptibility at multiple loci have profound long-term effects on pregnancy outcome
(29). While in utero development severely limits experimental elucidation of the
mechanisms and timing of critical events affected by nutrition during early embryonic
development, recent studies suggest that the zebrafish may be an informative, genetically
tractable model organism for such analysis (14, 22, 30).
The notochord is a useful structure for examining the complex interplay of genes
and nutrition in early vertebrate development. This organ is readily visible throughout
early zebrafish development, is the first to fully differentiate during embryogenesis, and
is essential for the patterning of surrounding ectodermal, mesodermal, and endodermal
tissues (31). The notochord is also a critical midline structure required for locomotion in
some chordates, and for axial skeletal formation in vertebrates (31). Furthermore, the cell
biological mechanisms underlying notochord maturation, involving cell vacuolation,
matrix biosynthesis, and sheath formation, have begun to be elucidated through a series
of elegant genetic experiments (17-20). Given the critical role of the notochord in
chondrogenesis and fate determination of surrounding tissues including neural tube,
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heart, and skeleton (16), as well as the large number of human structural birth defects
arising from these tissues, elucidation of the nutritional and genetic mechanisms of
notochord formation may be of direct relevance to our understanding of the etiology of
congenital malformations.
During studies examining the role of copper in embryonic development, we
discovered a critical role for this nutrient in late notochord formation (14). These findings
suggested that specific cuproenzymes may be required for the structural integrity of the
zebrafish notochord sheath, a concept supported by recent studies in Xenopus laevis (32).
In this current study we have determined a role for two specific lysyl oxidase genes in
notochord formation, and defined a complex biological pathway modulated by copper
nutrition that underlies this process. Our data suggest that copper status during embryonic
development should be interpreted in the context of environmental and genetic
modulators of cuproenzyme activity. Indeed, the results raise the intriguing possibility
that suboptimal copper availability, due either to nutritional or genetic variation during
embryonic development, contributes to human birth defects of the axial skeleton.
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Materials and methods
Zebrafish strains and maintenance
Zebrafish were reared under standard conditions at 28.5°C (33) and staged as described
(34). Synchronous, in vitro fertilized embryos were obtained from AB or AB/WIK stocks
for all experiments.
Pharmacologic treatment
Pharmacologic compounds were purchased from Sigma (St. Louis, MO).aminopropionitrile (A3134) and neocuproine (N1501) were prepared as 100 mM stocks
in egg water and dimethyl sulfoxide, respectively, and diluted in egg water. Embryos
were incubated in compound starting at 3 hpf and examined with an Olympus SZX12
zoom stereomicroscope at 24, 30, 48, and 72 hpf. Images of representative fish mounted
in 2% methylcellulose were acquired with an Olympus DP70 camera.
Identification and annotation of zebrafish lysyl oxidase genes
Exons encoding conserved regions of the lysyl oxidase catalytic domain (35) were
detected by TBLASTN search of the Ensembl zebrafish genome (Zv5). A clone of lox
was commercially available (Open Biosystems #6971279); full-length cDNA sequences
of all other family members were obtained using 5‟ and 3‟ rapid amplification of cDNA
ends (RACE) and RT-PCR based on sequence homology to human, mouse, and frog
lysyl oxidase sequences. Primers were as follows: loxl1 forward primer 5‟CGCCTTCTTTTATTAGTCTTCTGG-3‟ and reverse primer 5‟ACAGCGACGTCAGGAATTCC-3‟; loxl2a – forward primer 5‟ATGGCGGTGTCTTCTGCATTGTGC-3‟ and reverse primer 5‟-
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CTATCTGAGGTGGTTCAGCTGGTTGC-3‟; loxl2b – forward primer 5‟GCCATACAATCTGAGCCTCTGTC-3‟ and reverse primer 5‟CTTTACCTGTGGGTCACCTGG-3‟; loxl3a – forward primer 5‟ATGGGACAGTTTGCTAACAGC-3‟ and reverse primer 5‟TTATGAGATCTTGTTGTTGAGCTGCC-3‟; loxl3b – forward primer 5‟GTGTTTGTGTCCTTTGATGC-3‟ and reverse primer 5‟GCTGTACATGAAGAGTGATCT-3‟; loxl5a – nested 5‟RACE primers 5‟CACTCGAGCTGTACGCTGAACTGGAAAGGC-3‟ (first reaction) and 5‟GCACAGGGCTTGAACGCACCACATGCCC-3‟ (second reaction), and 3‟ PCR
amplification with forward primer 5‟-CATTAAGATGTGCCGCAGAGG-3‟and reverse
primer 5‟-CTCACCCGGTGATCCTACAGTTG-3‟; loxl5b – forward primer 5‟CCCACATCCAGAGGAGCGAA-3‟ and reverse primer 5‟TCCTCACCCAGTTATGATGCAG-3‟. GenBank accession numbers are: lox –
EF030479; loxl1 – EF030480; loxl2a – EF030481; loxl2b – EF030482; loxl3a –
EF030483; loxl3b – EF030484; loxl5a – EF030485; loxl5b – EF030486. An alignment
of the C-terminal portion of zebrafish and human lysyl oxidases was created in ClustalW
with human CD163 as outgroup (36, 37), and phylogenetic analysis carried out according
to the parsimony method (38). Bootstrap values over 100 replicates are noted. Signal
peptides and scavenger-receptor, cysteine rich domains were predicted using SignalP 3.0
and Motif scan (39, 40). Copper binding domains, Bone Morphogenetic Protein-1 (BMP1) cleavage sites, and lysyl-tyrosyl quinone cofactor residues were identified based on
homology to known lysyl oxidase sequences (41-43).
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Whole mount in situ hybridization and frozen sections
Lysyl oxidase and col2a1 (44) probe constructs were generated as partial clones by RTPCR and ligated into pCRII (Invitrogen). DIG-labeled antisense RNA probes were
synthesized from these constructs using a DIG-labeling kit (Roche), and whole mount in
situ hybridization performed as previously described (14, 45). Embryos for frozen
sections were subsequently embedded in PBS containing 1.5% agarose/5% sucrose.
Blocks were equilibrated in 30% sucrose at 4C, mounted with O.C.T. (Tissue-Tek), and
cut on a Leica Cryostat after freezing with liquid nitrogen. 14 M sections were collected
on Superfrost slides (Fisher) and mounted in 50% glycerol-PBS for visualization on an
Olympus BX60 microscope.
Morpholino and mRNA injections
Morpholino oligonucleotides (27) targeting splice sites of exons encoding the lysyl
oxidase copper binding domain (43) were resuspended in Danieau buffer, diluted to
include 0.05% phenol red, and injected into one- to four-cell embryos. Morpholinos
targeting the start sites of loxl1 and loxl5b, the 5‟ splice acceptor site of an exon
corresponding to exon 48 of the human col2a1 orthologue, and standard control
morpholino (Gene Tools, LLC) were likewise prepared and injected. Morpholino
sequences are as follows: loxl1 (splice) – 5‟- GTGTAGATGTGGACTCACTGATGGC3‟; loxl1 (splice) – 5‟- GTAATGCCTGATGGAGACAAGAGAC-3‟ (Fig. 7 and Fig. 8);
loxl1 (start) – 5‟-AGTACATGCAGCATATTGAGAAGAC-3‟; loxl2b – 5‟GATCTGGAGCAGCTAGAAAAAACAA-3‟; loxl3b – 5‟CAGCTGCGGACATAAACAAACAAAT-3‟;
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loxl5b (splice) – 5‟-GCCTGTGGAATAAACACCAGCCTCA-3‟; loxl5b (start) – 5‟TAAAGCTGTATGATTCGCTCCTCTG-3‟; col2a1 – 5‟CCTGAAGGTCCCTATTATAAATAAC-3‟. Capped, polyadenylated mRNA for rescue
experiments was generated from full-length clones of loxl1, loxl5b, and control
transposase (46) using the mMESSAGE mMACHINE kit (Ambion), with 300 pg of
mRNA injected per embryo. Rescue was calculated by taking the difference between the
percentages of embryos with distorted notochords injected with lysyl oxidase and control
mRNA, and then dividing this number by the percentage of embryos with distorted
notochords injected with control mRNA. Statistical analysis was conducted using oneway ANOVA for independent samples based on the percentages of embryos with the
distorted notochord phenotype from at least three separate experiments. In all cases,
abnormal splicing was detected by RT-PCR of RNA from 15 embryos injected with
control or lysyl oxidase morpholino using primers to exons flanking the putative splice
site. Nucleotide sequencing of putative splice products identified on agarose or
polyacrylamide gels confirmed the presence of a premature stop codon in the splice
variants. The intensity of wild-type PCR products was quantified using non-saturated gel
pictures and ImageJ 1.37v software (47), and the percentage of wild-type splice form
remaining after morpholino knockdown calculated.
Transmission Electron Microscopy
Dechorionated embryos were fixed in 2.5% glutaraldehyde/0.1 M sodium cacodylate and
sequentially stained with osmium tetroxide and uranyl acetate. They were then
dehydrated, embedded in PolyBed 812, and thin sectioned on a Reichert-Jung Ultra-Cut.
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Slices were post-stained in 4% uranyl acetate and lead citrate, and viewed on a Zeiss 902
electron microscope. Photographs were recorded with Kodak EM film.
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Results

-aminopropionitrile recapitulates the notochord phenotype of copper deficiency
Copper deficiency, induced by either chemical (neocuproine) or genetic (calamityvu69)
means, results in a pleiotropic phenotype that includes a distorted, wavy notochord (14).
Lysyl oxidases are copper-dependent enzymes that stabilize extracellular matrix by
crosslinking elastin and collagens (35, 43), a process thought to be important for
maintaining notochord sheath integrity during notochord vacuolation. aminopropionitrile irreversibly inhibits lysyl oxidases by binding the active site of the
catalytic domain (48, 49), and incubation of 3 hpf zebrafish embryos with βaminopropionitrile resulted in striking notochord distortion and blunted somites, similar
to what is observed with the copper chelator neocuproine (Fig. 1 and S. Fig. 1).
Equivalent results were also obtained after incubation with semicarbazide, another known
inhibitor of lysyl oxidases (data not shown), suggesting that these enzymes play a central
role in notochord formation. β-aminopropionitrile treatment does not result in the
pleiotropic phenotype of copper deficiency, including absence of melanin pigmentation,
midbrain-hindbrain degeneration, and loss of red blood cells (Fig. 1B vs. 1C), reflecting
the broader scope of cuproenzyme inhibition achieved with neocuproine. Furthermore,
the effect of -aminopropionitrile on notochord morphology was not due to copper
chelation as this phenotype was not reversible with CuCl2 (data not shown). Although the
notochord distortion observed with -aminopropionitrile in Figure 1 is less than that with
neocuproine, the mechanisms resulting in this process are likely the same because ten-
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fold higher doses of -aminopropionitrile result in a degree of distortion identical to that
seen with neocuproine (S. Fig. 1).
The zebrafish genome encodes eight lysyl oxidases
These data suggested a requirement for lysyl oxidase activity in zebrafish notochord
development. The human genome encodes five lysyl oxidase family members
characterized by the presence of a conserved copper binding domain and residues for a
lysyl-tyrosyl quinone cofactor. Although experimental evidence suggests a role for two of
these lysyl oxidases in elastin and collagen crosslinking (50-54), the precise role of each
family member in extracellular matrix formation, cancer biology, and intracellular
signaling remains undetermined. Using a bioinformatic approach, we identified and
cloned eight unique zebrafish lysyl oxidase genes, revealing that each human lysyl
oxidase has a zebrafish orthologue except LOXL4 (Fig. 2 and S. Fig. 2). While lysyl
oxidase genes are well conserved between humans and zebrafish based on nucleotide
sequence alignment, Loxl3a and Loxl3b lack a signal peptide and the full complement of
scavenger receptor domains found in human LOXL3 (Fig. 2A and S. Fig. 2). Our analysis
also revealed two novel zebrafish lysyl oxidases, Loxl5a and its paralogue Loxl5b, that
are closely related to LOX and LOXL1 by phylogenetic analysis but have not been
previously described in other species (Fig. 2B and S. Fig. 2A). The presence of
paralogues for some zebrafish lysyl oxidases likely reflects a genome duplication event
and subsequent partitioning of gene function (55, 56).
Four lysyl oxidases are expressed throughout the developing notochord
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To elucidate the role of specific lysyl oxidases in notochord formation, we assessed lysyl
oxidase mRNA expression in zebrafish embryos by whole-mount in situ hybridization.
Four lysyl oxidase family members – loxl1, loxl2b, loxl3b, and loxl5b – were readily
detected throughout the notochord during early zebrafish development (Fig. 3), and were
specifically expressed within the vacuolar cells, as seen in frozen sections of 15 somite
embryos (Fig. 4). Lysyl oxidase expression was observed as early as the 5 somite stage
(Fig. 3A,M), well before notochord vacuolation begins, and was extinguished after
vacuolation is complete, between 24 hpf and 48 hpf (data not shown). While loxl1 and
loxl5b were robustly expressed at the caudal tip (Fig. 3D,P, arrowheads), loxl2b and
loxl3b were not (Fig. 3H,L), possibly reflecting a differential requirement for their
activity during notochord elongation. Closer inspection revealed that loxl5b is expressed
anterior to the notochord, in the prechordal plate region (Fig. 3O, asterix), and that loxl1
is expressed in the hypochord (Fig. 4A, arrows), providing a new marker for this
structure and suggesting a role for loxl1 in crosslinking extracellular matrix near the
developing aorta (57, 58). lox, loxl3a, and loxl5a were not expressed in or near the
notochord between the 5 somite stage and 48 hpf, but could be detected by 5 dpf, while
loxl2a was faintly and transiently expressed in a limited region of the anterior notochord
before 24 hpf and was not studied further (data not shown).
Morpholino knockdown of loxl1 or loxl1 and loxl5b together results in a distorted
notochord
To determine the precise developmental functions of individual lysyl oxidases expressed
throughout the notochord, we conducted knockdown experiments using morpholino
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antisense oligonucleotides (Fig. 5 and Table 1). Whereas control morpholino had no
observable effect on developing zebrafish embryos (Fig. 5A and Table 1), a splice
morpholino to loxl1 recapitulated the notochord distortion and blunted somites observed
with -aminopropionitrile and neocuproine (Fig. 5B and Table 1), revealing that this
family member is necessary for late notochord formation in zebrafish. Morpholino
knockdown of loxl2b, loxl3b, and loxl5b induced minor changes to notochord
architecture, including occasional notochord kinks (Fig. 5C-E and Table 1), and the
loxl5b morpholino also caused caudal vein edema (Fig. 5E, arrows). In all cases, a
specific effect of these splice morpholinos on lysyl oxidase gene transcription was
confirmed by demonstrating abnormal splicing and generation of a premature stop codon
(S. Fig. 3 and data not shown). Since very few embryos injected with morpholinos to
loxl2b, loxl3b, and loxl5b alone developed the distorted notochord phenotype at high
morpholino doses (Fig. 5C-E and Table 1), we tested all possible combinations of lysyl
oxidase morpholinos. Morpholino doses of loxl1 and loxl5b that did not result in
notochord distortion when used alone, together recapitulated the notochord phenotype
and blunted somites observed with -aminopropionitrile and neocuproine (Fig. 5F and
Table 1). This was the only morpholino combination resulting in a notochord phenotype
(Table 1 and S. Table 1), and was similarly recapitulated with morpholinos targeting the
start sites of loxl1 and loxl5b (Table 1 and S. Fig. 1). Taken together, these observations
indicate that these two lysyl oxidases have specific overlapping functions in notochord
development. The notochord distortion elicited by combined knockdown of loxl1 and
loxl5b (Fig. 5F and Table 1) was specifically rescued with co-injection of either loxl1 or
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loxl5b mRNA (Fig. 5H,I and Table 2), but not control mRNA (Fig. 5G and Table 2).
Importantly, each of the lysyl oxidase splice morpholinos also resulted in head necrosis
(Fig. 5B-E) that was not rescued with specific mRNA injection (data not shown),
suggesting that this phenotype results from a non-specific morpholino effect. Consistent
with this concept, head necrosis is not observed following treatment with either aminopropionitrile or neocuproine (S. Fig. 1).
Nutrient, gene interactions in notochord distortion
Since the notochord phenotype observed with combined loxl1 and loxl5b knockdown is
identical to that seen with -aminopropionitrile and neocuproine, we next examined the
interaction of copper availability and lysyl oxidase gene expression in notochord
formation (Fig. 6). For these experiments, doses of loxl5b morpholino and neocuproine
were determined such that they did not cause notochord distortion when used alone (Fig.
6B,C and Table 3). In striking contrast, embryos subjected to combined treatment with
these same doses of loxl5b morpholino and neocuproine developed distorted notochords
(Fig. 6D and Table 3). Experiments using loxl1 morpholino and neocuproine yielded
similar results (Table 3), supporting the model that specific inhibition of two lysyl
oxidases accounts for the notochord abnormalities observed with -aminopropionitrile
and neocuproine. Most significantly, these data also reveal that copper availability
influences the phenotypic outcome of notochord development according to the genetic
content of the embryo.
In this context, we also examined the role of collagen II, a structural component
of the notochord sheath, in notochord formation. Collagen II is a lysyl oxidase substrate
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whose spatio-temporal pattern of expression corresponds with that of the notochordexpressed lysyl oxidases during early zebrafish development (44). We determined the
highest dose of col2a1 morpholino that could be injected without phenotypic
abnormalities (Fig. 6E), and incubated these injected embryos in a dose of neocuproine (2
M) that was also without effect. This combined treatment resulted in notochord
distortion (data not shown), revealing the importance of copper nutrition in the context of
collagen II disruption and predicting a genetic interaction between collagen II and the
notochord-expressed lysyl oxidases. Consistent with this prediction, about half of the
embryos injected with loxl5b and col2a1 morpholinos together revealed a conspicuously
distorted notochord (Fig. 6F and Table 4), demonstrating that decreased expression of
loxl5b sensitizes embryos to col2a1 disruption. A comparable result was also obtained
using the loxl1 and col2a1 morpholinos (Table 4). The specificity of this effect was
confirmed by detection of a splicing defect resulting from the col2a1 morpholino that
causes a premature stop codon (S. Fig. 3 and data not shown). The observation that in
each case only about 50% of the embryos displayed the abnormal notochord phenotype
may be due either to additional lysyl oxidase substrates that play a role in notochord
formation or to submaximal disruption of col2a1 gene expression at this morpholino dose
(S. Fig. 3). Taken together, these data illustrate the complex interplay of multigenic
expression and nutrition required for notochord formation in developing zebrafish
embryos.
col2a1 expression persists in notochord vacuolar cells after lysyl oxidase inhibition
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The foregoing experiments suggest that collagen II is a substrate for both Loxl1 and
Loxl5b in zebrafish. As recently demonstrated (59), col2a1 expression persists in the
vacuolar cells of the notochord at 24 hpf when embryos are treated with a dose of
neocuproine that causes notochord distortion (Fig. 7B). One possible explanation for this
phenomenon is impairment of a feedback mechanism that normally downregulates
production of col2a1 upon collagen crosslinking in the notochord sheath. Consistent with
this idea, embryos treated with -aminopropionitrile (Fig. 7C) or injected with
morpholinos to loxl1 and loxl5b (Fig. 7D) continued to express col2a1 in the vacuolar
cells of the notochord at 24 hpf, whereas control embryos did not (Fig. 7A). The
persistent expression of col2a1 was not due to developmental delay, as embryos added
somites at the same rate under all experimental conditions (data not shown).
We next considered whether the persistent col2a1 expression was specific to a
reduction in crosslinking or was a generalized response to mechanical distortion of the
notochord. To explore this idea, we incubated embryos in a dose of neocuproine (2 M)
that did not cause notochord distortion but that partially disrupted crosslinking, as
revealed by the combined neocuproine and loxl5b studies. Persistent col2a1 expression
was observed within the notochord vacuolar cells at 24 hpf under these conditions (S.
Fig. 4), similar to what is observed in neocuproine-treated embryos incubated with
anesthetic to prevent notochord distortion (59). These data are consistent with a feedback
mechanism originating from the products of the crosslinking process.
The col2a1 expression data suggest a model where lysyl oxidase inhibition affects
the final stages of notochord development at a time when the extracellular matrix
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components, including collagen II, are already in place in the notochord sheath. The
notochord sheath in zebrafish is composed of three distinct layers: an internal basal
lamina, a middle fibrillar layer, and an external granular layer (Fig. 8A) (16, 60).
Inspection of the notochord sheath by electron microscopy revealed that inhibition of
lysyl oxidase activity by neocuproine, -aminopropionitrile, or combined loxl1 and
loxl5b knockdown was without effect on these layers (Fig. 8B-D). This observation is
consistent with the idea that lysyl oxidase inhibition alters the final stages of notochord
sheath formation.
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Discussion
These studies reveal an essential role for two specific lysyl oxidase genes, loxl1 and
loxl5b, in notochord formation, and demonstrate a complex interplay of gene expression
and nutrient availability that is relevant to the pathogenesis of human structural birth
defects (Fig. 9A,B). A role for lysyl oxidases in notochord formation was hypothesized
from previous work using small molecules (14, 32), and our current data establish a
genetic basis for this pharmacologic notochord distortion. Various lysyl oxidases have
been implicated in tumor metastasis, wound healing, cardiac fibrosis and elastin fiber
homeostasis (50, 54, 61, 62). However, the precise function of individual lysyl oxidase
family members in development has been difficult to discern given the lack of inhibitors
unique to any given enzyme. This study is the first to demonstrate that genetic deficiency
of specific lysyl oxidases results in notochord distortion, and elucidates a specific and
novel interaction between gene function (lysyl oxidases) and nutrition (copper) during
development. While it is logical that copper-dependent enzymes such as lysyl oxidases
would be inactive in the complete absence of copper, it is more difficult to predict the
effect of mild copper deficiency on enzyme activity, and more importantly, to determine
what components of the developing notochord would become essential in the setting of
impaired – but not absent – lysyl oxidase function. The specific role for loxl1 and loxl5b
in notochord formation is supported by sensitization experiments using neocuproine (Fig.
6 and Table 3), and these genes may be candidates for late notochord mutants identified
in previous forward genetic screens (17, 18) or for human disorders of the axial skeleton.
Though we cannot completely rule out the possibility that the low penetrance of a
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distorted notochord phenotype using splice morpholinos to loxl2b, loxl3b, or loxl5b alone
(Table 1) results from incomplete disruption of gene expression (S. Fig. 3), combinations
involving these morpholinos did not convincingly demonstrate a role for loxl2b or loxl3b
in notochord formation (Table 1 and S. Table 1).
Our data also demonstrate a genetic interaction between two lysyl oxidases (loxl1
and loxl5b) and the collagen substrate col2a1 (Fig. 6). This could reflect either direct
crosslinking of this collagen substrate or crosslinking of additional extracellular matrix
proteins that interact with collagen II for proper notochord formation. The latter
possibility has been proposed in recent morphological studies on the notochord sheath of
teleosts (63) and could account for observations in coatomer I protein complex mutants
(19), where defects in the secretion of lysyl oxidases or additional such extracellular
matrix components would give rise to the notochord sheath abnormalities. In all cases,
reduced crosslinking of collagen fibrils from impaired lysyl oxidase activity would
prevent the feedback inhibition of col2a1 produced by notochord vacuolar cells, resulting
in prolonged col2a1 expression (Fig. 7). Alternatively, persistent col2a1 expression could
result indirectly from a general loss of notochord sheath integrity.
The observed lysyl oxidase expression patterns and phenotypes (Fig. 3, Fig. 4,
Fig. 5 and data not shown) suggest that the zebrafish will be a useful model organism for
elucidating the complex and specific roles of lysyl oxidases in development. In addition,
the phylogenetic analysis (Fig. 2B) may prove helpful. The lack of a zebrafish orthologue
to LOXL4 is consistent with a BLAST search revealing such orthologues only in
mammals (data not shown), and the markedly different expression patterns of this gene in
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human and mouse (64-66) may indicate that it has divergent, specialized roles in these
organisms. Moreover, it is now apparent that scavenger receptor, cysteine-rich domains
are a more variable feature of lysyl oxidase structure than previously anticipated.
LOXL2, LOXL3, and LOXL4 are considered related because they all possess four
scavenger receptor, cysteine-rich domains, which are completely absent in LOX and
LOXL1. However, zebrafish loxl3a and loxl3b encode only a single scavenger receptor,
cysteine-rich domain that is truncated (Fig. 2A), as does a Xenopus clone of loxl3
previously assumed to be partial (S. Fig. 2C) (32). While the function of these domains
remains unknown, a splice variant of LOXL3 that excludes some scavenger-receptor,
cysteine-rich domains has recently been described, and appears to have altered substrate
specificity (67).
Definitive demonstration of a role for specific lysyl oxidases in notochord
formation is of direct relevance to embryonic environmental exposures to nitrile
compounds in plasticizers and carbamates in pesticides. Recent toxicological studies
demonstrate that such pesticides induce notochord distortion in developing zebrafish
embryos (59, 68) as well as persistent expression of col2a1 by vacuolar cells of the
notochord (59). These findings are identical to our observations with loxl1, loxl5b, and
col2a1 morpholino knockdown combined with neocuproine treatment (Fig. 5B,F, Fig. 6
and Fig. 7), suggesting that the pesticides act through direct or indirect inhibition of these
lysyl oxidase family members. Importantly, these data raise the distinct possibility that
embryonic exposure to such toxins in specific genetic contexts may predispose to the
later development of structural birth defects (Fig. 9B), where the inheritance of this
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genetic variation would not be reflected in Mendelian ratios of the observable
phenotypes.
The notochord is a critical structure required for vertebral column patterning in
vertebrates (69) and its distortion in zebrafish phenotypically mimics a number of axial
skeletal defects in humans including idiopathic scoliosis. Of note, while aminopropionitrile causes notochord distortion in zebrafish (Fig. 1B and S. Fig. 1), it is
also well known to cause scoliosis in rats and other mammals (70). Interestingly,
disruptions in extracellular matrix components involved in notochord formation have
been identified in clinical syndromes that include scoliosis. Two different mutations in
exon 48 of the COL2A1 gene cause spondyloepiphyseal dysplasia with scoliosis in
humans (71, 72). Furthermore, the kyphoscoliosis type of Ehler-Danlos syndrome (EDS
VI) (73) results from loss of function mutations in the gene encoding lysyl hydroxylase
type 1, which catalyzes the conversion of lysine to hydroxylysine in collagen prior to
oxidization by lysyl oxidases. Taken together with the nutritional (copper) and toxicology
findings noted above, these data raise the intriguing possibility that polymorphisms at
multiple extracellular matrix component loci, including the lysyl oxidase genes identified
here, may predispose to axial skeletal malformations in situations where nutrition or
environment might otherwise be considered adequate (Fig. 9B). This concept is
supported by our previous findings revealing a hierarchy of nutrient distribution to the
developing embryo under limiting conditions (14) and as such is of broad relevance to
our understanding of the pathogenesis of structural birth defects. The data reported here
provide a testable model for these ideas with regards to common defects of the axial
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skeleton and reveal that zebrafish permit unique insights into the complex interplay of
genes, environment and nutrition in development and disease.
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Figure legends
Fig. 1. β-aminopropionitrile recapitulates the notochord phenotype of copper
deficiency. Wild-type embryos were incubated in vehicle (A), 10 M neocuproine (B), or
10 mM -aminopropionitrile supplemented with 10 M CuCl2 (C). At 48 hpf, the
notochord (arrowheads) is distorted in embryos treated with neocuproine (B) and aminopropionitrile (C); however, melanocytes (arrows) are present after aminopropionitrile (C) but not neocuproine treatment (B), demonstrating thataminopropionitrile does not act through copper chelation.
Fig. 2. Lysyl oxidase family members in zebrafish. (A) The zebrafish genome encodes
eight distinct lysyl oxidases, all of which contain a conserved copper binding domain
depicted in yellow. Scavenger receptor, cysteine-rich domains (SRCR) of unknown
function are in blue and are truncated in Loxl3a and Loxl3b (SR with strikethrough). (B)
Phylogenetic tree depicting the evolutionary relationship between human and zebrafish
lysyl oxidases. HsCD163 is used as an outgroup, and bootstrap values over 100 replicates
are noted. Loxl5a and Loxl5b (green) represent new additions to the lysyl oxidase family
that closely resemble LOX and LOXL1 in structure. Zebrafish encode orthologues to all
human lysyl oxidase genes except LOXL4.
Fig. 3. Four lysyl oxidases are expressed throughout the developing zebrafish
notochord by in situ hybridization. (A-D) loxl1; (E-H) loxl2b; (I-L) loxl3b; and (M-P)
loxl5b. Stages of development are 5 somites (A,E,I,M); 10 somites (B,F,J,N); 15 somites
(C,G,K,O); and 20 somites (D,H,L,P). loxl1 and loxl5b are robustly expressed at the
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caudal notochord tip (arrowheads) while loxl5b is also expressed anterior to the
notochord (asterix).
Fig. 4. Lysyl oxidases are expressed by notochord vacuolar cells. (A-D) Frozen crosssections of 15 somite embryos were obtained after in situ hybridization with the
following probes: (A) loxl1; (B) loxl2b; (C) loxl3b; and (D) loxl5b. The notochord is
indicated (arrowheads). Hypochord staining of loxl1 (arrows) suggests a role for this
family member in extracellular matrix crosslinking near the developing aorta. (E)
Cartoon demonstrating the location of the hypochord (h) and floorplate (f), which are
closely apposed to the notochord (n). Lysyl oxidases are not expressed in the floorplate.
Fig. 5. Morpholino knockdown of loxl1 or loxl1 and loxl5b together results in
notochord distortion. Wild-type embryos were injected with morpholinos (MO) to
notochord-expressed lysyl oxidases and photographed at 24 hpf. (A) 12 ng standard
control; (B) 6 ng loxl1; (C) 3.7 ng loxl2b; (D) 12 ng loxl3b; (E) 7.4 ng loxl5b; (F) 2.4 ng
loxl1 and 5 ng loxl5b. The notochord (arrowheads) is strikingly distorted after
knockdown of loxl1 (B), and caudal vein edema develops with the loxl5b morpholino (E,
arrows). Combining doses of loxl1 and loxl5b morpholino that do not cause notochord
distortion alone also recapitulates the notochord phenotype seen with neocuproine and aminopropionitrile treatment (F). This distortion is specifically rescued by co-injection of
mRNA encoding either loxl1 (H) or loxl5b (I), but not control sequence (G).
Fig. 6. Partial knockdown of loxl5b sensitizes embryos to notochord distortion in the
presence of suboptimal copper nutrition (A-D) or disruption of col2a1 (E,F). Wildtype embryos were injected with 5 ng of control morpholino (A,C) or loxl5b morpholino
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(B,D), and incubated with (C,D) or without (A,B) 2 M neocuproine starting at 3 hpf.
Embryos injected with loxl5b morpholino develop notochord distortion (arrowhead) in
the context of diminished copper availability (D). Embryos injected with 7.4 ng of col2a1
morpholino (E) are sensitized to develop notochord distortion (arrowhead) upon coinjection of 5 ng of loxl5b morpholino (F), demonstrating a genetic interaction between
col2a1 and loxl5b. Photographs were obtained at 30 hpf (A-D) and 24 hpf (E,F).
Fig. 7. Expression of col2a1 mRNA by notochord vacuolar cells persists late
following lysyl oxidase inhibition. Wild-type embryos were injected with 7.4 ng control
morpholino (A), incubated in 10 M neocuproine (B), incubated in 10 mM aminopropionitrile supplemented with 10 M CuCl2 (C), or injected with 3.7 ng each of
loxl1 and loxl5b morpholino (D). In situ hybridization was carried out at 24 hpf, and
frozen sections confirmed persistent col2a1 expression following lysyl oxidase inhibition
(B-D, arrowhead), as well as floorplate and hypochord staining (A-D, arrows).
Fig. 8. Electron micrographs of the notochord sheath from cross-sections of 30 hpf
embryos: (A) 7.4 ng control morpholino; (B) 10 M neocuproine; (C) 10 mM aminopropionitrile; (D) 3.7 ng each of loxl1 and loxl5b morpholino. Sheath components
include a basal lamina (I), fibrillar layer (II), and granular layer (III). All three layers are
preserved after lysyl oxidase inhibition.
Fig. 9. Model of pathways involved in notochord formation. (A) The cuproenzymes
Loxl1 and Loxl5b crosslink collagen II in the notochord sheath, which suppresses
vacuolar cell expression of col2a1 as the notochord differentiates. (B) Polymorphisms at
multiple genetic loci interact with environmental factors to cause disease. As a result,
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what is normally considered adequate nutrition may in fact be suboptimal during a
specific developmental window. The gene atp7a encodes a transporter required for
copper uptake (14).
Table 1. loxl1 is necessary for notochord formation in developing zebrafish
embryos, and overlaps in function with loxl5b. Wild-type embryos were injected with
morpholinos to notochord-expressed lysyl oxidases and examined at 24 hpf. The number
and percentage of embryos with and without a distorted notochord phenotype is noted.
Injection of 6 ng of loxl1 splice morpholino causes notochord distortion in 88% of
embryos, an effect not seen with morpholinos to loxl2b, loxl3b, or loxl5b alone. However,
injection of 2.4 ng of loxl1 morpholino and 5 ng of loxl5b morpholino together causes
notochord distortion in 94% of embryos, demonstrating that loxl1 and loxl5b have
overlapping roles in notochord formation. This finding was recapitulated in separate
experiments with start site (ATG) morpholinos to loxl1 and loxl5b. The number of
embryos examined includes dead embryos that could not be scored for notochord
phenotype; the loxl2b morpholino causes significant embryo death at higher doses. Data
shown are the pooled results of three independent experiments.
Table 2. The distorted notochord phenotype resulting from combined loxl1 and
loxl5b knockdown is specific and can be rescued by co-injection of mRNA encoding
either loxl1 or loxl5b. Wild-type embryos injected with control or loxl1 and loxl5b
morpholinos together were co-injected with control or lysyl oxidase mRNA, as indicated.
The number and percentage of embryos with and without a distorted notochord
phenotype at 24 hpf is noted, as well as the percentage rescue attributable to each mRNA.
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Exogenously-supplied loxl1 or loxl5b mRNA produces a marked improvement in
notochord morphology, substantially decreasing the proportion of embryos with
notochord distortion. Injection of lysyl oxidase mRNA alone did not result in any
overexpression phenotype. The number of embryos examined includes dead embryos that
could not be scored for notochord phenotype. Data shown are the pooled results of three
independent experiments.
Table 3. Partial knockdown of loxl1 or loxl5b sensitizes embryos to notochord
distortion in the presence of suboptimal copper nutrition. Wild-type embryos were
injected with control or lysyl oxidase-specific morpholino, as indicated, and incubated
with or without neocuproine at doses that were determined not to cause notochord
distortion alone. Embryos injected with lysyl oxidase-specific morpholino and incubated
in 2 M neocuproine were sensitized to develop notochord distortion. The number of
embryos examined includes dead embryos that could not be scored for notochord
phenotype. Each result is pooled from three independent experiments, which were scored
at 24 hpf.
Table 4. Genetic interaction of loxl1 and loxl5b with col2a1. Wild-type embryos were
injected with the indicated morpholino combinations and scored for notochord distortion
at 24 hpf. Partial knockdown of loxl1 and col2a1 together, but not alone, causes the
distorted notochord phenotype. An identical result is obtained with morpholinos to loxl5b
and col2a1, suggesting that diminished activity of these lysyl oxidases sensitizes embryos
to notochord distortion in the presence of col2a1 disruption. Importantly, collagen II is a
lysyl oxidase substrate produced by the notochord vacuolar cells and present in the
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notochord sheath. The number of embryos examined includes dead embryos that could
not be scored for notochord phenotype. Each result is pooled from three independent
experiments.
S. Fig. 1. Comparison of the notochord distortion obtained in zebrafish using three
distinct methods of lysyl oxidase inhibition at 24 hpf. Wild-type embryos were
incubated in 10 M neocuproine (A), 10 mM -aminopropionitrile supplemented with 10
M CuCl2 (B), 100 mM -aminopropionitrile supplemented with 10 M CuCl2 (C), or
injected with 6 ng each of loxl1 and loxl5b start (ATG) morpholino (D). 10 M
neocuproine (A) causes greater notochord distortion than 10 mM -aminopropionitrile
(B), but an identical phenotype is obtained with 100 mM -aminopropionitrile (A vs. C).
Melanin pigmentation has not yet developed in the embryos pictured, but is not affected
by -aminopropionitrile treatment or by the morpholino injection.
S. Fig. 2. Protein sequence alignment of zebrafish lysyl oxidase family members with
human orthologues. (A) lox, loxl1, loxl5a, and loxl5b; (B) loxl2a and loxl2b; (C) loxl3a
and loxl3b with Xenopus laevis clone XL051k10 included for comparison. A number of
conserved elements are indicated including predicted signal peptides (bold, underlined),
BMP-1 cleavage sequences (bold, italicized), scavenger receptor cysteine-rich domains
(gray, underlined), copper binding domains (gray), and lysyl-tyrosyl quinone cofactor
residues (bold).
S. Fig. 3. Lysyl oxidase and collagen II splice morpholinos decrease the abundance
of wild-type splice forms and cause specific changes in splice site usage. (A) loxl1 (B)
loxl2b (C) loxl3b (D) loxl5b and (E) col2a1. Wild-type embryos injected with the
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indicated doses of morpholino were harvested at 20 hpf and cDNA prepared from equal
amounts of RNA. The intensity of the wild-type (WT) product obtained by PCR was
quantified and the percentage of wild-type splice form remaining after morpholino
knockdown determined, as noted. This measure is independent of processes that may
depress levels of the mutant (Mut) splice products, including degradation through
nonsense-mediated decay. The primer set used to amplify loxl1 does not amplify the
mutant band.
S. Fig. 4. Persistent expression of col2a1 by notochord vacuolar cells after lysyl
oxidase inhibition is not due to mechanical distortion of the notochord. Wild-type
embryos incubated with (B) or without (A) 2 M neocuproine were probed for col2a1
expression at 24 hpf. col2a1 expression persists in the notochord vacuolar cells after
treatment with 2 M neocuproine, which affects crosslinking but does not cause
mechanical distortion. This suggests that the signal to downregulate col2a1 expression in
the vacuolar cells of the notochord originates from the products of the crosslinking
reaction.
S. Table 1. Morpholinos to combinations of lysyl oxidase family members other than
loxl1 and loxl5b do not result in notochord distortion. Wild-type embryos were
injected with the indicated morpholino doses and examined at 24 hpf for notochord
distortion. The number of embryos examined includes dead embryos that could not be
scored for notochord phenotype. Each result is pooled from three independent
experiments.
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Figure 1
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Figure 2

39

Figure 3

40

Figure 4
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Figure 5
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Specific Morpholino

Dose of
morpholino (ng)
12
Ctrl
6
loxl1
2.4
loxl2b
12
loxl3b
5
loxl5b
2.4
loxl1
2.4/5
loxl1/loxl5b
12
Ctrl
12
loxl1 ATG
12
loxl5b ATG
6/6
loxl1 ATG/loxl5b ATG
*p < 0.01 versus controls by ANOVA

# of embryos
examined
302
271
212
190
263
297
292
173
158
159
188

Table 1
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Phenotype of notochord distortion
+
278 (100%)
0 (0%)
30 (12%)
217 (88%*)
122 (98%)
3 (2%)
128 (96%)
6 (4%)
237 (98%)
6 (2%)
272 (99%)
2 (1%)
17 (6%)
254 (94%*)
138 (100%)
0 (0%)
145 (100%)
0 (0%)
140 (92%)
12 (8%)
33 (19%)
145 (81%*)

Specific
Morpholino

Dose of
morpholino
(ng)
7.4

Specific
mRNA

# of embryos
examined

Phenotype of notochord
distortion
+
Ctrl
240
226
0 (0%)
Ctrl
(100%)
2.4/5
Ctrl
223
8 (4%)
195 (96%)
loxl1/loxl5b
2.4/5
loxl1
238
137 (63%) 80 (37%*)
loxl1/loxl5b
2.4/5
loxl5b
251
197 (86%) 33 (14%*)
loxl1/loxl5b
*p < 0.01 versus loxl1/loxl5b MO with Ctrl mRNA by ANOVA

Table 2
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Rescue of
notochord
phenotype
NA
NA
62%
85%

Figure 6
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Specific
Morpholino

Dose of
Pharmacologic
morpholino
treatment
(ng)
2.4
None
Ctrl
2.4
Ctrl
2 M neocuproine
2.4
None
loxl1
2.4
loxl1
2 M neocuproine
5
None
Ctrl
5
Ctrl
2 M neocuproine
5
None
loxl5b
5
loxl5b
2 M neocuproine
*p < 0.01 versus controls by ANOVA

# of embryos
examined
104
113
143
132
139
138
147
147

Table 3
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Phenotype of notochord
distortion
+
104 (100%)
0 (0%)
111 (98%)
2 (2%)
127 (100%)
0 (0%)
49 (39%)
77 (61%*)
136 (100%)
0 (0%)
132 (99%)
2 (1%)
126 (95%)
7 (5%)
1 (1%)
140 (99%*)

Specific Morpholino

Dose of
morpholino (ng)
2.4 /7.4
loxl1/ctrl
7.4 /2.4
col2a1/ctrl
7.4/2.4
col2a1/loxl1
5/7.4
loxl5b/ctrl
7.4/5
col2a1/ctrl
7.4/5
col2a1/loxl5b
*p < 0.01 versus controls by ANOVA

# of embryos
examined
202
206
258
151
122
217

Table 4
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Phenotype of notochord distortion
+
146 (99%)
1 (1%)
161 (98%)
4 (2%)
118 (58%)
84 (42%*)
137 (93%)
10 (7%)
116 (99%)
1 (1%)
111 (54%)
96 (46%*)

Figure 7
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Figure 8

49

Figure 9
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Supplementary Figure 1
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A
HsLOX
DrLox
HsLOXL1
DrLoxl1
DrLoxl5a
DrLoxl5b

MRFAWTVLLLGPLQLCALVHCAPPAAGQQQPPREPPAAPGAWRQQIQWENNGQVFSLLSL
MSMSLIDTFIYAFAHVCLLSCIAQTG---QTQRQGNTGAAALRQTIQWQHNGKLFSILSQ
MALARGSRQLGALVWGACLCVLVHGQ---QAQPGQGSDPARWRQLIQWENNGQVYSLLNS
--------MLHVLLMSLWVLGSVTGQ---SQS--QPDDTNPWRQMIQWENNGRVYSLLNS
--MTKYSFIFCLSIHLCVLVFLNTAQ-----------NHGAWQHKVKWETNGQVYSLLSA
MFFTISNFIFFLYL-LQGLNNLTSAQ-----------SSAQWRNRVRWVNNGQVFSLMST
:
:
:: ::* **:::*::.

60
57
57
47
47
48

HsLOX
DrLox
HsLOXL1
DrLoxl1
DrLoxl5a
DrLoxl5b

GSQYQPQ--RRRDP----------GAAVPGAANASAQQPRTPILLIRDNRTA------AA
GSEYQPP--LKRD-----------GNKEQAQARPVAIVRNDDAATRTDSSAP------SR
GSEYVPAGPQRSES----------SSRVLLAGAPQAQQRRSHGSPRRRQAPSLPLPGRVG
GAEYVPARNQERDR----------NHRVLLADAP---NRRSQGGNVRRQAPS-----RGS
SSQYHAPASGKQHARFLLRRQIIPSFTGRIFMGQFAKTRMHTAGHVVRSSPVPGHIGLNA
GSEFHAPVPSRRQSRVYQ------SSRTDAVPGRSMQIRLEAMDRPANSAPDSALLGPDR
.::: .
. .
.
. .

102
98
107
89
107
102

HsLOX
DrLox
HsLOXL1
DrLoxl1
DrLoxl5a
DrLoxl5b

RTRTAGSSGVTAGR-PRPTARHWFQAGYSTSRARERGASRAENQTAPGEVPALSNLRPPS
ASQSRGSVRVPSGTGARGGASRWLSG----DGARTRGVHGRRNHTDP-LRSINGTDRPAG
SDTVRGQARHPFGFGQVPDNWREVAVGDSTGMARARTSVSQQRHGG--SASSVSASAFAS
SETVRGQARHPFGFGQVPENWRQQQG----AVGRSETSRFQSQTGSRYRPSSGASSSASS
KHMISGHIRNNNQLPLHAKKVAFSSD----ETLRTQTWPYRTSPTGTTTHGPVKNSEISR
AQYIMANSRAPGARQMQVMQRHRAPP----ASRNNSTVPSEYSGGGGRTG------ENTR
.
.
.

161
153
165
145
163
152

HsLOX
DrLox
HsLOXL1
DrLoxl1
DrLoxl5a
DrLoxl5b

RV--------------------------------------------DGMVG--------DD--------------------------------------------EVMVG--------TYRQQPSYPQQFPYPQAPFVSQYENYDPASRTYDQGFV---YYRPAGGGVGAGAAAVASA
SYPQYP-IPQ-----QPPFGAPYDQVS--DRSYEPPFLGTGYSAGTGGGFGGGSYGGYST
APKQHK--------------------------------------ITSQPVAKQPSPATGK
R---------------------------------------------GQAVAN-------..

168
160
222
197
185
159

HsLOX
DrLox
HsLOXL1
DrLoxl1
DrLoxl5a
DrLoxl5b

------------------------------------------------DDPYNPYKYSD------------------------------------------------DDPYNPYKSTDP
GVIYPYQPRARYEEYGGGEELPEYPPQGFYPAPERPYVPPPPPPPDGLDRRYSHSLYSEG
GSFGGGNP-ANDDRYR------FYPPFG-QQYQAVPAQPAQPPFSDGLDHRYTHSLFNED
PPTPEEKQHAKPQPIS-----------NATNKSKLSPSLDAPSASGNVRNVRNPLVQVEA
-----FQQIAAPTDNS-----------NTVN-------------SDNENEARTPNVPAEQ
.
:

179
172
282
249
234
190

HsLOX
DrLox
HsLOXL1
DrLoxl1
DrLoxl5a
DrLoxl5b

--------------------DNPYYNYYDTYERPRP-------------------------------------------DNPYYNYYDTYERPRP-----------------------TPGFEQAYPDPGPEAAQAHGGDPRLGWYPPYANPPPEAYGPPRALEPPYLPVRSSDTPPP
NPAVPNGASSNTGSSFQPAVQSPQYEQFPPYGRPQP---------QPPFLQPAPRNPLVS
RG-GESMIDDEPTN--HQANRNSFYNLLPYGNTNRS-----------------------GATSETMPGDDPRN--RNT---VFYNIYPPGGRTII------------------------

195
188
342
300
267
221

HsLOX
DrLox
HsLOXL1
DrLoxl1
DrLoxl5a
DrLoxl5b

------GGRYRPGYGTGYFQYG----LPDLVADPYYIQASTYVQKMSMYNLRCAAEENCL
------AQ--RPGYGTGYFQNG----LPDLVGDPYYIQASTYVQRVPMYNLRCAAEENCL
GGERNGAQQGRLSVGSVYRPNQNGRGLPDLVPDPNYVQASTYVQRAHLYSLRCAAEEKCL
----NTAENPNINVGSVYRPQQ--RGLPDLVPDPNYVQASTYVQRAHMYSLRCAAEEKCL
----PQRE---TGHGTRYFLNG----LPDLIPDPYYIQAASYIQRVQMYTLRCAAEENCL
----PRRPPPGTGYGTRFFQNG----LPDLVPDPYSIQAGSYIQRVQMYALRCAAEENCL
. *: :
****: ** :**.:*:*: :* *******:**

245
236
402
354
316
273

HsLOX
DrLox
HsLOXL1
DrLoxl1
DrLoxl5a
DrLoxl5b

ASTAYRADVRDYDHRVLLRFPQRVKNQGTSDFLPSRPRYSWEWHSCHQHYHSMDEFSHYD
ASSAYRSSVRDYDMRMLLRFPQRVKNQGTSDFLPSRPRYTWEWHSCHQHYHSMDEFSHYD
ASTAYAPEATDYDVRVLLRFPQRVKNQGTADFLPNRPRHTWEWHSCHQHYHSMDEFSHYD
ASSAYNAETTDYSVRVLLRFPQRVKNQGTADFMPNRPRHTWEWHSCHQHYHSMDEFSHYD
SSSAYSSSVRDLDYRVLLRFPQRVKNQGTADFLPVKPHYDWEWHSCHQHYHSMDAFSNYD
ARTAYRPTVRDLDYRVLLRFPQKVRNMGTADFLPVKPRHQWEWHSCHQHYHSMDAFSHYD
: :** . . * . *:******:*:* **:**:* :*:: ************** **:**

305
296
462
414
376
333
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HsLOX
DrLox
HsLOXL1
DrLoxl1
DrLoxl5a
DrLoxl5b

LLDANTQRRVAEGHKASFCLEDTSCDYGYHRRFACTAHTQGLSPGCYDTYGADIDCQWID
LLDATTHRRVAEGHKASFCLEDTSCDYGYYRRYACTSHTQGLSPGCYDTYNADIDCQWID
LLDAATGKKVAEGHKASFCLEDSTCDFGNLKRYACTSHTQGLSPGCYDTYNADIDCQWID
LLEVSSGRKVAEGHKASFCLEDTTCDFGHLKRYACTAHTQGLSPGCFDTYNADIDCQWID
LLDAATGRKVAEGHKASFCLEDTSCDPGVRRRYACTAHTQGLGPGCYDTYHANIDCQWID
LLDISTGRKVAEGHKASFCLEDTGCDPGFHRRYACTAHTQGLSPGCHDTYAANIDCQWID
**: : ::*************: ** * :*:***:*****.***.*** *:*******

HsLOX
DrLox
HsLOXL1
DrLoxl1
DrLoxl5a
DrLoxl5b

ITDVKPGNYILKVSVNPSYLVPESDYTNNVVRCDIRYTGHHAYASGCTISPY
ITDVKPGNYILKVSVNPSYQVPESDYSNNVVRCDVRYTGNYAYVSGCHISQY
ITDVQPGNYILKVHVNPKYIVLESDFTNNVVRCNIHYTGRYVSATNCKIVQS
ITDVQPGNYILKLQVNPKYLVLESDFTNNIVRCNIHYTGRYAKTTNCKISQS
ITDVSPGDYILKVTVNPGFQVQGSDFSNNIVRCDIRYTGLYVQTNNCRITGITDVPPGNYILKVTVNPDFLVAESDFSNNVVRCEVIYTGIYIQTRNCIITG**** **:****: *** : * **::**:***:: *** : . .* *

365
356
522
474
436
393

417
408
574
526
487
444

B
HsLOXL2
DrLoxl2a
DrLoxl2b

MERPLCSHLCSCLAMLALLSPLSLAQYDSWPHYPEYFQQPAPEYHQPQAPANVAKIQLRL 60
------MAVSSA----LCVFGL-------LVLVQAQSELQQ------------PKIELRL 31
-----MLALWSISFVLLCSWRLSYAQYEHLGFAIAYQEPEQDLYTPPELPADTPRIQLRL 55
: *
*
:
.:*:***

HsLOXL2
DrLoxl2a
DrLoxl2b

AGQKRKHSEGRVEVYYDGQWGTVCDDDFSIHAAHVVCRELGYVEAKSWTASSSYGKGEGP 120
AGDKRKHYEGRLEVFYNNEWGTVCDDDFSIEAAHVACRQLGFLGAVAWSPSAKFGQGEGR 91
AGEKRKHNEGRVEVFYEGEWGTVCDDDFTIHAAQVICRELGYFEAISWSPSSKYGKGEGR 115
**:**** ***:**:*:.:*********:*.**:* **:**:. * :*:.*:.:*:***

HsLOXL2
DrLoxl2a
DrLoxl2b

IWLDNLHCTGNEATLAACTSNGWGVTDCKHTEDVGVVCSDKRIPGFKFDNSLINQIENLN 180
IWLDNVHCTGRENSLAACPSNGFGVSDCRHSEDVGVICNQKRIPGHRFINIMNNNIETLE 151
IWFDNVHCKGKEKSLAQCESNGIGVSDCKHSEDVGVVCSDKRIPGFKFVNTLTNNINSLN 175
**:**:**.*.* :** * *** **:**:*:*****:*.:*****.:* * : *:*:.*:

HsLOXL2
DrLoxl2a
DrLoxl2b

IQVEDIRIRAILSTYRKRTPVMEGYVEVKEGKTWKQICDKHWTAKNSRVVCGMFGFPGER 240
ERVEEIRIRPISS-HLKRIPITEGYVEVKEWGKWRQICDEEWTPLNSRVVCGMYGFPGEK 210
IQVEDVRIRPILASYRKRIPVTEGYVEVKDGGKWKQICDDEWTQMNSRVICGMFSFPGQK 235
:**::***.* : : ** *: *******: .*:****..** ****:***:.***::

HsLOXL2
DrLoxl2a
DrLoxl2b

TYNTKVYKMFASRRKQRYWPFSMDCTGTEAHISSCKLGPQVSLDPMKNVTCENGLPAVVS 300
NYNNKVYRSLSMRKKKNYWGFLVNCTGNEAHMSSCRLG--KALEPKRNGTCGRGLPVVVS 268
RYNTRVYKMFARRRKPSYWDYTINCTGKEAHLSSCTLG--HTLS---NSTCEEGTPVVVS 290
**.:**: :: *:* ** : ::***.***:*** **
:*.
* ** .* *.***

HsLOXL2
DrLoxl2a
DrLoxl2b

CVPGQVFSPDGPSRFRKAYKPEQPLVRLRGGAYIGEGRVEVLKNGEWGTVCDDKWDLVSA 360
CVPGRAFAPSSSIGFRKAYRPEQPLVRLRGGANVGEGRVEVLKNGVWGTVCDDNWNLKAA 328
CIPGRAFAPTPMTGYKKAFRQEQPLVRLRGGAVVGEGRVEVLKNGEWGTICDDNWNLLAA 350
*:**:.*:*
::**:: *********** :*********** ***:***:*:* :*

HsLOXL2
DrLoxl2a
DrLoxl2b

SVVCRELGFGSAKEAVTGSRLGQGIGPIHLNEIQCTGNEKSIIDCKFNA--ESQGCNHEE 418
TVVCRELGFGSAKEALTGAKLGQGMGPVHMNEVECSGFEKSLTDCYFNN--DALGCSHEE 386
TVVCRELGFGSAKEALSGGQLGQGMGPVHMNEVQCSGFEKSVTECSFNMEKDSEGCSHEE 410
:**************::*.:****:**:*:**::*:* ***: :* **
:: **.***

HsLOXL2
DrLoxl2a
DrLoxl2b

DAGVRCNTPAMGLQKKLRLNGGRNPYEGRVEVLVERNGSLVWGMVCGQNWGIVEAMVVCR 478
DAAVRCNVPAMGFQKRIRLSGGRNPFEGRVEVLAEKNGSLVWGTVCSENWGIIEAMVVCR 446
DAGVKCNVPAMGFQQRLRLSGGRNPFEGRVEVLVERNGSLVWGTVCGEGWTTMEAMVVCR 470
**.*:**.****:*:::**.*****:*******.*:******* **.:.* :*******

HsLOXL2
DrLoxl2a
DrLoxl2b

QLGLGFASNAFQETWYWHGDVNSNKVVMSGVKCSGTELSLAHCRHDGEDVACPQGGVQYG 538
QLGLGFASHAFQETWYWAGDANADNVVMSGVRCSGTEMSLPQCLHHGKHINCPKGGGRFA 506
QLGLGFASNAFQETWYWPGAVNADAVVMSGVRCAGTEMSLSHCLHHGEYLSCPKGGGRFA 530
********:******** * .*:: ******:*:***:**.:* *.*: : **:** ::.

HsLOXL2
DrLoxl2a
DrLoxl2b

AGVACSETAPDLVLNAEMVQQTTYLEDRPMFMLQCAMEENCLSASAAQTDPTTGYRRLLR 598
AGVSCSDTAPDLVLNAQLVEQTTYLEDRPMYALQCALEENCLSSTARKNDHSS-YRRLLR 565
AGVSCSETAPDLVLNPQVVEQTTYLEDRPMFMLQCAYEENCLASTSSATPANS-PRRLLR 589
***:**:********.::*:**********: **** *****:::: . .: *****
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HsLOXL2
DrLoxl2a
DrLoxl2b

FSSQIHNNGQSDFRPKNGRHAWIWHDCHRHYHSMEVFTHYDLLNLNGTKVAEGHKASFCL 658
FSSQIHNVGQSDFRPKLGYHAWTWHECHRHYHSMEVFTHYDLLSLNGTKVAEGHKASFCL 625
FSSQIHNNGQSDFRPKISRENWVWHDCHRHYHSMEVFTHYDLLSTNGTKVAEGHKASFCL 649
******* ******** . . * **:*****************. ***************

HsLOXL2
DrLoxl2a
DrLoxl2b

EDTECEGDIQKNYECANFGDQGITMGCWDMYRHDIDCQWVDITDVPPGDYLFQVVINPNF 718
EDTHCDEGISKRYHCANFGEQGITVGCWDTYRHDIDCQWIDVTDVKPGDYIFQVVINPNY 685
EDSECDEGIEKRYECANFGEQGITVGCWDTYRHDIDCQWVDITDVKPGDYIFQIVINPNY 709
**:.*: .*.*.*.*****:****:**** *********:*:*** ****:**:*****:

HsLOXL2
DrLoxl2a
DrLoxl2b

EVAESDYSNNIMKCRSRYDGHRIWMYNCHIGGSFSEETEKKFEHFSGLLNNQLSPQ 774
DVAESDYTNNVMKCKCRYDGYRIWTYSCHIGGSRSSD-MDEYS---GMSNQLNHLR 737
EVAESDYTNNIVKCRCRYDGHRIWMYNCHIGGSFSAETEDTFP---GLINNQVTHR 762
:******:**::**:.****:*** *.****** * : . :
*: *:
:

C
HsLOXL3
DrLoxl3a
DrLoxl3b
XlLoxl3

MRPVSVWQWSPWGLLLCLLCSSCLGSPSPSTGPEKKAGSQGLRFRLAGFPRKPYEGRVEI 60
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

HsLOXL3
DrLoxl3a
DrLoxl3b
XlLoxl3

QRAGEWGTICDDDFTLQAAHILCRELGFTEATGWTHSAKYGPGTGRIWLDNLSCSGTEQS 120
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

HsLOXL3
DrLoxl3a
DrLoxl3b
XlLoxl3

VTECASRGWGNSDCTHDEDAGVICKDQRLPGFSDSNVIEVEHHLQVEEVRIRPAVGWGRR 180
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

HsLOXL3
DrLoxl3a
DrLoxl3b
XlLoxl3

PLPVTEGLVEVRLPDGWSQVCDKGWSAHNSHVVCGMLGFPSEKRVNAAFYRLLAQRQQHS 240
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

HsLOXL3
DrLoxl3a
DrLoxl3b
XlLoxl3

FGLHGVACVGTEAHLSLCSLEFYRANDTARCPGGGPAVVSCVPGPVYAASSGQKKQQQSK 300
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

HsLOXL3
DrLoxl3a
DrLoxl3b
XlLoxl3

PQGEARVRLKGGAHPGEGRVEVLKASTWGTVCDRKWDLHAASVVCRELGFGSAREALSGA 360
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

HsLOXL3
DrLoxl3a
DrLoxl3b
XlLoxl3

RMGQGMGAIHLSEVRCSGQELSLWKCPHKNITAEDCSHSQDAGVRCNLPYTGAETRIRLS 420
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

HsLOXL3
DrLoxl3a
DrLoxl3b
XlLoxl3

GGRSQHEGRVEVQIGGPGPLRWGLICGDDWGTLEAMVACRQLGLGYANHGLQETWYWDSG 480
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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HsLOXL3
DrLoxl3a
DrLoxl3b
XlLoxl3

NITEVVMSGVRCTGTELSLDQCAHHGTHITCKRTGTRFTAGVICSETASDLLLHSALVQE
----MVMSGVKCKGDEMTLTDCQHH-SVVSCKRAGAQFSAGVICSDMASDLVLNAPLVEQ
----MVMSGVKCTGDEMSISQCQHH-RTVNCQKAAARFAAGVICSETASDLVLNAPLVQQ
----MVLSGVRCTGREMSLEQCSHH-SSVSCKNTGTRHAAGVICSETASDLVLHSSLVQE
:*:***:*.* *::: :* **
:.*:.:.::.:******: ****:*::.**::

540
55
55
55

HsLOXL3
DrLoxl3a
DrLoxl3b
XlLoxl3

TAYIEDRPLHMLYCAAEENCLASSARSANWPYGHRRLLRFSSQIHNLGRADFRPKAGRHS
TVYIEDRPLHLLYCAAEENCLAKSAAQASWPYGHRRLLRFSSEIHNIGKADFRPRLGRHS
TTYIEDRPLHMLYCAAEEDCLSKSAASANWPYGHRRLLRFSSQIHNIGRADFRPKAGRHS
TAYIEDRPLHMLYCAAEENCLSSSARHANWPYGHRRLLRFSSQIHNNGRADFRPKAGRHS
*.********:*******:**:.** *.*************:*** *:*****: ****

600
115
115
115

HsLOXL3
DrLoxl3a
DrLoxl3b
XlLoxl3

WVWHECHGHYHSMDIFTHYDILTPNGTKVAEGHKASFCLEDTECQEDVSKRYECANFGEQ
WVWHECHRHYHSMDIFTYYDLLSLNGTKVADGHKASFCLEDTECHEGVSKRYECANFGEQ
WVWHACHGHYHSMDIFTHYDLMSANGTKVAEGHKASFCLEDTDCDEGVSKRYECANFGEQ
WVWHECHGHYHSMDIFTHYDMLTPNGTKVAEGHKASFCLEDSECQELVSKRYECANFGEQ
**** ** *********:**::: ******:**********::*.* *************

660
175
175
175

HsLOXL3
DrLoxl3a
DrLoxl3b
XlLoxl3

GITVGCWDLYRHDIDCQWIDITDVKPGNYILQVVINPNFEVAESDFTNNAMKCNCKYDGH
GITVGCWDLYRHDIDCQWIDITDVSPGNYILQVIINPNFEVAESDFTNNAMRCNCKYDGH
GITVGCWDLYRHDIDCQWIDITDVKPGNYILQVVINPNYEVSESDFTNNAMKCNCKYDGH
GITVGCWDLYRHDIDCQWIDITDVKPGNYILQVVINPNFEVAESDFTNNAMKCNCKYDGH
************************.********:****:**:*********:********

720
235
235
235

HsLOXL3
DrLoxl3a
DrLoxl3b
XlLoxl3

RIWVHNCHIGDAFSEEANRRFERYPGQTSNQII--------------------RVWLHKCHLGDSFSEEAEKEFEHYPGQLNNKIS--------------------RIWVHNCHIGDAFSEEAEKKFEKYPGQLNNQIS--------------------RIWIHNCHLGDAFSEEANKRFEHTGENLTTRYFDAWFSTGLKTPSFFATRNKLE
*:*:*:**:**:*****::.**:
: ..:

Supplementary Figure 2
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753
268
268
289

Supplementary Figure 3
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Specific Morpholino
loxl1/loxl2b
loxl1/loxl3b
loxl2b/loxl3b
loxl2b/loxl5b
loxl3b/loxl5b

Dose of
morpholino (ng)
2.4/1.6
2.4/5
1.6/5
1.6/5
5/5

# of embryos
examined
53
49
44
45
42

Phenotype of notochord distortion
+
49 (100%)
0 (0%)
32 (78%)
9 (22%)
18 (100%)
0 (0%)
26 (90%)
3 (10%)
32 (86%)
5 (14%)

Supplementary Table 1
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Supplementary Figure 4
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CHAPTER 3

2-Mercaptopyridine-N-oxide is a novel, potent lysyl oxidase inhibitor

Unpublished material and material excerpted from:
Chemical genetics suggests a critical role for lysyl oxidase in
zebrafish notochord morphogenesis
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Abstract
2-Mercaptopyridine-N-oxide causes notochord distortion in zebrafish embryos similar to
what is observed after lysyl oxidase cuproenzyme inhibition with -aminopropionitrile.
We demonstrate in vitro that 2-mercaptopyridine-N-oxide potently inhibits amine oxidase
activity in adult zebrafish extracts. We also demonstrate that 2-mercaptopyridine-N-oxide
causes notochord distortion in haploid embryos at nanomolar concentrations, making it
practical to conduct forward genetic sensitivity screens using a sub-threshold dose of this
compound.
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Introduction
The notochord is one of the most conspicuous organs visible during zebrafish
embryogenesis, allowing pharmacologic compounds that affect notochord formation to
be easily identified. 2-Mercaptopyridine-N-oxide was noted to recapitulate the notochord
distortion observed in copper-deficient zebrafish embryos without diminishing melanin
pigmentation except at very high concentrations (74). Based on the known hierarchy of
copper metabolism (14), this suggested that copper chelation is not the principal mode of
action of 2-mercaptopyridine-N-oxide and that this compound directly inhibits the lysyl
oxidases required for notochord formation. We demonstrate by biochemical assay that 2mercaptopyridine-N-oxide potently diminishes amine oxidase activity in adult zebrafish
extracts and that it causes notochord distortion in gynogenetic haploid embryos.
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Materials and methods
Zebrafish maintenance
Zebrafish were reared under standard conditions at 28.5C (33) and staged as described
(34). All experiments were carried out in accordance with Washington University‟s
Division of Comparative Medicine guidelines.
Pharmacologic treatment
Pharmacologic compounds were purchased from Sigma-Aldrich (St. Louis, MO). βAminopropionitrile (A3134) and 2-mercaptopyridine-N-oxide (188549) were prepared as
100 mM stocks in water and dimethyl sulfoxide, respectively, and diluted in water. For
experiments with haploid embryos, egg water (33) was used instead of water and
embryos were placed in compound between 3 and 6 hpf.
Lysyl oxidase assay (75)
Fish were euthanized and pulverized in liquid nitrogen with a mortar and pestle. The
powder was collected in PBS and rocked for 1 h at 4 °C before centrifuging at 10 000 g
for 30 min to obtain an insoluble fraction, which was mechanically homogenized and
extracted overnight in 6 M urea–50 mM sodium borate pH 8.2 with agitation at 4 °C. The
supernatant was isolated after a second centrifugation at 30 000 g for 30 min and diluted
to 1.2 M urea with 50 mM sodium borate, pH 8.2. Lysates were then concentrated using
Amicon YM-10 columns and the flow-through saved.
Assays were carried out in triplicate at 37 °C using 150 µL of lysate or flowthrough and 50 µL of a 4x reaction buffer containing 4 U mL–1 type II horseradish
peroxidase, 40 mM cadaverine, and 40 µM Amplex UltraRed in 1.2 M urea–50 mM
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sodium borate, pH 8.2. Amplex UltraRed fluorescence was measured at defined intervals
using an excitation of 560 nm and an emission of 590 nm. For each sample, the
background fluorescence of the corresponding flow-through with or without drug was
subtracted to generate a corrected fluorescence, reported in relative fluorescent units
(RFU).
Haploid embryo generation
Gynogenetic haploid embryos were generated as described (33). Briefly, sperm from
multiple adult male fish was pooled in 300 L of Hank‟s buffer (“Final”), deposited on a
chilled watch glass, and subjected to UV irradiation for 7 seconds at maximum power in
a UV Stratalinker 1800 (Stratagene). It was then collected with a new tip and stored on
ice. 10 L aliquots were used to fertilize individual clutches from female fish.
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Results
2-Mercaptopyridine-N-oxide inhibits zebrafish amine oxidase activity in vitro
Work performed by our collaborators demonstrated that wild-type diploid embryos
exposed to nanomolar concentrations of 2-mercaptopyridine-N-oxide develop a
phenotype of notochord distortion similar to the one obtained with lysyl oxidase
inhibition. To determine whether 2-mercaptopyridine-N-oxide inhibits zebrafish amine
oxidase activity in vitro, we performed a biochemical assay (75) using extracts from adult
fish. In this assay, addition of 500 μM β-aminopropionitrile inhibited amine oxidase
activity almost 80%, while addition of 5 μM 2-mercaptopyridine-N-oxide reduced
activity by almost 30% (Fig. 1). Interestingly, addition of both compounds resulted in an
additive effect, suggesting that the mechanisms of action of β-aminopropionitrile and 2mercaptopyridine-N-oxide are different. Approximately the same amount of inhibition is
obtained with 100 μM β-aminopropionitrile as with 5 μM 2-mercaptopyridine-N-oxide
(data not shown), reflecting the greater potency of β-aminopropionitrile as a lysyl oxidase
inhibitor in vitro. Importantly, β-aminopropionitrile causes notochord distortion in wildtype zebrafish embryos at millimolar concentrations (see Chapter 2), confirming that 2mercaptopyridine-N-oxide also has superior potency in vivo. Concentrations of 2mercaptopyridine-N-oxide higher than 5 μM could not be used in the assay because they
diminished fluorescence non-specifically.
2-mercaptopyridine-N-oxide causes notochord distortion in haploid embryos
We next tested the effect of 2-mercaptopyridine-N-oxide on wild-type gynogenetic
haploid embryos to determine if this compound would be useful in a forward genetic
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sensitivity screen. Titration experiments revealed consistent notochord distortion at
concentrations of 200 nM and no distortion at 50 nM (Table 1). This was of particular
interest because -aminopropionitrile lacks the potency to induce notochord distortion in
gynogenetic haploid embryos at concentrations as high as 1 mM(Table 2).
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Discussion
Taken together with detailed studies conducted by our collaborators, the phenotypic and
biochemical data presented here demonstrate that lysyl oxidases are direct targets of 2mercaptopyridine-N-oxide. In addition, the titration experiments (Table 1) reveal that this
compound induces notochord distortion in gynogenetic haploid embryos, a finding that
now permits forward genetic sensitivity screens where notochord formation is examined
in the context of impaired lysyl oxidase function.
The in vitro inhibition of amine oxidase activity observed with aminopropionitrile provides biochemical evidence for the evolutionary conservation of
lysyl oxidase enzymatic activity between zebrafish and mammals. While 1 mM aminopropionitrile does not cause notochord distortion in gynogenetic haploids, higher
concentrations of this inhibitor may result in the anticipated phenotype.
These studies suggest that high-throughput screening of pharmacologic
compounds could be used to identify additional lysyl oxidase inhibitors by examining
embryos for the phenotype of notochord distortion in the context of normal melanin
pigmentation. Inhibitors of specific lysyl oxidase family members would help elucidate
the individual roles of these proteins in development and could be useful in preventing
hypoxia-induced cancer metastasis (54).

66

Figure legends
Fig. 1. 2-Mercaptopyridine-N-oxide inhibits lysyl oxidase activity. Lysyl oxidase
activity in crude fish extracts was measured in the absence and presence of a known lysyl
oxidase inhibitor β-aminopropionitrile (βAPN) or 2-mercaptopyridine-N-oxide (MCP) or
both combined. Data shown is representative of three separate experiments and activity is
presented in relative fluorescent units with each data point as the mean of three triplicate
measurements, error bars indicate standard deviation.
Table 1. 2-Mercaptopyridine-N-oxide causes notochord distortion in haploid
embryos. Gynogenetic haploid embryos were incubated in increasing concentrations of
2-mercaptopyridine-N-oxide and examined for notochord distortion at 24 hpf. Some but
not all embryos in 75 nM 2-mercaptopyridine-N-oxide exhibited notochord distortion. All
embryos in 200 nM 2-mercaptopyridine-N-oxide exhibited notochord distortion.
Table 2. Effect of -aminopropionitrile on notochord formation in haploid embryos.
Gynogenetic haploid embryos were incubated in increasing concentrations of aminopropionitrile and examined for notochord distortion at 24 hpf. Notochord distortion
was not observed at concentrations of -aminopropionitrile ranging from 50 M to 1
mM.
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Figure 1
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CHAPTER 4

Essential role for fibrillin-2 in zebrafish notochord and vascular morphogenesis

John M. Gansner,1 Erik C. Madsen,1 Robert P. Mecham,2 and Jonathan D. Gitlin1
Departments of Pediatrics1 and Cell Biology and Physiology2
Washington University School of Medicine
St. Louis, Missouri 63110
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Abstract
Recent studies demonstrate that lysyl oxidase cuproenzymes are critical for zebrafish
notochord formation, but the molecular mechanisms of copper-dependent notochord
morphogenesis are incompletely understood. We therefore conducted a forward genetic
screen for zebrafish mutants that exhibit notochord sensitivity to lysyl oxidase inhibition,
yielding a mutant with defects in notochord and vascular morphogenesis, puff daddygw1
(pfdgw1). Meiotic mapping and cloning reveal that the pfdgw1 phenotype results from
disruption of the gene encoding the extracellular matrix protein fibrillin-2, and the spatiotemporal expression of fibrillin-2 is consistent with the pfdgw1 phenotype. Furthermore,
each aspect of the pfdgw1 phenotype is recapitulated by morpholino knockdown of
fibrillin-2. Taken together, the data reveal a genetic interaction between fibrillin-2 and the
lysyl oxidases in notochord formation and demonstrate the importance of fibrillin-2 in
specific early developmental processes in zebrafish.
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Introduction
Structural birth defects are a significant cause of morbidity and mortality in humans and
result from both genetic and environmental factors (76-78). Nutrition is a critical
environmental factor affecting early development (29), and deficiencies in several
nutrients during pregnancy are known to cause structural birth defects (77, 79). As
nutritional status can now be increasingly interpreted within a specific genetic context,
identification of alleles that confer susceptibility to nutritional or metabolic abnormalities
may allow for therapeutic intervention or prevention of birth defects. Zebrafish provide a
genetically tractable model to examine gene-nutrient interactions during early vertebrate
development as early morphogenesis can be directly observed and levels of specific
nutrients precisely controlled in the embryonic milieu via pharmacologic manipulation
(14, 30, 80).
The zebrafish notochord is well suited to the study of gene-nutrient interactions
during development. This prominent organ is easily visualized, consisting of a series of
notochord vacuolar cells that exert turgor pressure on an extracellular matrix sheath (31).
The notochord provides axial support to the growing embryo, is essential for subsequent
vertebral column formation, and secretes signaling molecules required for neural
patterning, muscle differentiation, and cardiac formation (16). Furthermore, defects in
extracellular matrix formation lead to compromised notochord sheath function and
notochord abnormalities and therefore can be readily detected. Indeed, large forward
genetic screens (17, 18) have established the importance of laminins and coatomer
proteins in notochord differentiation and sheath formation (19, 20).
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The fibrillins are a family of extracellular matrix proteins that form 10 nmdiameter microfibrils around the notochord and in other tissues during development (8184). The human genome encodes three fibrillins which are numbered sequentially, have a
highly modular and conserved domain organization, and exhibit about 68% amino acid
identity with each other (85). Because of this similarity, fibrillin family members have
historically been distinguished by a few salient features, including a single internal
unique region which is proline-rich in fibrillin-1, glycine-rich in fibrillin-2, and
proline/glycine-rich in fibrillin-3 (84). The composition of this domain, which may act as
a hinge region (86), is thought to contribute to functional differences between individual
family members (84). In addition, the number and location of integrin-binding RGDmotifs and N-glycosylation sites differ between family members (84). While little is
known about fibrillin-3, the other fibrillins have a long history and were first studied in
avian development using monoclonal antibodies to fibrillin-1 (clone 201) (87) and
fibrillin-2 (the JB3 antibody) (82). In particular, the role of fibrillin-2 in embryo
patterning and axis formation has been extensively studied in avians (88-90).
Our laboratory has recently delineated the phenotype of copper deficiency in a
zebrafish model of Menkes disease, which includes a strikingly distorted notochord (14).
This notochord distortion is due to the inhibition of two specific copper-dependent lysyl
oxidases that normally crosslink collagens and other extracellular matrix proteins in the
notochord sheath (80). Partial disruption of collagen II, a lysyl oxidase substrate and
notochord sheath protein, sensitizes embryos to notochord distortion after suboptimal
copper nutrition or partial lysyl oxidase inhibition, demonstrating a complex interplay of

74

gene dosage and nutrient availability critical to notochord formation (80). To understand
the molecular mechanisms of notochord formation in relation to copper nutrition, we
conducted a forward genetic screen for mutants exhibiting notochord sensitivity to lysyl
oxidase inhibition. In this current study, we report the identification and characterization
of one such mutant with defects in notochord and vascular morphogenesis, puff daddy
(pfdgw1).
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Materials and methods
Zebrafish maintenance
Zebrafish were reared under standard conditions at 28.5C (33) and staged as described
(34). Synchronous, in vitro fertilized embryos were obtained for all experiments, which
were carried out in accordance with Washington University‟s Division of Comparative
Medicine guidelines. AB stocks were used except when pfdgw1 was crossed to WIK for
mapping and to Tg(fli1a:EGFP)y1 (91) for visualization of vascular defects. In Figs. 1, 2,
3A-D, 4, 5, 7A-J, and 8, “wild-type” refers to either +/+ or +/- embryos, which could not
be phenotypically distinguished.
Chemical mutagenesis and forward genetic screening
Mutagenesis was carried out with N-ethyl-N-nitrosourea according to standard methods
(92). Briefly, male zebrafish were incubated for 1 hour in 3 mM N-ethyl-N-nitrosourea at
weekly intervals for five consecutive weeks and outcrossed to generate F1 carriers
(AB*/AB) after a rest period. Gynogenetic haploid offspring from F1 females were
screened using a dose (50 nM) of the lysyl oxidase inhibitor 2-mercaptopyridine-N-oxide
(74) that is slightly lower than the dose required to cause notochord distortion in
haploids. In addition, frank notochord mutants detected in concurrent screens were also
interrogated for notochord sensitivity to partial lysyl oxidase inhibition by this method.
Random intercrosses of F2 progeny confirmed transmission of the mutation.
Microscopy
Live embryos were anesthetized in tricaine, mounted in 2% methylcellulose, and imaged
using either Olympus SZX12 (bright-field) or Olympus MVX10 (fluorescent)
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microscopes fitted with Olympus DP70 cameras. Frozen sections mounted on slides were
imaged using an Olympus BX60 microscope fitted with a Zeiss AxioCam. Electron
microscopy was carried out as previously described (80).
Pharmacologic treatment
All pharmacologic compounds were purchased from Sigma-Aldrich (St. Louis, MO)
except losartan, which was purchased from AK Scientific, Inc. (Mountain View, CA). βAminopropionitrile (A3134) was prepared as a 100 mM stock in egg water (33) and
diluted in egg water; neocuproine (N1501) and 2-mercaptopyridine-N-oxide (188549)
were prepared as 100 mM stocks in dimethyl sulfoxide and diluted in egg water. Losartan
(I497) was prepared as a 50 mM stock in dimethyl sulfoxide, diluted in water, and used at
final concentrations of 5 and 50 M. Embryos were incubated in each compound starting
at 3-6 hpf. Statistical analysis was performed as previously described (80).
Meiotic mapping
F2 carriers were mapcrossed to the polymorphic WIK strain and the progeny (AB*/WIK)
raised to adulthood. The pfdgw1 mutation was assigned to chromosome 22 by centromeric
linkage analysis (26, 93) using simple sequence length polymorphism (SSLP) markers
(94) and DNA from early pressure gynogenetic diploids. For fine mapping, 597 mutant
embryos from AB*/WIK females crossed to AB*/AB males were collected and assessed
for recombination along chromosome 22 by SSLP analysis. Embryos were incubated in 2
M neocuproine to accentuate the mutant phenotype and facilitate rapid mutant
identification. When necessary, candidate marker primer pairs for BAC sequences were
generated using the Zebrafish SSR search website of the Massachusetts General Hospital
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(http://danio.mgh.harvard.edu/markers/ssr.html). Primers for the BAC markers used in
Fig. 6A are: zC124A3 – forward 5‟-GAGTGTTGCAAGTGTAACTTGCCC-3‟ and
reverse 5‟-ATGGGAAACTAGTTATTTGGCACAG-3‟; zC239M17 – forward 5‟GAGTCTAATCAGTGGAGACTTGG-3‟ and reverse 5‟CGTACAGATGCTGATCTGGG-3‟; zK49M19 – forward 5‟GCATCGTTGCAACTTGCTT-3‟ and reverse 5‟TGATGGCAGAATAGTTTCACACA-3‟; bZ36A1 – forward 5‟GGCAATAGATTTCAAAGGTGTTTT-3‟ and reverse 5‟AATCCAAGGCAATGCAGAAA-3‟. DNA from wild-type and heterozygote embryos as
well as WIK and AB grandparents was used to ensure polymorphism between AB and
WIK. Based on available genetic maps of the zebrafish genome (94, 95), the pfdgw1
mutation was localized to a telomeric region of chromosome 22.
Cloning and protein annotation
Zebrafish fibrillin-2 was cloned first in pieces and then in its entirety using Superscript III
reverse transcriptase (Invitrogen) and Phusion DNA polymerase with high-fidelity buffer
(Finnzymes). The pfdgw1 mutation was initially detected by cloning the 5‟ end of fibrillin2 from mutant embryo and wild-type adult fin cDNA into pCRII (Invitrogen) using
forward primer 5‟-AGGGTGAGGCACATTTACCG-3‟ and reverse primer 5‟GTGTCTTCACACTCGTCGATG-3‟. Full-length wild-type fibrillin-2 was subsequently
cloned into pCR-XL-TOPO (Invitrogen) after amplification from 52 hpf embryo cDNA
using forward primer 5‟-AGGGTGAGGCACATTTACCG-3‟ and reverse primer 5‟CTGCAGTGAAGGGCATAGGG-3‟. Full-length clones from 3 separate PCR reactions
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were sequenced and compared, allowing mutations introduced during PCR to be
identified. No alternative splice forms were detected. The start site of fibrillin-2 was
confirmed by 5‟ rapid amplification of cDNA ends (RACE) using wild-type RACE-ready
cDNA from 15-somite embryos and the primer 5‟GACCCTCTGCTGCACCTCCCCCTCAG-3‟. The full-length zebrafish fbn2 sequence is
available at Genbank (accession number EU449516). The 5‟ portion of zebrafish
fibrillin-4 (accession number EU854565) was cloned in two overlapping pieces using the
following primer sets: A) forward primer 5‟-GCAGTCCTTCTGTTGTCCAGG-3‟ and
reverse primer 5‟-CAGACAGATGATGACCAGGCGG-3‟ and B) forward primer 5‟CCTTTCACTGTGCAATGGAGGC-3‟ and reverse primer 5‟CCACATTATTGACACACCGACC-3‟. The start site was inferred from an EST
(EE319589). The 3‟ portion of zebrafish fibrillin-4 (accession number EU854566) was
cloned in multiple overlapping pieces using the following primer sets: A) forward primer
5‟-CGAATGTGGTCAGAATCCTC-3‟ and reverse primer 5‟CCCATGACCTCCATTACAGC-3‟ B) forward primer 5‟GTGAATGTGGTGTTGGGTTC-3‟ and reverse primer 5‟GGTGTTGTGTGTAACCCTGTGG-3‟ C) forward primer 5‟CCTGGGATATGTGCTCCTGG-3‟ and reverse primer 5‟CCCATGACCTCCATTACAGC-3‟ D) forward primer 5‟CGTTTAACACCACCAAAGCC-3‟ and reverse primer 5‟GCAGTGGCATCTGTAAGAGC-3‟. An 86 bp sequence connecting the 5‟ and 3‟
portions was inferred from Zv7_Scaffold988 based on the modular nature of fibrillins. A
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253 bp extension to the 3‟ end was also inferred in this manner. The far 3‟ end and stop
codon could not be determined. For both fibrillins, conserved protein domains were
identified using Motif Scan (40) and by comparison with annotated orthologues (84). The
NetNGlyc 1.0 Server (http://www.cbs.dtu.dk/services/NetNGlyc/) was used to predict Nglycosylation sites with a potential greater than 0.32.
Phylogenetic analysis
DNA coding sequences were aligned using ClustalW2 (96) and a phylogenetic tree was
constructed in TOPALi v2.5 by the maximum likelihood method (PhyML) using HKY
substitution and gamma rate models (97-99). 100 bootstrap runs were performed. Similar
trees were obtained with MEGA4.0 using maximum parsimony or minimum evolution
methods (100), except that pDrfbn4 diverged before all other fibrillins to form its own
one-member group. Accession numbers for the non-zebrafish sequences used were:
HsFBN1 – NM_000138; HsFBN2 – NM_001999; HsFBN3 – NM_032447; MmFbn1 –
NM_007993; MmFbn2 – NM_010181; RnFbn1 – NM_031825; RnFbn2 – NM_031826;
BtFbn1 – NM_174053; pXlfbn – DQ310728; and HsLTBP1 – NM_000627.
Whole-mount in situ hybridization and frozen sections
Embryos from pfdgw1/+ intercrosses were manually dechorionated at the indicated
developmental stages, fixed in 4% paraformaldehyde-PBS, and dehydrated by methanol
series. Three fibrillin-2 probe constructs were generated by cloning nonoverlapping
fragments of the cDNA into pCRII (Invitrogen). DIG-labeled antisense RNA probes were
synthesized from these constructs using a DIG-labeling kit (Roche), and whole-mount in
situ hybridization performed as previously described (14, 45). All embryos of the same
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developmental stage were processed in a single well to ensure identical reaction
conditions. Frozen sections were prepared as described (80).
Genotyping
DNA was extracted from embryos or caudal fin tissue and PCR amplified using primers
flanking the mutation: forward primer 5‟-GCGGTGTGCGAGAGCGGATG-3‟ and
reverse primer 5‟-GCATTCTTGAAGGAGCCCCG-3‟. The resulting product was then
digested with the restriction enzyme AvaII (New England Biolabs) for 5 hrs at 37C and
a small aliquot run on a 10% TBE polyacrylamide gel for visualization. PCR product
derived from the mutant allele is not cut by AvaII. For genotyping after whole-mount in
situ hybridization, embryos were first rehydrated to PBS and incubated in 300 mM NaCl
for 4 hours at 65°C to reverse crosslinking. They were then placed in DNA extraction
buffer (80 mM KCl, 10 mM Tris pH 8, 1 mM EDTA, 0.3% Tween 20, 0.3% Igepal),
boiled 10 minutes, and the DNA phenol-chloroform extracted. Genotyping was
performed by restriction digest, as described above.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
RNA was obtained from pooled wild-type embryos or unfertilized eggs using Trizol
reagent (Invitrogen) and RT-PCR performed with the SuperScript III One-Step RT-PCR
Platinum Taq HiFi kit (Invitrogen). Half a microgram of total RNA was used per 25 L
reaction. The primer annealing temperature was 57C and 30 cycles of PCR were
performed. Fibrillin-2 primers were: forward primer 5‟CACCTGTAAATGCCCCTCGG-3‟ and reverse primer 5‟GAAGCCCACCCCATTGATGC-3‟. Spadetail primers were: forward primer 5‟-
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GAAGATGTTTACTGACCACTCAG-3‟ and reverse primer 5‟GCCTGTTTGTTTAAGACATT-3‟.
Morpholino and mRNA injections
Morpholino oligonucleotides (27) targeting start and splice sites in fibrillin-2 were
resuspended in Danieau buffer (start MO) or water (splice MO), diluted to include 0.05%
phenol red, and injected into 1-cell embryos. Standard control morpholino (Gene Tools,
LLC) was resuspended in Danieau buffer and likewise injected. Morpholino sequences
were: 5‟-GCGACTCCTGAAGCGCCGGTAAATG-3‟ (start MO) and 5‟GGGATACTTACGAACTATACACTGG-3‟ (splice MO). The splice MO was used at a
dose of 1.7 ng. The loxl5b splice morpholino (5‟GCCTGTGGAATAAACACCAGCCTCA-3‟) was prepared as previously described (80)
and was used at a dose of 5 ng. Capped, polyadenylated mRNA for rescue experiments
was generated from a full-length clone of zebrafish fibrillin-2 using the mMESSAGE
mMACHINE kit (Ambion). Individual embryos from pfdgw1/+ intercrosses were injected
with between 100 and 1000 pg of mRNA in multiple separate experiments. Statistical
analysis was performed as previously described (80).

82

Results
The pfdgw1 mutation disrupts notochord and vascular development
To elucidate the role of copper homeostasis in development, we performed a screen that
couples N-ethyl-N-nitrosourea mutagenesis to pharmacologic sensitization using a subthreshold dose of the lysyl oxidase inhibitor 2-mercaptopyridine-N-oxide (74). A mutant,
puff daddy (pfdgw1), was identified with notochord abnormalities (Fig. 1B, black arrow)
and normal melanin pigmentation (Fig. 1B, white arrowhead) characteristic of the
previously identified phenotype of impaired lysyl oxidase function. pfdgw1 mutants also
display a cavernous caudal vein (Figs. 1B, D, white arrows) and fin fold attenuation
(Figs. 1B, D, black arrowheads) not present in wild-type (+/+ and +/-) embryos at 30 hpf
(Figs. 1A, C). Skin distention secondary to edema occurs in the lateral truncal region near
the yolk-sac extension of pfdgw1 mutants by 30 hpf (Fig. 1F vs. Fig. 1E, arrowheads), and
blood cell extravasation is visible in this space (Fig. 1F, arrow).
The pfdgw1 mutation disrupts venous plexus and axial vessel formation
To examine vascular development in pfdgw1 fish, pfdgw1 was crossed to a transgenic line
that expresses enhanced green fluorescent protein in vascular endothelial cells (91). In
wild-type embryos, the caudal vein forms a venous plexus with a characteristic reticular
pattern (Fig. 2A, arrowheads), and the dorsal aorta and cardinal vein are appropriately
lumenized (Fig. 2C, circles). In pfdgw1 mutants, endothelial cells are disorganized around
a cavernous caudal vein (Fig. 2B, arrowheads), and the diameters of the large axial
vessels are reduced to a variable degree (Fig. 2D, circles). Blood cells do not circulate in
mutants with particularly small-diameter axial vessels despite a pumping heart (data not
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shown), and increased vascular resistance due to reduced vessel diameter may contribute
to the observed impaired heart contractility in pfdgw1 mutants (data not shown). The
distended area in the lateral truncal region of pfdgw1 mutants (Fig. 1F, arrowheads) is not
lined by fli1-expressing cells (data not shown), a finding consistent with edema. While
the notochord, fin fold, and vascular abnormalities are consistently penetrant in clutches
from pfdgw1 fish, by 3 dpf, the truncal edema resolves and blood flow occurs through the
caudal vein in most pfdgw1 mutants. However, the swim bladder does not inflate, resulting
in embryonic lethality (data not shown).
The outer layer of the notochord sheath is disrupted in pfdgw1 mutants
The phenotype of pfdgw1 mutants suggested a defect in notochord sheath formation, and
we therefore imaged this organ in pfdgw1 mutants and wild-type embryos by transmission
electron microscopy (Figs. 3A-D). Ultrastructurally, the notochord sheath consists of
inner, medial, and outer layers, all of which are clearly visible in a cross-section from a
wild-type embryo at 30 hpf (Figs. 3A, C). While the inner and medial sheath layers are
present in pfdgw1 mutants, the outer layer is strikingly diminished in size at the region of
notochord folding (Figs. 3B, D).
pfdgw1 mutants are sensitized to lysyl oxidase inhibition
Interestingly, lysyl oxidase inhibition results in impaired notochord formation without an
effect on the outer sheath layer (Figs. 3E, F and Gansner et al., 2007), suggesting that the
product of the pfdgw1 locus has roles in addition to those related to lysyl oxidase
crosslinking. To examine this, we first incubated clutches from pfdgw1/+ intercrosses in
vehicle (Figs. 4A, B and Table 1) or a dose of the copper chelator neocuproine that does
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not cause notochord distortion in wild-type embryos (Fig. 4C, Table 1, and Gansner et
al., 2007). Consistent with the results of our original screen, pfdgw1 mutants were
sensitized to increased notochord distortion under copper-limiting conditions (Fig. 4D vs.
Fig. 4B and Table 1), presumably due to partial inhibition of lysyl oxidase activity (80).
To confirm this finding, we incubated clutches from pfdgw1/+ intercrosses in a dose of the
irreversible lysyl oxidase inhibitor -aminopropionitrile that causes very mild notochord
herniation in wild-type embryos (Fig. 4E, white arrowhead). Under these conditions,
notochord sensitization in pfdgw1 mutants was again observed (Fig. 4F vs. Fig. 4B and
Table 1). Importantly, pfdgw1 mutants could be distinguished from heterozygote and wildtype siblings in these experiments by the cavernous caudal vein and truncal edema
present in the mutants. These additional phenotypes are never observed after lysyl
oxidase inhibition with neocuproine or -aminopropionitrile, even when higher doses of
these compounds are used (80).
We next tested for a genetic interaction between the lysyl oxidases involved in
late notochord formation (80) and the pfdgw1 product by injecting clutches from pfdgw1/+
intercrosses with control morpholino (Figs. 5A, B and Table 2) or morpholino targeting
loxl5b (Figs. 5C, D and Table 2). The specificity of this lysyl oxidase morpholino has
been demonstrated previously (80), and partial morpholino knockdown of loxl5b that
does not cause notochord distortion in wild-type embryos (Fig. 5C and Gansner et al.,
2007) exacerbates the notochord phenotype of pfdgw1 mutants compared to control
morpholino (Fig. 5D vs. Fig. 5B and Table 2). Once the pfdgw1 lesion was identified (see
below), we genotyped a subset of 32 embryos from these experiments to confirm the
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genotype assignments in Table 2. Each directly-determined genotype matched the one
assigned in Table 2 (data not shown), and testing of 17 phenotypically wild-type embryos
that appeared worse after loxl5b morpholino injection (Table 2) revealed that 15 were
heterozygous for the pfdgw1 lesion (data not shown), possibly due to a slight increase in
the sensitivity of heterozygote embryos to lysyl oxidase inhibition.
The consistent worsening of the notochord phenotype in pfdgw1 mutants after
partial lysyl oxidase inhibition demonstrates an interaction between the pfdgw1 product
and the lysyl oxidases. However, the notochord distortion observed in pfdgw1 mutants in
these sensitization experiments does not adopt the characteristic sine-wave pattern seen in
wild-type embryos treated with high-dose neocuproine (Fig. 5E), and at this dose of
neocuproine, the notochords of pfdgw1 mutants never develop this classic shape (Fig. 5F
vs. Fig. 5E). These observations, taken together with the electron microscopy studies
(Fig. 3), suggest that the pfdgw1 product and the lysyl oxidases have overlapping but also
distinct roles in late notochord formation.
The pfdgw1 mutation disrupts the zebrafish fibrillin-2 gene
To determine the molecular basis for the notochord sensitivity to lysyl oxidase inhibition
and other phenotypes observed in pfdgw1 mutants, we identified the locus mutated in
pfdgw1 fish (Fig. 6). Meiotic mapping localized the pfdgw1 lesion to a telomeric region of
chromosome 22, and inspection of the physical genome assembly (Zv6) for candidate
genes in this region revealed sequence coding for an extracellular matrix protein
of the fibrillin family (Fig. 6A). A fragment of this gene is annotated as fibrillin-3 in the
current zebrafish genome assembly (Zv7), and human orthologues to the flanking genes
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timm44 and trh1 (Fig. 6A) flank human fibrillin-3. However, BLAST searches using the
translated fibrillin EST sequences (Fig. 6A) demonstrated better hits in both cases with
human fibrillin-1 and fibrillin-2 than with fibrillin-3 (data not shown), suggesting that the
zebrafish gene might exhibit greater amino acid identity to a fibrillin besides fibrillin-3.
Sequencing of a 5‟ segment of the zebrafish fibrillin on chromosome 22 revealed
a nonsense mutation in pfdgw1 mutant embryos that was absent in adult, wild-type fish
(Fig. 6B). This mutation abrogates an AvaII restriction enzyme site, allowing wild-type
and heterozygote embryos to be distinguished (Fig. 6C) and permitting genotyping of fish
stocks. Genotyping of stored DNA samples confirmed that the original pfdgw1 mutant
identified in our screen was heterozygous for the nonsense mutation indicated in Fig. 6B,
and that this mutation was absent in both the WIK grandparent used for the mapcross (see
Experimental Procedures) and the AB fish used for the outcross (data not shown). Since
all 7 recombinants at the flanking markers shown in Fig. 6A were homozygous for the
mutation (data not shown), the recombination rate at this location is 0% (0 out of 597
meiotic events), consistent with the hypothesis that the nonsense mutation causes the
pfdgw1 phenotype.
Cloning of the full-length zebrafish fibrillin on chromosome 22 revealed that it
encodes a 2868 amino acid protein highly similar to human, mouse, and rat fibrillin-2
(Figs. 6D, E and S. Fig. 1). In particular, the glycine-rich domain and location of the
RGD motifs are characteristic of fibrillin-2 but not fibrillin-1 or fibrillin-3 (Figs. 6D, E
and S. Fig. 1) (84, 85). In addition, 11 of 12 potential N-glycosylation site are conserved
(S. Fig. 1) and two calcium-binding EGF-like domains are encoded before the first TGF-
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 binding (TB) domain (Fig. 6D and S. Fig. 1), a sequence arrangement that is observed
in human fibrillin-2 but not in human fibrillin-3 (Fig. 6E) (85). Overall, the zebrafish
fibrillin on chromosome 22 exhibits 75% amino acid identity with human fibrillin-2 but
only 67% and 68% identity with human fibrillin-1 and fibrillin-3, respectively (Fig. 6E).
In view of the high amino acid sequence identity with human fibrillin-2 and the presence
of functional domains that have historically been used to distinguish fibrillin-2 from other
fibrillins (the glycine-rich domain, RGD motifs, and N-glycosylation sites), we name this
gene fibrillin-2 (fbn2). The premature stop codon identified in pfdgw1 mutants is predicted
to result in a severely truncated protein product of only 161 amino acids (Fig. 6D).
Since the current zebrafish genome assembly (Zv7) contains a gene fragment
annotated as fibrillin-2 on chromosome 10 (data not shown), we cloned the majority of
this gene to determine whether it is a paralogue of zebrafish fbn2 (S. Fig. 2). Surprisingly,
the fibrillin gene on chromosome 10 encodes a protein without RGD motifs and with a
novel proline/glutamine-rich domain not found in any fibrillin reported to date (Fig. 6E
and S. Fig. 3). Consistent with previous nomenclature that differentiates fibrillins based
on these attributes (84), we name this gene fibrillin-4 (fbn4) (Fig. 6E). Compared to the
three human fibrillins, zebrafish fibrillin-4 exhibits highest amino acid identity with
human fibrillin-2 (Fig. 6E). However, this identity (68%) is relatively low, since it is
comparable to the identity between individual human fibrillin family members (85).
Importantly, zebrafish fibrillin-2 exhibits greater amino acid identity with human
fibrillin-2 than does zebrafish fibrillin-4 (Fig. 6E). In addition, zebrafish fibrillin-2 and
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fibrillin-4 are only 66% identical, suggesting that these zebrafish fibrillins are not
paralogues created by a genome duplication event in teleosts (55).
In order to determine the evolutionary relationship of zebrafish fibrillin-2 and
fibrillin-4 to fibrillins in other species, we performed a phylogenetic analysis based on
nucleotide coding sequences (Fig. 6F). This revealed that zebrafish fibrillin-2 is
evolutionarily related to human fibrillin-3, and that zebrafish fibrillin-4 is distantly
related to human fibrillin-2 (Fig. 6F). These findings were corroborated by examining the
exon structure of the zebrafish fibrillins. In zebrafish fbn2, a single exon encodes both the
sixth calcium-binding EGF-like motif and the first half of the second TB domain (data
not shown), analogous to what is observed in human fibrillin-3 but not in other human
fibrillins (85). By contrast, the exon structure of zebrafish fbn4 at this location is identical
to that of human fibrillin-2 (data not shown). Importantly, a putative orthologue of
fibrillin-2 in Xenopus laevis (101, 102) clusters with zebrafish fbn2 and human FBN3 in
the phylogenetic tree (Fig. 6F, arrow). This suggests that in fish and amphibians, a
fibrillin with highest amino acid identity to human fibrillin-2 has evolved at the fibrillin-3
locus.
fbn2 expression is consistent with the pfdgw1 phenotype and dramatically reduced in
pfdgw1 mutants
To determine the developmental expression of zebrafish fbn2, whole-mount in situ
hybridization was performed on embryos from pfdgw1/+ intercrosses (Fig. 7). fbn2
expression is first visible during gastrulation in the hypoblast (mesendoderm) of embryos
at 9 hpf (Fig. 7A). In 3-somite embryos, fbn2 expression occurs in the paraxial mesoderm
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(Fig. 7B, arrowheads) and notochord (Fig. 7B, arrow), consistent with a role for zebrafish
fibrillin-2 in notochord morphogenesis. In 7-somite embryos, fbn2 is expressed in the
somites and notochord (Fig. 7C, arrow), with foci of increased staining present near
notochord-somite boundaries (Fig. 7C, arrowheads). By the 20-somite stage, fbn2 is also
expressed in the developing venous plexus (Fig. 7D, arrowhead), which forms
abnormally in pfdgw1 mutants, and in the eye (Fig. 7D, arrow). Frozen sections of 20somite embryos revealed that this eye expression is restricted to the lens placode (Fig.
8A, arrowheads) and demonstrated fbn2 expression in the notochord, hypochord,
floorplate, and paraxial mesoderm (Fig. 8B). At 24 hpf, fbn2 is expressed in the
hypochord (Fig. 7E and Fig. 8C, arrows), which plays a critical role in axial vascular
development (57, 58), and in the fin fold epidermis (Fig. 7E and Fig. 8C, arrowheads),
where fbn2-expressing cells form two parallel lines on either side of the midline (Figs.
8C, D, arrowheads). Despite expression of fbn2 in the lens placode (Fig. 8A), no
differences in lens morphology were observed by electron microscopy between pfdgw1
mutants and wild-type embryos at 30 hpf (data not shown).
Expression of fbn2 was almost completely absent in a quarter of embryos from
pfdgw1/+ intercrosses at each developmental stage (Figs. 7F-J and data not shown). At 24
hpf, the mutant phenotype correlated with loss of fbn2 expression, and genotyping of
embryos after in situ hybridization demonstrated an exact concordance between the
homozygous mutant genotype and abrogation of fbn2 expression at three different stages
of development examined (data not shown). Furthermore, heterozygote embryos
exhibited an intermediate level of fbn2 expression (Fig. 9), revealing that compensatory
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up-regulation of the wild-type allele does not occur in heterozygous mutant embryos. The
reduced amount of staining in heterozygous and homozygous mutant embryos supports
the specificity of the in situ hybridization reactions. Given the distribution of the in situ
probes across the entire length of the zebrafish cDNA (see Experimental Procedures),
these findings mitigate against the presence of alternative splice products and suggest
nonsense-mediated decay of the fbn2 transcript (103).
We also examined the developmental onset of fbn2 expression by reverse
transcriptase-polymerase chain reaction (RT-PCR), which is more sensitive than in situ
hybridization (Fig. 7K). This revealed that fibrillin-2 mRNA is expressed at very low
levels in wild-type embryos maternally and until 6-7 hpf, when it is upregulated but is not
yet detectable by in situ hybridization (Fig. 7K and data not shown). At 9 hpf and the 3somite stage, more robust fbn2 expression is apparent (Fig. 7K), and this correlates with
the detection of fbn2 by in situ hybridization (Figs. 7A, B). As a control, RT-PCR was
performed in parallel with primers to the gene spadetail (spt) (Fig. 7K). spt expression is
relatively constant over the time period examined except that it is not present maternally
(Fig. 7K) (104). Importantly, an RT-PCR product was not obtained if the reactions were
performed in the absence of RNA (Fig. 7K).
fbn2 knockdown recapitulates the pfdgw1 phenotype
To confirm that the pfdgw1 phenotype directly results from loss of fibrillin-2, we designed
morpholinos to abrogate zebrafish fbn2 expression (Fig. 10). Whereas wild-type embryos
injected with control morpholino demonstrated normal formation of the notochord,
caudal vein, and fin folds (Figs. 10A, C), embryos injected with a fbn2 start morpholino
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exhibited notochord kinks (Fig. 10B, black arrows), a cavernous caudal vein without
venous plexus formation (Figs. 10B, D, white arrows), and fin fold attenuation (Figs.
10B, D, arrowheads). The fbn2 start morpholino also caused truncal skin distention
characteristic of pfdgw1 mutants (Fig. 10F, arrowheads) that was not observed with control
morpholino (Fig. 10E, arrowheads). These findings were consistent and were dose
dependent (Table 3). The fbn2 start morpholino had no visible effect on embryos at a
dose of 0.12 ng (Table 3), and at an intermediate dose of 0.48 ng, only a cavernous
caudal vein with truncal edema was observed (data not shown), possibly reflecting
differences in transcript abundance between notochord and caudal vein. At a dose of 7.2
ng, embryos developed non-specific findings suggestive of morpholino toxicity, such as
reduced melanin pigmentation and mild necrosis (data not shown). Injection of fbn2 start
morpholino into pfdgw1 mutant embryos did not alter their phenotype (Fig. 10H vs. Fig.
10G), indicating that the pfdgw1 mutation results in a null phenotype, consistent with the
early location of the premature stop codon and the in situ hybridization findings (Fig. 6D
and Figs. 7F-J). Importantly, it also did not result in the reduced melanin pigmentation or
necrosis observed with high dose (7.2 ng) fbn2 start morpholino, providing evidence that
these phenotypes are non-specific. Injection of a morpholino targeting a splice site in
fbn2 also recapitulated the pfdgw1 phenotype (data not shown), further confirming the
specificity of the fbn2 knockdown.
Injection of mRNA encoding full-length (9 kb) fbn2 into clutches from pfdgw1/+
intercrosses did not rescue the pfdgw1 phenotype, but expression of zebrafish fibrillin-2 in
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mutant embryos could not be confirmed by western immunoblotting since none of the
available antibodies cross-reacted with zebrafish fibrillin-2 (data not shown).
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Discussion
These data reveal a previously unappreciated role for fibrillin-2 in zebrafish notochord
and vascular morphogenesis. Fibrillins are large glycoproteins that polymerize to form
microfibrils in a wide variety of elastic and non-elastic connective tissues (84).
Microfibrils associate with many different extracellular matrix proteins, bind cell-surface
integrins, and have recently been shown to modulate the activity of soluble signaling
factors (105). The demonstration in this current work that the notochords of pfdgw1
mutants are sensitized to lysyl oxidase inhibition (Fig. 4 and Fig. 5) is consistent with the
recent realization that microfibril structural elements are part of larger, more complex
networks associated with impaired morphogenesis (106). Indeed, our data reveal genegene and gene-nutrient interactions between fibrillin-2 and the copper-dependent lysyl
oxidases in notochord formation that were not previously apparent. Interestingly, our
findings are consistent with the recent discovery in yeast that whereas only ~20% of gene
deletions have an obvious phenotypic consequence, 97% exhibit a measurable growth
phenotype under situations of specific chemical or environmental stress (107). In
addition, the findings add to previous elegant genetic studies that elucidated novel
molecular pathways required for notochord sheath formation in zebrafish (16, 19, 20).
Fibrillin gene nomenclature in zebrafish
The zebrafish genome appears to encode three fibrillins, similar to what is observed in
human and other vertebrate genomes (data not shown). In the current work, we present
sequences for two of these fibrillins, which we name fibrillin-2 (fbn2) and fibrillin-4
(fbn4) (Figs. 6D, E). The third fibrillin, a putative orthologue of fibrillin-1 (fbn1), has not
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been cloned but has been targeted using morpholinos (108), and we have independently
confirmed its embryonic expression (data not shown).
The two cloned zebrafish fibrillins are named based on amino acid identity to
human fibrillins and on the presence of unique domains that are thought to modulate
fibrillin function. Zebrafish fibrillin-2 exhibits the highest amino acid identity with
human fibrillin-2 (Fig. 6E) and encodes a glycine-rich internal unique region
characteristic of fibrillin-2 in other species (S. Fig. 1). It also possesses two RGD motifs
located in the same relative positions as human fibrillin-2 (Figs. 6D, E, and S. Fig. 1).
Fibrillin RGD motifs mediate interactions with specific cell-surface integrins, and
increasing data suggest that these interactions are determined in part by the surrounding
amino acid sequence (109-112). It is therefore not surprising that the two RGD motifs in
fibrillin-2 have different receptor specificities (111), and the spacing of the RGD motifs,
which differs between human fibrillin-2 and fibrillin-3, may thus affect integrin binding
and protein function.
In contrast to zebrafish fibrillin-2, zebrafish fibrillin-4 exhibits relatively low
amino acid identity to human fibrillins, with only 68% identity to human fibrillin-2 (Fig.
6E). Furthermore, zebrafish fibrillin-4 contains a novel proline/glutamine-rich internal
unique region not found in other fibrillins and also completely lacks RGD motifs.
Zebrafish fbn4 is thus unlikely to function as a fibrillin-2 orthologue, although it appears
to be a distant evolutionary relative of human fibrillin-2 by phylogenetic analysis (Fig.
6F) and is flanked by the zebrafish orthologue of SLC27A6 that flanks human fibrillin-2
(data not shown).
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The zebrafish fibrillin nomenclature presented here has been informed by studies
in amphibians (101, 102). Xenopus laevis fibrillin contains an antigenic determinant
recognized by the JB3 antibody to fibrillin-2, and the cloned 3‟ fragment of this fibrillin
exhibits 77% amino acid identity with human fibrillin-2 but only 68% and 71% identity
with fibrillin-1 and fibrillin-3, respectively (101). Although the 5‟ sequence of Xenopus
fibrillin is unknown, it seems likely based on the published expression and functional
data that this fibrillin is an orthologue of human fibrillin-2 (101, 102). Importantly, the
amino acid sequences of Xenopus fibrillin and zebrafish fbn2 are 75% identical over the
region cloned, and their expression patterns are similar (see below). Since both genes
cluster phylogenetically with human fibrillin-3 (Fig. 6F), the data suggest that Xenopus
fibrillin and zebrafish fbn2 are functional orthologues of fibrillin-2 that have evolved at
the human fibrillin-3 locus. The fact that fibrillin family members are already fairly
similar (~68% amino acid identity in humans), may help to explain how this could have
occurred.
Conservation of fibrillin-2 gene expression
The spatiotemporal expression of zebrafish fbn2 is similar to that of fibrillin-2 in other
vertebrates. In chick and quail, fibrillin-2 protein localization has been directly and
extensively studied using the JB3 monoclonal antibody (82, 90, 113, 114). In chick, the
earliest fibrillin-2 immunostaining is detected in the primitive streak, which gives rise to
notochord and mesodermal structures that exhibit persistent fibrillin-2 staining
throughout development (82, 114). In particular, fibrillin-2 containing microfibrils are
detected extracellularly around the notochord and somites (compare Figs. 7B, C), and
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also in splanchnic mesoderm and segmental plate mesoderm, which is equivalent to
paraxial mesoderm in zebrafish (Fig. 7B) (82, 114). In quail, immunostaining using the
JB3 antibody revealed prominent fibrillin-2 deposition around the notochord and somites,
as well as fibrillin-2 immunoreactivity in the primitive mesocardium and segmental plate
mesoderm (90). Of note, fibrillin-2 appeared to physically integrate somites and
notochord (90), which may explain the increased fbn2 expression at notochord-somite
boundaries observed in zebrafish (Fig. 7C, arrowheads). Overall, the findings in avian
species using the JB3 antibody are consistent with the zebrafish RT-PCR and in situ
hybridization results reported above (Fig. 7 and Fig. 8), both in terms of time of onset
(pre-gastrulation) and tissue distribution (compare Fig. 7B with Fig. 3 of Rongish et al.,
1998).
Zebrafish fbn2 expression is also similar to that of Xenopus fibrillin, a putative
orthologue of fibrillin-2 (101, 102). RNase protection assays demonstrate that Xenopus
fibrillin is markedly upregulated in mid-gastrula embryos (101), which correlates well
with the initial increase in zebrafish fbn2 transcript at 6-7 hpf observed by RT-PCR (Fig.
7K). In addition, fibrillin-2 expression is first detectable by in situ hybridization during
gastrulation in both organisms (Fig. 7A) (101). Exact comparison of fibrillin-2 expression
between Xenopus and zebrafish at post-gastrula stages is difficult because Xenopus has a
distinct neurulation period before segmentation whereas these stages overlap in zebrafish
and a distinct neurulation period is absent (34). Nevertheless, Xenopus fibrillin is
expressed in the notochord, somites, floorplate, hypochord, and eye by in situ
hybridization (101), analogous to what is observed in zebrafish (Figs. 7B-D and Figs. 8A,
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B). At later stages, Xenopus fibrillin is also expressed in tail fins (101), mimicking
zebrafish fin fold expression (Fig. 7E and Figs. 8C, D). Interestingly, while notochord
staining is stronger than somite staining in Xenopus (101), the opposite is true in
zebrafish (Figs. 7B, C and Fig. 8B), possibly due to a differential requirement for
fibrillin-2 in axial extension. Future studies using antibodies to zebrafish fibrillin-2 will
be required to determine the exact timing of zebrafish fibrillin-2 protein deposition in the
notochord-somite boundary during gastrulation, but this may occur later in zebrafish than
in Xenopus, as is the case in chick (101).
Fibrillin-2 expression has also been studied during human and mouse embryonic
development. In humans, immunostaining demonstrates that fibrillin-2 has a wide tissue
distribution and is present in fetal eye as well as in the notochordal sheath and
perinotochordal mesenchyme (83, 115). In mouse, a wide tissue distribution with
prominent mesenchyme staining has been noted (116). The overall conserved expression
pattern of fibrillin-2 argues for conservation of function among these different species.
Functions of microfibrils
The functions of specific microfibrillar proteins in various tissues during development are
incompletely characterized (105). Fibrillin-2 binds multiple other microfibrillar proteins
in vitro, including microfibril-associated glycoprotein-1 and fibrillin-1 (117-119), and
morpholino knockdown of zebrafish microfibril-associated glycoprotein-1 or the
predicted zebrafish fibrillin-1 results in caudal vein dilation and altered plexus formation
(108) similar to what is observed in pfdgw1 mutants (Fig. 2B). A specialized type of
heterofibril composed of fibrillin-1, fibrillin-2, and microfibril-associated glycoprotein-1
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may thus be required for venous plexus formation in zebrafish. By contrast, tissuespecific roles unique to fibrillin-2 are indicated by the notochord kinks, reduced axial
vessel diameters, fin fold attenuation, and truncal edema observed in pfdgw1 mutants but
not fibrillin-1 or microfibril-associated glycoprotein-1 morphants (Fig. 1 and Fig. 2 vs.
Chen et al., 2006).
The precise role of microfibrils in notochord formation is unclear, but our results
suggest that microfibrils contribute to the strength of the sheath that envelops the
notochord, at least in zebrafish. The sensitivity of the notochord phenotype in pfdgw1
mutants to lysyl oxidase inhibition (Fig. 4 and Fig. 5) may result in part from an impaired
ability to recruit or correctly position lysyl oxidases at their site of action in the notochord
sheath, a hypothesis supported by studies demonstrating a role for microfibril-associated
proteins in this process (50, 120). This model is also consistent with the observation that
the heterozygote pfdgw1 mutants are largely unaffected by lysyl oxidase inhibition (Fig. 4
and Fig. 5), provided that enough fibrillin-2 is present in these fish to allow for proper
targeting of lysyl oxidase.
Our data from mutant and morphant zebrafish demonstrate that loss of fibrillin-2
causes early embryonic phenotypes in zebrafish (Fig. 1B, Figs. 2B, D, and Fig. 10B).
Interestingly, morpholino knockdown of Xenopus fibrillin-2 results in gastrulation arrest
(102), a finding that likely reflects differences in the mechanisms of axial extension
employed by Xenopus and zebrafish embryos. Alternatively, an additional fibrillin family
member may compensate for the loss of fibrillin-2 in zebrafish but not in Xenopus during
gastrulation. In this regard, mice homozygous for a null allele of fibrillin-2 are viable but
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die in utero when crossed into a fibrillin-1 deficient background, suggesting partial
functional redundancy between fibrillin-1 and fibrillin-2 (121-123). Fibrillin-2 knockout
mice exhibit syndactyly and congenital contractures of the forelimbs (122) but not
notochord or vascular abnormalities, possibly due to evolutionary differences between
mice and zebrafish.
Microfibril signaling
Microfibrils have recently been demonstrated to modulate critical morphogenetic
signaling events (122, 124-127), and the phenotypes observed in pfdgw1 mutants may
therefore result in part from altered signaling. While the notochord distortion observed in
pfdgw1 mutants (Fig. 1B) likely results from weakness of the notochord sheath due to
disruption of the outer sheath layer (Figs. 3B, D), the etiology of the endothelial cell
disorganization and altered caudal vein formation in pfdgw1 mutants (Fig. 2B) is less
certain. The mechanisms of venous plexus formation may be similar to those involved in
epithelial branching morphogenesis, where signaling by bone morphogenetic protein-7
plays a prominent role (128, 129). A genetic interaction between fibrillin-2 and bone
morphogenetic protein-7 has been demonstrated in fibrillin-2 knockout mice (122), and
epithelial branching morphogenesis is inhibited in embryonic lung cultures after fibrillin2 knockdown (130). Signaling by bone morphogenetic protein-7 or other morphogens
may therefore be required for endothelial cell branching and venous plexus
morphogenesis in pfdgw1 mutants. Since heterofibrils of fibrillin-2 and fibrillin-1 may be
required for caudal vein formation, and mutations in fibrillin-1 lead to excessive
transforming growth factor- activity (124-127), we considered whether increased
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transforming growth factor- signaling could explain the caudal vein abnormalities in
pfdgw1 mutants. However losartan, an inhibitor of transforming growth factor- signaling
(126) does not rescue the vascular phenotype of pfdgw1 mutants (data not shown).
Microfibrils in human disease
Mutations in human fibrillin-2 cause congenital contractural arachnodactyly, a rare
disease with autosomal dominant inheritance that is characterized by congenital joint
contractures, arachnodactyly, kyphoscoliosis, malformed ear helices, and vascular
abnormalities (131). The pathogenesis of congenital contractural arachnodactyly is
uncertain and could result from haploinsufficiency or a gain of function mutation
(antimorphic and/or neomorphic) in fibrillin-2. Our results demonstrate that
heterozygosity for a null allele at the fbn2 locus in zebrafish does not cause any overt
phenotype (Figs. 1A, C, E and data not shown) even in mature fish (data not shown), a
finding corroborated by mice heterozygous for a null allele of fibrillin-2 (121-123).
Furthermore, the mutations that are known to cause congenital contractural
arachnodactyly all cluster within a well-defined region near the middle of human
fibrillin-2, a finding that is statistically unexpected and suggests a role for this region in
mediating interactions with other proteins (131-133). These data suggest that a gain of
function mutation (antimorphic and/or neomorphic) in human fibrillin-2 is required to
cause congenital contractural arachnodactyly, a hypothesis now testable through
transgenic expression experiments in the pfdgw1 mutant. Taken together, the data reveal a
genetic interaction between fibrillin-2 and the lysyl oxidases in late notochord formation,
demonstrate the importance of fibrillin-2 in specific early developmental processes in
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zebrafish, and provide insight into the pathogenesis of congenital contractural
arachnodactyly. Furthermore, the pfdgw1 mutant described here should now permit studies
to elucidate the cell biological mechanisms of fibrillin-2 in early development.
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Figure legends
Fig. 1. The pfdgw1 mutation disrupts notochord and vascular development. (A) The
notochord (black arrow), caudal vein (white arrow), and fin fold (black arrowheads) form
normally in wild-type embryos, and melanin pigmentation is present (white arrowhead).
(B) pfdgw1 mutants exhibit notochord kinking (black arrow), a cavernous caudal vein with
loss of the usual reticular venous plexus (white arrow), and fin fold attenuation (black
arrowheads). Melanin pigmentation is present (white arrowhead). (C) Fin fold
(arrowheads) and caudal vein (arrow) in a wild-type embryo. (D) Attenuated fin fold
(arrowheads) and cavernous caudal vein (arrow) typical of pfdgw1 mutants. (E, F) Ventral
views of a wild-type embryo (E) and a pfdgw1 mutant (F) demonstrating skin distention
secondary to edema in the mutant (F, arrowheads). Red blood cells have extravasated into
the edematous area (F, arrow). All embryos were photographed at 30 hpf.
Fig. 2. The pfdgw1 mutation disrupts venous plexus and axial vessel formation. (A-D)
pfdgw1 was crossed into a fli1:EGFP transgenic line to allow visualization of endothelial
cells. (A) The caudal vein of wild-type embryos has a well-formed venous plexus
(arrowheads). (B) The caudal vein of pfdgw1 mutants has lost its characteristic reticular
pattern, and endothelial cells are disorganized (arrowheads). (C, D) Dorsal aorta (upper
circle) and cardinal vein (lower circle) in a wild-type embryo (C) and a pfdgw1 mutant (D),
demonstrating reduced axial vessel diameters in the mutant (D, circles). Embryos were
photographed at 30 hpf (C, D) and 35 hpf (A, B).
Fig. 3. The outer layer of the notochord sheath is disrupted in pfdgw1 mutants. (A-F)
Transmission electron micrographs of truncal cross-sections from embryos at 30 hpf. (A)
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Notochord sheath of a wild-type embryo (between arrows). The area in the white square
is shown at higher magnification in panel C. (B) Notochord sheath of a pfdgw1 mutant
(between arrows). The area in the white square is shown at higher magnification in panel
D. (C) Notochord sheath of a wild-type embryo with inner (i), medial (m), and outer (o)
layers. (D) Notochord sheath of a pfdgw1 mutant where inner (i) and medial (m) layers are
normal, but the outer (o) layer is reduced in size. (E, F) Notochord sheaths of wild-type
embryos treated with 10 M neocuproine (E) or 10 mM -aminopropionitrile (F). Not =
notochord.
Fig. 4. pfdgw1 mutants are sensitized to inhibition of lysyl oxidase. Clutches from
pfdgw1/+ intercrosses were incubated in vehicle (A, B), the copper chelator neocuproine (2
M) (C, D), or the lysyl oxidase inhibitor -aminopropionitrile (1 mM) (E, F). Notochord
is normal in wild-type embryos treated with vehicle or neocuproine (A, C) and shows a
very mild herniation event in -aminopropionitrile (E, arrowhead). Notochords of pfdgw1
mutants in neocuproine and -aminopropionitrile (D, F, arrowheads) are substantially
more distorted than mutants incubated in vehicle (B, arrowhead). Embryos were
incubated in PTU to inhibit melanin pigmentation and photographed at 30 hpf.
Fig. 5. pfdgw1 mutants are sensitized to notochord distortion after partial knockdown
of loxl5b. Embryos from pfdgw1/+ intercrosses were injected with 5 ng control MO (A, B)
or 5 ng loxl5b MO (C, D) and examined at 30 hpf. Neither morpholino induced
notochord distortion in wild-type embryos (A, C). However, pfdgw1 mutants injected with
lysyl oxidase morpholino developed striking notochord distortion (D, arrowheads)
compared to mutants injected with control morpholino (B, arrowheads). (E) Wild-type
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embryo incubated in high-dose (6 M) neocuproine, demonstrating classic sine-wave
appearance of lysyl oxidase inhibition at 30 hpf. (F) pfdgw1 mutant at 30 hpf with irregular
notochord distortion after incubation in 6 M neocuproine. Embryos were treated with
PTU to inhibit melanin pigmentation.
Fig. 6. The pfdgw1 mutation disrupts the zebrafish fbn2 gene. (A) The pfdgw1 lesion
was meiotically mapped to a telomeric region bounded by markers zC124A3 and z33723
on chromosome 22. The number of recombinants is noted for each marker; a single
recombinant was identified at z33723. Marker, gene, and fibrillin EST locations relative
to BACs and scaffolds (scfld) are illustrated on the physical map, which is based on Zv6.
(B) Sequencing traces from the fibrillin on chromosome 22 revealed a nonsense mutation
(arrow) in pfdgw1 mutants that abrogates an AvaII restriction enzyme site. (C) Genotyping
of pfdgw1 fish by restriction digest of a PCR product encompassing the mutated sequence.
PCR product from the wild-type allele (+) is cleaved to generate fragments of 143 bp and
43 bp; product from the mutant allele (-) is not cleaved. (D) Structure of zebrafish
fibrillin-2 illustrating the conserved modular domains of this 2868 amino acid protein.
The glycine-rich domain and location of the RGD motifs (asterisks) are characteristic of
fibrillin-2 but not fibrillin-1 or fibrillin-3 orthologues. The pfdgw1 mutation is predicted to
result in a truncated protein product (arrow). (E) Structure of the three human fibrillins
and zebrafish fibrillin-4. The percent amino acid identity with zebrafish fibrillin-2 and
fibrillin-4 is indicated. The dashed line indicates sequence that is presumed to exist but
has not been determined. (F) Phylogenetic tree of fibrillin DNA coding sequences from
various vertebrate species. Latent transforming growth factor-beta binding protein 1
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(LTBP1) is used as the outgroup. Species are identified using standard two-letter
abbreviations with zebrafish genes in bold. The arrow indicates Xenopus laevis fibrillin, a
predicted fibrillin-2 orthologue. The scale bar reflects expected substitutions per site, and
partial sequences begin with “p”.
Fig. 7. fbn2 expression is consistent with the pfdgw1 phenotype and dramatically
reduced in pfdgw1 mutants. (A-J) Clutches from pfdgw1/+ intercrosses were subjected to
whole-mount in situ hybridization at the indicated developmental stages using probes to
fbn2. (A) Lateral view of a wild-type embryo at 9 hpf. (B) Dorsal view of a wild-type
embryo at the 3-somite stage demonstrating fbn2 expression in the notochord (arrow) and
paraxial mesoderm (arrowheads). (C) Dorsal view of a wild-type embryo at the 7-somite
stage demonstrating fbn2 expression in the notochord (arrow) and somites, with foci of
increased staining near notochord-somite boundaries (arrowheads). (D) Lateral view of a
wild-type embryo at the 20-somite stage with fbn2 expression in the region of the
developing caudal vein (arrowhead) and eye (arrow). (E) Lateral view of a wild-type
embryo at 24 hpf with hypochord (arrow) and prominent fin fold expression
(arrowheads). (F-J) fbn2 expression is dramatically reduced in pfdgw1 mutants at all stages
analyzed. (K) RT-PTCR for fibrillin-2 (fbn2) or spadetail (spt) using RNA from embryos
at the indicated developmental stages. Unfert. = unfertilized.
Fig. 8. fbn2 expression in frozen sections (A-C), and at high-power magnification in
a whole-mount specimen (D). (A) Cross-section through the head of a wild-type embryo
at the 20-somite stage demonstrating fbn2 expression in the lens placodes (arrowheads).
(B) Cross-section through the trunk of a wild-type embryo at the 20-somite stage
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demonstrating fbn2 expression in the notochord (n), floorplate (arrow), hypochord
(arrowhead), and paraxial mesoderm (p). (C) Cross-section through the trunk of a wildtype embryo at 24 hpf demonstrating fbn2 expression in the hypochord (arrow) and fin
fold (arrowheads). The plane of section is schematized for A-C. (D) Dorsal view of a
wild-type embryo at 24 hpf demonstrating fbn2 expression in two parallel lines of fin fold
cells.
Fig. 9. pfdgw1 heterozygote embryos exhibit an intermediate level of fbn2 expression.
(A-C) Clutches from pfdgw1/+ intercrosses were subjected to whole-mount in situ
hybridization at the 20-somite stage using probes to fbn2, photographed, and then
genotyped. fbn2 expression is robust in wild-type embryos (A), dramatically reduced in
mutant embryos (C), and intermediate in heterozygote embryos (B).
Fig. 10. Morpholino knockdown of fbn2 recapitulates the pfdgw1 phenotype. (A)
Wild-type embryos injected with 2.4 ng of control morpholino exhibit normal notochord
(black arrow), caudal vein (white arrow), and fin fold formation (arrowheads). (B)
Embryos injected with 2.4 ng of a start morpholino targeting fbn2 develop notochord
kinks (black arrows), a cavernous caudal vein with loss of the usual reticular venous
plexus (white arrow), and fin fold attenuation (arrowheads). The caudal vein and fin fold
abnormalities in fbn2 morphants are better appreciated at higher magnification (D vs. C).
(E, F) Ventral views demonstrating truncal edema with skin distention in wild-type fish
injected with fbn2 morpholino (F, arrowheads) but not control morpholino (E,
arrowheads). (G, H) pfdgw1 mutants injected with control morpholino (G) or fbn2
morpholino (H) are indistinguishable. All embryos were treated with PTU to inhibit
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melanin pigmentation and photographed at 30 hpf. Embryos in G and H were
photographed and then genotyped.
Table 1. pfdgw1 mutants are sensitized to pharmacologic inhibition of lysyl oxidase.
Embryos were treated as indicated and scored for notochord phenotype at 30 hpf.
Embryos with mild notochord herniation events in -aminopropionitrile were scored as
normal (if wild-type) or mild (if pfd). Data shown are the pooled results of four
independent experiments.
Table 2. Genetic interaction between loxl5b and the pfdgw1 locus. Embryos were
injected with morpholino as indicated and the number of live embryos sorted to new
dishes at 10 hpf noted; these embryos were scored for notochord phenotype at 30 hpf.
The number of sorted embryos that were either dead or dysmorphic at 30 hpf is also
noted. Data shown are the pooled results of three independent experiments.
Table 3. Morpholino knockdown of fbn2 consistently recapitulates the pfdgw1 mutant
phenotype. Wild-type embryos were injected with morpholino as indicated and the
number of live embryos sorted to new dishes at 10 hpf noted; these embryos were scored
for the pfdgw1 mutant phenotype at 30 hpf. The number of sorted embryos that were either
dead or dysmorphic at 30 hpf is also noted. Data shown are the pooled results of three or
more independent experiments.
S. Fig. 1. Protein sequence alignment of zebrafish fibrillin-2 with human, mouse,
and rat orthologues. Conserved elements are highlighted using colors as follows:
predicted furin cleavage sites, purple (2); EGF-like domains (3), light gray; hybrid motifs
(2), red; TB domains (7), blue; calcium-binding EGF-like domains (43), dark gray;
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glycine-rich domain (1), gold; potential N-glycosylation sites (12-13), green; RGD motifs
(2), yellow. The number of times each element is observed is in parentheses.
S. Fig. 2. Partial sequence of zebrafish fibrillin-4. (A) Nucleotide sequence with the
predicted translation start site highlighted in red. EST sequence from EE319589 is in
small caps and is supported by BAC CT027715. Sequence in pink is inferred from
Zv7_scaffold988. All other sequence was cloned, suggesting that CT027715 should be
joined to Zv7_scaffold988 in the physical genome assembly. (B) Protein sequence
derived from translation of the nucleotide sequence in A.
S. Fig. 3. Protein sequence alignment of zebrafish, Xenopus laevis, and human
fibrillins. Conserved elements are highlighted using colors as follows: predicted furin
cleavage sites, purple; EGF-like domains, light gray; hybrid motifs, red; TB domains,
blue; calcium-binding EGF-like domains, dark gray; internal unique domains (glycinerich, proline-rich, proline/glycine-rich or proline/glutamine-rich), gold; RGD motifs,
yellow.
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Figure 1
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Figure 2
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Figure 3
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Figure 4

114

Pharmacologic treatment

None
Neocuproine (2 M)
-aminopropionitrile (1 mM)

Observed Phenotype
Wild-type
pfd mutant
Normal
Worse
Mild
Severe
110 (100%)
0 (0%)
33 (97%)
1 (3%)
114 (99%)
1 (1%**)
0 (0%)
35 (100%*)
114 (96%)
5 (4%**)
1 (3%)
31 (97%*)

*p < 0.01 vs. no treatment by 1-way ANOVA
**p not significant vs. no treatment by 1-way ANOVA

Table 1
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Figure 5

116

Specific
Morpholino
Control
loxl5b

Dose of
Morphol
-ino (ng)
5

Embryos
injected
(#)
280

Embryos
sorted/
scored (#)
191

Dead or
dysmorphic
embryos (#)
13

5

300

222

13

*p < 0.01 vs. no treatment by 1-way ANOVA
†p < 0.05 vs. wild-type by 1-way ANOVA

Table 2
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Observed Phenotype
Wild-type
pfd
Normal
Worse
Mild
Severe
135
0 (0%)
41
2 (5%)
(100%)
(95%)
143
19
3 (6%)
44
(88%)
(12%*)
(94%*†)

Figure 6
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Figure 7

119

Figure 8

120

Figure 9

121

Figure 10

122

Specific
Morpholino
Control
fbn2 (start)
fbn2 (start)

Dose of
morpholino
(ng)
7.2
2.4
0.12

Embryos
injected
(#)
533
545
320

Embryos
sorted/
scored (#)
377
406
212

Dead or
dysmorphic
embryos (#)
39
33
37

*p < 0.01 vs. control by 1-way ANOVA
**p not significant vs. control by 1-way ANOVA

Table 3

123

Observed Phenotype
Wild-type
Mutant
338 (100%)
8 (2%)
175 (100%)

0 (0%)
365 (98%*)
0 (0%**)

DrFbn2
HsFBN2
MmFBN2
RnFBN2

MGVWK----------LANVVLWWA---------------------AVHSVQGQGDGDIQA
MGRRRRLCLQLYFLWLGCVVLWAQGTAGQPQPPPPKPPRPQPPPQQVRSATAGSEGGFLA
MGRRRRLCLQPYFVWLGCVALWAQGTDGQPQPPPPKTLRPQPPPQQVRPAVAGSEGGFMG
MGRRRRLCLRPYFVWLGCVALWAQGTDGQPQPPPPKTLRPQPPPQQVRPAGAS-EGGFAG
** :
*. *.**
*:.. . :*.: .

29
60
60
59

DrFbn2
HsFBN2
MmFBN2
RnFBN2

SRFTGKPEGEVQQRVRRRGQ-ESLRGPNVCGSRFHSYCCPGWKTLPGGNQCIVPICRNSC
PEYREE-GAAVASRVRRRGQQDVLRGPNVCGSRFHSYCCPGWKTLPGGNQCIVPICRNSC
PEYRDE-GAVAASRVRRRGQQEILRGPNVCGSRFHSYCCPGWKTLPGGNQCIVPICRNSC
PEYRDE-GALAASRVRRRGQQEILRGPNVCGSRFHSYCCPGWKTLPGGNQCIVPICRNSC
..: : . . .******* : *************************************

88
119
119
118

DrFbn2
HsFBN2
MmFBN2
RnFBN2

GDGFCSRPNMCTCSSGHLAPSCGAAAVQSCSVRCMNGGMCNEDACSCQKGYTGTHCGQPV
GDGFCSRPNMCTCSSGQISSTCGSKSIQQCSVRCMNGGTCADDHCQCQKGYIGTYCGQPV
GDGFCSRPNMCTCSSGQISPTCGAKSIQQCSVRCMNGGTCADDHCQCQKGYIGTYCGQPV
GDGFCSRPNMCTCSSGQISPTCGGKSIQQCSVRCMNGGTCADDHCQCQKGYIGTYCGQPV
****************:::.:**. ::*.********* * :* *.***** **:*****

148
179
179
178

DrFbn2
HsFBN2
MmFBN2
RnFBN2

CESGCQNGGRCIGPNRCACVYGFTGPQCERDYRTGPCFTQVNNQMCQGQLSGIVCTKTLC
CENGCQNGGRCIGPNRCACVYGFTGPQCERDYRTGPCFTQVNNQMCQGQLTGIVCTKTLC
CENGCQNGGRCIGPNRCACVYGFTGPQCERDYRTGPCFTQVNNQMCQGQLTGIVCTKTLC
CETGCQNGGRCIGPNRCACVYGFTGPQCERDYRTGPCFTQVNNQMCQGQLTGIVCTKTLC
**.***********************************************:*********

208
239
239
238

DrFbn2
HsFBN2
MmFBN2
RnFBN2

CATIGRAWGHPCEMCPAQPHPCRRGFIPNIRTGACQDVDECQAVPGLCAGGNCINTVGSY
CATIGRAWGHPCEMCPAQPQPCRRGFIPNIRTGACQDVDECQAIPGICQGGNCINTVGSF
CATIGRAWGHPCEMCPAQPQPCRRGFIPNIRTGACQDVDECQAIPGLCQGGNCINTVGSF
CATIGRAWGHPCEMCPAQPQPCRRGFIPNIRTGACQDVDECQAIPGLCQGGNCINTVGSF
*******************:***********************:**:* **********:

268
299
299
298

DrFbn2
HsFBN2
MmFBN2
RnFBN2

ECKCPAGHRQSETNQKCEDIDECATISGVCDGGECTNTAGSYVCTCPRGYITSTDGSRCV
ECRCPAGHKQSETTQKCEDIDECSIIPGICETGECSNTVGSYFCVCPRGYVTSTDGSRCI
ECRCPAGHKQSETTQKCEDIDECSVIPGVCETGDCSNTVGSYFCLCPRGFVTSTDGSRCI
ECRCPAGHKQSETTQKCEDIDECSVVPGICETGDCSNTVGSYFCLCPRGFVTSTDGSRCI
**:*****:****.*********: :.*:*: *:*:**.***.* ****::********:

328
359
359
358

DrFbn2
HsFBN2
MmFBN2
RnFBN2

DHRIGTCFSSLANGRCASELSGQYTKMQCCCDTGRCWALGHIPEMCPVRGSDEYRRLCIQ
DQRTGMCFSGLVNGRCAQELPGRMTKMQCCCEPGRCWGIGTIPEACPVRGSEEYRRLCMD
DQRAGTCFSGLVNGRCAQELPGRMAKAQCCCEPGRCWSIGTIPEACPVRGSEEYRRLCLD
DQRTGTCFSGLVNGRCAQELPGRMAKAQCCCEPGRCWGIGTIPEACPVRGSEEYRRLCLD
*:* * ***.*.*****.**.*: :* ****:.****.:* *** ******:******::

388
419
419
418

DrFbn2
HsFBN2
MmFBN2
RnFBN2

RLPFG--TGNGGIIHDGNGGLN------IGGYGKGPS--QNGNGGGGYIYGSEHTFTNGN
GLPMGGIPGSAGSRPGGTGGNGFAPSGNGNGYGPGGTGFIPIPGGNGFSPGVGGAGVGAG
GLPMGGIPGSSVSRPGGTGST-------GNGYGPGGTGFLPIPGDNGFSPGVGGAGVGAG
GLPMGGIPGSSVSRPGGSGSN-------SNGYGPGGTGFLPIPGGNGFSPGVGGAGVGAG
**:* .*..
.*.*.
.*** * :
*..*: *
: ....

438
479
472
471

DrFbn2
HsFBN2
MmFBN2
RnFBN2

GNGGQKIQISQLNETTIDVCKHFTNLCLNGRCIPTPTSYRCECNMGYRQDVRGECIDVDE
GQGPIITGLTILNQT-IDICKHHANLCLNGRCIPTVSSYRCECNMGYKQDANGDCIDVDE
GQGPIITGLTILNQT-IDICKHHANLCLNGRCIPTVSSYRCECNMGYKQDANGDCIDVDE
GQGPIITGLTILNQT-IDICKHHANLCLNGRCIPTVSSYRCECNMGYKQDANGDCIDVDE
*:*
:: **:* **:***.:*********** :**********:**..*:******

498
538
531
530

DrFbn2
HsFBN2
MmFBN2
RnFBN2

CVSNPCVNGDCVNTQGSYHCKCHEGYQGTPTKQACIDIDECIVNGVMCRNGRCVNTDGSF
CTSNPCTNGDCVNTPGSYYCKCHAGFQRTPTKQACIDIDECIQNGVLCKNGRCVNTDGSF
CTSNPCSNGDCVNTPGSYYCKCHAGFQRTPTKQACIDIDECIQNGVLCKNGRCVNTDGSF
CTSNPCSHGDCVNTPGSYYCKCHAGFQRTPTKQACIDIDECIQNGVLCKNGRCVNTDGSF
*.**** :****** ***:**** *:* ************** ***:*:***********

558
598
591
590

DrFbn2
HsFBN2
MmFBN2
RnFBN2

QCICNAGFEISPDGKNCIDHDECATTNMCLNGMCINEDGSFKCICKPGFALAPNGRYCTD
QCICNAGFELTTDGKNCVDHDECTTTNMCLNGMCINEDGSFKCICKPGFVLAPNGRYCTD
QCICNAGFELTTDGKNCVDHDECTTTNMCLNGMCINEDGSFKCVCKPGFILAPNGRYCTD
QCICNAGFELTTDGENCVGHDECTTTNMCLNGMCINEDGSFKCVCKPGFVLAPNGRCCTD
*********::.**:**:.****:*******************:***** ****** ***

618
658
651
650

124

DrFbn2
HsFBN2
MmFBN2
RnFBN2

IDECHTSGICMNGRCVNTEGSFRCECPPGLAIDVDGRVCVDTHMRTTCYGAIKMGVCSRP
VDECQTPGICMNGHCINSEGSFRCDCPPGLAVGMDGRVCVDTHMRSTCYGGIKKGVCVRP
VDECQTPGICMNGHCINNEGSFRCDCPPGLAVGVDGRVCVDTHMRSTCYGEIKKGVCVRP
VDECQTPGICMNGHCINNEGSFRCDCPPGLAVGVDGRVCVDTHMRSTCYGEIKKGVCVRP
:***:*.******:*:*.******:******:.:***********:**** ** *** **

678
718
711
710

DrFbn2
HsFBN2
MmFBN2
RnFBN2

FPGAVTKSECCCANPEHGFGEPCQPCPAFNSAEFQAVCSSGPGITTDGRDINECALDPDI
FPGAVTKSECCCANPDYGFGEPCQPCPAKNSAEFHGLCSSGVGITVDGRDINECALDPDI
FPGAVTKSECCCANPDYGFGEPCQPCPAKNSAEFHGLCSSGIGITVDGRDINECALDPDI
FPGAVTKYECCCANPDYGFGEPCQPCPAKNSAEFHGLCSGGVGITVDGRDINECALDPDI
******* *******::*********** *****:.:**.* ***.**************

738
778
771
770

DrFbn2
HsFBN2
MmFBN2
RnFBN2

CQNGICENLRGSYRCICNIGYESDASGKNCVDINECLVNRLLCDNGMCRNTPGSYTCSCP
CANGICENLRGSYRCNCNSGYEPDASGRNCIDIDECLVNRLLCDNGLCRNTPGSYSCTCP
CANGICENLRGSYRCNCNSGYEPDASGRNCIDIDECLVNRLLCDNGLCRNTPGSYSCTCP
CANGICENLRGSYRCNCNSGYEPDASGRNCIDIDECLVNRLLCDNGLCRNTPGSYSCTCP
* ************* ** ***.****:**:**:************:********:*:**

798
838
831
830

DrFbn2
HsFBN2
MmFBN2
RnFBN2

KGFSFKADSETCEDINECDSNPCINGICRNIAGSFNCECSHGSKLDSTNTVCVDSMKGTC
PGYVFRTETETCEDINECESNPCVNGACRNNLGSFNCECSPGSKLSSTGLICIDSLKGTC
PGYVFRTETETCEDVNECESNPCVNGACRNNLGSFHCECSPGSKLSSTGLICIDSLKGTC
PGYVFRTETETCEDVNECESNPCVNGACRNNLGSFHCECSPGSKLSSTGLICIGSLKGTC
*: *::::*****:***:****:** *** ***:**** ****.**. :*:.*:****

858
898
891
890

DrFbn2
HsFBN2
MmFBN2
RnFBN2

WLNIQDGRCEVNINGATLKSECCSTLGAAWGSPCERCEIDPACSKGFGRMKGLVCEDINE
WLNIQDSRCEVNINGATLKSECCATLGAAWGSPCERCELDTACPRGLARIKGVTCEDVNE
WLNIQDNRCEVNINGATLKSECCATLGAAWGSPCERCELDAACPRGFARIKGVTCEDVNE
WLNIQDNRCEVNINGATLKSECCATLGTAWGSPCERCELDAACPRGFARIKGVTCEDVNE
******.****************:***:**********:*.**.:*:.*:**:.***:**

918
958
951
950

DrFbn2
HsFBN2
MmFBN2
RnFBN2

CEVFPGVCTNGRCVNTQGSFRCECPEGLTLDGAGRTCVDVRSEQCYMKWDEDECVEPLPG
CEVFPGVCPNGRCVNSKGSFHCECPEGLTLDGTGRVCLDIRMEQCYLKWDEDECIHPVPG
CEVFPGVCPNGRCVNSKGSFHCECPEGLTLDGTGRVCLDIRMEHCFLKWDEDECIHPVPG
CEVFPGVCPNGRCVNNKGSFHCECPEGLTLDGTGRVCLDVRMEHCFLKWDEDECVHPVPG
********.******.:***:***********:**.*:*:* *:*::*******:.*:**

978
1018
1011
1010

DrFbn2
HsFBN2
MmFBN2
RnFBN2

RYRVDMCCCTVGAAWGVDCEACPKPNTNEFKTICPRGPGIANRGDILTGRPFYKDVNECK
KFRMDACCCAVGAAWGTECEECPKPGTKEYETLCPRGAGFANRGDVLTGRPFYKDINECK
KFRMDACCCAVGAAWGTECEECPKPGTKEYETLCPRGPGFANRGDILTGRPFYKDINECK
KFRMDACCCAVGAAWGTECEECPKPGTKEYETLCPRGPGFANRGDILTGRPFYKDINECK
::*:* ***:******.:** ****.*:*::*:****.*:*****:*********:****

1038
1078
1071
1070

DrFbn2
HsFBN2
MmFBN2
RnFBN2

VFRGLCTHGTCRNTIGSFKCRCDSGFALTMEERNCTDIDECTISPDLCGHGVCVNTPGSF
AFPGMCTYGKCRNTIGSFKCRCNSGFALDMEERNCTDIDECRISPDLCGSGICVNTPGSF
AFPGMCTYGKCRNTIGSFKCRCNNGFALDMEERNCTDIDECRISPDLCGSGICVNTPGSF
ALPGMCTYGKCRNTIGSFKCRCNSGFALDMEERNCTDIDECRISPDLCGNGICVNTPGSF
.: *:**:*.************:.**** ************ ******* *:********

1098
1138
1131
1130

DrFbn2
HsFBN2
MmFBN2
RnFBN2

ECECFDGYESGFMMMKNCMDIDECERDPLLCRGGTCLNTEGSYECDCPPGHQLSTEASAC
ECECFEGYESGFMMMKNCMDIDECERNPLLCRGGTCVNTEGSFQCDCPLGHELSPSREDC
ECECFEGYESGFMMMKNCMDIDECERNPLLCRGGTCVNTEGSFQCDCPLGHELSPSREDC
ECECFEGYESGFMMMKNCMDIDECERNPLLCRGGTCVNTEGSFQCDCPLGHELSPSREDC
*****:********************:*********:*****::**** **:**.. . *

1158
1198
1191
1190

DrFbn2
HsFBN2
MmFBN2
RnFBN2

EDVNECQLSDNLCKHGQCVNMVGTYQCSCETGYQVTPDRQGCVDIDECTIMNGGCDTHCT
VDINECSLSDNLCRNGKCVNMIGTYQCSCNPGYQATPDRQGCTDIDECMIMNGGCDTQCT
VDINECSLSDNLCRNGKCVNMIGTYQCSCNPGYQATPDRQGCTDIDECMIMNGGCDTQCT
IDINECSLSDNLCRNGKCVNMIGTYQCSCNPGYQATPDRQGCSDIDECMIMNGGCDTQCT
*:***.******::*:****:*******:.***.******* ***** ********:**

1218
1258
1251
1250

DrFbn2
HsFBN2
MmFBN2
RnFBN2

NSEGSYECSCSEGYALMPDLRTCADIDECEDTPDICDGGQCTNIPGEYRCLCYDGFMASM
NSEGSYECSCSEGYALMPDGRSCADIDECENNPDICDGGQCTNIPGEYRCLCYDGFMASM
NSEGSYECSCSEGYALMPDGRSCADIDECENNPDICDGGQCTNIPGEYRCLCYDGFMASM
NSEGSYECSCSEGYALMPDGRSCADIDECENNPDICDGGQCTNIPGEYRCLCYDGFMASM
******************* *:********:.****************************

1278
1318
1311
1310

125

DrFbn2
HsFBN2
MmFBN2
RnFBN2

DMRTCIDVNECDLNPNICLHGDCENTKGSFICHCQLGYFVKKGSTGCTDVDECEIGAHNC
DMKTCIDVNECDLNSNICMFGECENTKGSFICHCQLGYSVKKGTTGCTDVDECEIGAHNC
DMKTCIDVNECDLNPNICMFGECENTKGSFICHCQLGYSVKKGTTGCTDVDECEIGAHNC
DMKTCIDVNECDLNPNICMFGECENTKGSFICHCQLGYSVKKGATGCTDVDECEIGAHNC
**:***********.***:.*:**************** ****:****************

1338
1378
1371
1370

DrFbn2
HsFBN2
MmFBN2
RnFBN2

DLHAACVNAPGSFKCRCRDGWEGDGIKCIDVDECVTEEHNCNPNAECLNTPGSYRCSCKE
DMHASCLNIPGSFKCSCREGWIGNGIKCIDLDECSNGTHQCSINAQCVNTPGSYRCACSE
DMHASCLNVPGSFKCSCREGWVGNGIKCIDLDECANGTHQCSINAQCVNTPGSYRCACSE
DMHASCLNVPGSFKCSCREGWVGNGIKCIDLDECANGTHQCSINAQCVNTPGSYRCACSE
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GFTGDGFTCSDVDECAENINLCENGQCLNVPGAYRCECEMGFTPASDSRSCQDIDECSFQ
GFTGDGFTCSDVDECAENTNLCENGQCLNVPGAYRCECEMGFTPASDSRSCQDIDECSFQ
GFTGDGFTCSDVDECAENINLCENGQCLNVPGAYRCECEMGFTPASDSRSCQDIDECSFQ
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NICVFGTCNNLPGMFHCICDDGYELDRTGGNCTDIDECADPINCVNGLCVNTPGRYECNC
NICVFGTCNNLPGMFHCICDDGYGLDRTGGHCTDIDECADPINCVNGLCVNTPGRYECNC
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PPDFQLNPTGVGCVDNRVGNCYLKFGPRGDGSLSCNTEVGVGVSRSSCCCSLGKAWGNPC
PPDFQLNATGVGCVDNRVGNCYLKFGPRGDGSLSCKTEVGVGVSCSSCCCSLGKAWGNPC
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ETCPPVNSTEYYTLCPGGEGFRPNPITIILEDIDECQELPGLCQGGNCINTFGSFQCECP
ETCPPVNSTEYYTLCPGGEGFRPNPITIILEDIDECQELPGLCQGGNCINTFGSFQCECP
ETCPPVNSTEYYSLCPGGEGFRPNQITIILEDIDECQELPGLCQGGNCINTFGSFQCECP
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TFDIHTGKAVDIDECKEIPGICANGVCINQIGSFRCECPTGFSYNDLLLVCEDIDECSNG
TFDIHTGKAVDIDECKEIPGICANGVCINQIGSFRCECPTGFSYNDLLLVCEDIDECSNG
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SVHASQVCRNGQCINNMGSFKCLCLDGYNLTPDGKNCVDINECVTLPGACQPGTCQNLDG
SSFFGQVCRNGRCFNEIGSFKCLCNEGYELTPDGKNCIDTNECVALPGSCSPGTCQNLEG
SSFFGQVCRNGRCFNEIGSFKCLCNEGYELTPDGKNCIDTNECVALPGSCSPGTCQNLEG
SSFFGQVCRNGRCFNEIGSFKCLCNEGYELTPDGKNCIDTNECVALPGSCSPGTCQNLEG
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SFRCICPPGYEVKSENCIDINECDEDPNICLFSSCTNTPGGFQCICPPGFVLSDNGRRCF
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YGHGTVPSLHDTREDVNECLESPGICSNGQCINTDGSFRCECPMGYNLDYTGVRCVDTDE
YGHGTVPSLHDTREDVNECLESPGICSNGQCINTDGSFRCECPMGYNLDYTGVRCVDTDE
YGHGTVPSLHDTREDVNECLESPGICSNGQCINTDGSFRCECPMGYNLDYSGVRCVDTDE
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CSIGNPCGNGTCTNVIGSFECNCNEGFEPGPMMNCEDINECAQNPLLCAFRCMNTFGSYE
CSIGNPCGNGTCTNVIGSFECTCNEGFEPGPMMNCEDINECAQNPLLCAFRCMNTFGSYE
CSIGNPCGNGTCANVIGSFECNCNEGFEPGPMMNCEDINECAQNPLFCAFRCMNTFGSYE
************:** *.***.*:*********.******** ***:*****:*******

2236
2276
2269
2268

DrFbn2
HsFBN2
MmFBN2
RnFBN2
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CTCPIGYALREDQKMCKDLDECAEGLHDCESRGMMCKNLIGTFMCICPPGMARRPDGEGC
CTCPVGYALREDQKMCKDLDECAEGLHDCESRGMMCKNLIGTFMCICPPGMARRPDGEGC
CTCPVGYALREDQKMCKDLDECAEGLHDCESRGMMCKNLIGTFMCICPPGMARRPDGEGC
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CGCPQGYIQHYQWNQCVDENECSNPNACGSASCYNTLGSYKCACPSGFSFDQFSSACHDV
CGCPQGYVQHYQWNQCVDENECSNPGACGSASCYNTLGSYKCACPSGFSFDQFSSACHDV
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NECSSSKNPCSYGCSNTEGGYLCGCPPGYFRVGQGHCVSGMGFNKGQYLSVDAEAEDDEN
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Supplementary Figure 1
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A)
gaggatttaggagggaattgggaatatgacagtttcggtccggggttcccgggatctttaaaacaacgtagccaatcagctaatgtaataattaaccccttttat
taattgaatattttattgcgtttacgtttcatcagtcagtcgaacaaatatgcgctattcatattattattattatctggttaaattaaagaacgatttgctatagcaatac
ccattcactcaagagtgcagagagttttgtcgcgtccagctgctagtgggtaacgttaggatagattggtgctggctggcgtcatgattttatatcgttcagtca
aacgtttaggatcctccttcattctcttcactaagtgcgctcctcctgtacttcaattcttattcttgtagctttacttttctggtcaaaaaccggatatgttatgatttcc
ctttcatctcatggactaacagactgtaaaggtacactgggttaaattgcactaggatatatcatgtcatctcagggggacctcaggtgtttatttggatttgttgct
ctgttgggaattttaacggggaaaatctctggaattcatggaaaagcaactgttcatattgatggatcacagagacgccaaaaacaagagtccctgagaggc
cctaatgtgtgtggatctcgtctGCAGTCCTTCTGTTGTCCAGGCTGGAAGACTCTGCCTGGGGGCAACCAGT
GTGTTGTGCCTATTTGCCGGAGTGACTGTGGGGATGGTTTCTGCTCCAGACCTAACATGTGCA
CATGTCCTGGTGGACAAACAGCTACAACCTGTTTTACTAAATCATCCAAACAATGCAAAATAA
GGTGTATGAATGGAGGAGTGTGTGAAGATGACTATTGTCAGTGTCCAAAGGGATATACAGGA
AGCTTTTGTGGACAACCTGTCTGTGAAAAAAACTGTCAGAATGGTGGACACTGCATTGGACCG
AACAGATGCGCGTGTGGATACGGCTTCACTGGACCACAGTGTGAGAGAGACTACCGGACAGG
CCCATGCTTCATCCAAGTGCACAGCAGGAAGTGTGCAGGTCAGAGCAGTGAATTTGTTTGCAG
TAAGGCCTTGTGCTGTGCCACAGTGGGTCAAGCGTGGGGTCACTCGTGCGAGCAGTGCCCACC
TATCAGCTCGCCCTGCACCAGAGGGTTCATCCCAAACACCCGCACAGGAGCCTGCCAAGATGT
TGATGAATGCAAGGTTGTCCCCGATCTGTGTAAAGGAGGAAGATGCATCAACACATTGGGTTC
ATATCAGTGCACGTGTCCTGTCGGTTACCAACAGCATGTGAGCATTTTGAAGTGCGAGGATGT
GGATGAATGCTCCACCATTGAACGTGCGTGTGAAGCGGGACACTGCATTAATTCGGCGGGCA
GTTTCTCCTGTGTGTGTCCTTCTGGATATGTGCTGTCTGCAGACCGGACTCGCTGTCTTGACCA
GCACACAGGGATCTGCTTTGCGTCAGTTGTGAATGGACGCTGTGCTCATGAAATCAGCGGACG
TTTCAATAAAATCCAGTGCTGCTGTGATCGTGGCCGGTGCTGGAGTCAAAGAACAACTCATGA
AATGTGTCCTGTACCAGGATCAGATGAATACTTGAGGATTTGTCTGGTAGGCTCTGCTCTGAG
TGGCTACAATGAGGAGGATCCTGAAATGAGCCCTCACCACCACAGCAGCTTCAGTGTTTCCCC
TAATGACCAGATACTTCACCCACATAATGGCAATGGACAAATAAAACCCCAGATTCGCCAAA
CACCTCAAATTCTGCAGTTTCCACAGATTCCACAGATCCCAAGGCATGACAATGGATTTAAAC
CACAACGACCTGTTGTTAGTGTGAATGAGACTGTGAACAGGTGCCGTTTGCTTCCTAATTTGT
GTCTGAATGGACGCTGTATTCCCATGGAGTCTGACTACCGATGTGACTGTAACACCGGATTCA
AAGAAGACAACAGAGGAGAGTGCTCAGATGTAGATGAGTGTGAGTTTGACCCCTGTGCTAAT
GGAAACTGCATCAACACTCCTGGTTCCTACTACTGCAGATGCCACACAGGCTTTCTTAGGGTT
ACAGGCAAACAAACCTGCATAGATATTGATGAATGTCTTCAGAATGGAGTGCTCTGTAAGAA
CGGCCGCTGTCTGAACACTGAGGGAAGCTTTCAGTGCATCTGCAACTCTGGATTTAAGCTTTC
ACCTGATGGGAGAAACTGTGTAGATCATGATGAATGTGCCGCCACAAACATGTGTCTTAACGG
CATGTGTATTAACGAAGACGGCAGCTTTAAATGTGTGTGTAAACCTGGATTCACCCTCAACTC
TAGTGGACGATACTGTACAGAAATCGATGAGTGCCGGACTCCAGGTGTGTGCATGAATGGAC
GATGTGTAAACACACAGGGCTCTTTCAGGTGTGAGTGTTTTGCAGGTCTTACTGTTGGAATAG
ACGGCCGAACATGTGTAGACACACACATGCGTAGCACCTGTTATGGGGCTGTAAAAAGAGGT
TTGTGTTTACGACCCTTCCAGCGTGCTGTCACCAAGTCACAGTGCTGCTGTGCCAACCCTGACT
ATGCCTTCGGTGAACCCTGCCATCCCTGCCCTGCCAAACACTCAGCTGAGTTTCAGGTCTTGTG
TGCGAGCGGTGTTGGATTTTCTGCTGATGGCAAAGACATTAATGAGTGCGCTCTGGATCCGGA
TATCTGCTCAAATGGAGTGTGTGAGAATCTCCGAGGAAATTTCCGCTGCATCTGTAACATTGG
CTATGAAAGTGACCAGAGCGGCAGAAACTGTTTAGATATTGATGAATGTGTGGTGAACAGTCT
CCTCTGTGATAATGGCCTGTGCCGGAATGTTCCAGGAAGCTACAGTTGCACCTGCCCGGCGGG
GTTCATCTTCAGACATGACACAGAGACATGTGAGGATGTGAATGAGTGTGTGAGCAGCCCAT
GCGTCAATGGAGTGTGTAAAAACAGTGCAGGCTCTTTCTACTGTGAATGTTCACAAGGAAGTA
AACTGGACAGCACTGGACTTTTATGTGTTGACAGTGTGAAGGGTTCATGCTGGTTAACTCTTC
AGGATGGTCGTTGTGAAGTTAACATCAACGGAGCTACACTGAGATCACAGTGCTGTGCCACAC
TAGGATTGGCGTGGGGCAGCCCATGTGAACCATGTCAAACTGATCTAGTGTGCGAACGAGGA
TTTGCTCGGTCAAGAGGGGCTTCATGTGAAGATGTGAATGAATGTGAGGTGTTTCCTGGTGTG
TGTCACAATGGACACTGTGTGAACACTAGAGGCTCATTTAAATGTCAGTGCCCAGAAAGCCTC
ACACTGGATGTCACTGGACGCCTCTGTGTTGATGTTCGTTCAGAGCCGTGCTTTCTTACTTACG
AAGAAGATGTGTGTACACAGCCGGTACCAGGACGCTTCCGCATGGACATGTGTTGCTGTACGG
TGGGTTTGGCTTGGGGCAAAGATTGTGACTTATGTCCTGAGCCTGGTACTCGGCAGTTTGACA
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CCCTGTGCCCAAGAGGACCAGGCTTCGCCAACAAAGGAGACGTGCTCACTGGCAGAGCTGTC
TATAAAGATATTAATGAGTGCAAAGTTTTCCAAAGCATTTGTGTCCATGGGAAATGTCGGAAC
ACCATTGGGAGCTTCAGATGTCGCTGTGATAGTGGATTTGCACTGGATACCAATGAGAAAAAC
TGCACAGATATTGACGAGTGCATGATCTCTCCTGATGTCTGTGGTCATGGCACATGTGTGAAC
ACTTTGGGCAGTTTCCAATGTGACTGTTTTCCTGGCTACGAAAGTGGAATCATGATGATGAAG
AACTGCATGGATATTGATGAATGTGAGCGTAACCTTTCACTGTGCAATGGAGGCACCTGTGAA
AACACTGACGGCAGCTACAAGTGTGTGTGTCCGCCTGGTCATCATCTGTCTGTGGATGGCAGT
GCCTGTGAAGACGTGAACGAGTGTGATCTGAGTAGCACACTTTGTCCTAATGGCTGGTGTGTG
AATTTGGTGGGAACCTACCAGTGCTCATGTAACTCTGGCTACCAGACGGCACCTGATTGGAAG
GGTTGCACAGATATAGATGAGTGCACAATAGAGAACGGAGGATGTGAGCTGTACTGTAGTAA
CTCAGAGGGCAGTTACTCCTGCAGCTGTGGTCAGGGTTACAGTCTCACGCCGGACCAGCGGAC
ATGTTCAGATGTGAATGAATGTGAAGAGGTTTTAGACATCTGTGAAGGTGGTCAGTGCACTAA
CGTTCCTGGAGCATATCATTGTTTGTGTTACGAAGGATTTATGGCTTCCGTGGACATGAAGAC
ATGTATTGATGTGAATGAGTGTGAACTGAACGACAACATCTGTGCATTTGGGGAGTGTGAGAA
CACCAAGGGTTCTTTCATCTGTCATTGTGACATAGGTTACGCCGTAAAAAAAGGAACCTCTGG
CTGCACTGATGTTAATGAGTGTGAGATTAACAGTCATAACTGTGACACACATGCCACCTGTGT
CAACACACCAGGACATTACCACTGCTCCTGCGGGGACGGATGGTTTGGAGATGGAGTCAAAT
GTGCTGATGTGGATGAGTGTGCTAACAGGACTAGCGTCTGCAGCGCTGATGCCGAGTGTGTGA
ACACAGCTGGCTCATACCACTGTGAATGTTCAGACGGGTTTATTGGAGACGGGGTTATCTGCT
CAGATTTGGATGAATGCGCTGAAGATGTGGATCTGTGTGAAAATGGCCAGTGTCTAAATGTTC
CTGGCAGCTATCGCTGTGAATGTGAGATGGGCTTCACACACACTTCAAACAGAAAAACCTGTC
GAGATATAGACGAGTGCTCCTTCCAGAACATCTGTGTGTTTGGCACATGTCAGAATATTCCAG
GAATGTTTCGCTGTATTTGTGATGAGGGGTATGAGCTGGACAGGACAGGTGGAAATTGCACA
GATGTGGACGAGTGTCTCGATTCCTTAAACTGTGTTAATGGTCACTGTGAGAACACAGCCGGC
TCGTACCAGTGTAACTGTCCTATTGACTTCGAGCTCAATCCTACTGGAATTGGATGCGTTGACA
CCCGGGTTGGAAACTGTTTTCTGGAGGTGGCGTACCATAGTAAGCTGGCATGTAGTGCTGAAA
TTGGATTTGGAGTCAGTCGTTCCTCATGTTGCTGTTCTCTGGGACGGGTGTGGGGTTACCCATG
TGACCACTGCCCTACACTCAACACCTCGGAATATAACACACTCTGTCCTGGAGGAGAGGGGTT
CAAACCCAACCCTGTCACCATCATCTTGGAAGATATCGATGAGTGTCAGGAGCTGCCCGGCCT
CTGTCAGGGTGGAAACTGTGTTAACACATTCGGAAGTTTCCAGTGTGAATGTCCAGCCGGATT
CTACCTTAACACACAGAGCCGCATCTGTGAAGATATCGATGAGTGTGTGCTCAGTTTGGGGGT
TTGTGGTCCAGGCACCTGCTACAACACACTGGGAAACTACACTTGTGTCTGTCCACAGGAATA
CATTCAGGTGAATGGAGGACACAGATGCATGGATATGAGGAAAAGTTTGTGCTATCGCAGCT
ACAATGGCAGTGCCTGTGAACATCAGCTCAACTTTAACATCACACACCGATTGTGTTGCTGTT
CCTACAATGTGGGAAAAGCCTGGAACAAGCCATGCCATGCCTGCCCGATACCTGGAACTGAT
GACTACAGCAGTCTTTGTGGCAGTGTGACTGGATTCTGGATCAACATTGCAACTGGAAAGCCA
AAAGATATTGACGAATGTCATGAAATCCCGGGAGTTTGTGCTCATGGTGTGTGTATAAACCAC
ATGGGCAGTTTCCACTGCGAGTGTCCCACTGGCTTCCTTTATAATGACCTGCTGCTCATCTGTG
AAGACATTGATGAATGCAGCAGCAGAGAGCCTGTGTGTCAGAGAAATGCAGACTGCATCAAC
CGTCCAGGCGGTTATCAGTGTGAATGTTCTGATGGGTATATACTCACACCTAATGGAGACTGT
AATGATCGTAATGAGTGCTTGGAGACACCCAGTGTGTGTCGTCATGGTGACTGTGTGGATATT
CCAGGAGGGTATGAGTGCATGTGCCACACCGGATTTACAGTAACACCAAACCGCAGGATGTG
TGTAGATGTCAATGAATGTTCACCTCAGCCGTGTGGGAATGGCACATGTAAAAACTCTGTTGG
ATCATTTAACTGTATCTGCCATCACGGATTTGAGCTCGCCACTAATAACTACTGTACAGATATC
GATGAGTGTGCAGTTTTTCACTCTCAGCTCTGCAGGAATGGTCGGTGTGTCAATAATGTGGGC
TCCTTCCAGTGTCTCTGTAGAGAAGGTTATGAACTCACTTTTGATGGCAAGACTTGTATGGATG
TTAATGAGTGTACAATCATTCCTGGGATATGTGCTCCTGGAACTTGTCTGAATCTGGATGGTTC
TTTCAGATGTGTCTGTCCTGATGGGTACATTGTCCAGAGTGATCACTGCGTAGATGTAAACGA
GTGTTCGGAGGAGCCTGGGATCTGCACATATGGGACCTGCTTCAACAGTCTGGGCAGCTTTGA
GTGTGTGTGTAAACCAGGATTTGTGCTGTCAGAAGATAAGCGCAGATGTTATGACACCAGAG
AGAGCTTCTGTTTCACACGCTTTGAGAACAGCAAGTGCTCTGTCCCGCAGGCGTTTAACACCA
CCAAAGCCAAGTGCTGCTGTAGTATCATGGCCAAGGAGGGCTGGGGCGACCCGTGTGAGCTG
TGCCCTAAAGAACATGATGCATTTCAGGATCTGTGCCCGTTTGGTCATGGGATCATTCCTGGT
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GTTGGGGACACACGTGTAGATTTAAACGAGTGTGTGGAGAATCCAGAGATCTGTGTAAACGG
ACGCTGCATCAACATGGATGGTTCCTTTCGCTGTGAGTGTCCAGCAGGGTACACTCTTGACTA
CACAGGAACACATTGTGATGATATCGATGAATGTTCAGTGAGAAACCCATGTGGAAACGGCA
CGTGCTCCAATGTAATCGGGGCATTTGAGTGTTTGTGTGAAGAAGGATTTGAGCCTGGACCGA
TGATGAGCTGTGAAGATGTGAACGAATGTGGTCAGAATCCTCTGCTCTGTGCATTTCGCTGCA
TCAACACTTTCGGGAGTTATGAATGCAGCTGTCCATCTGGTTACACACTGAGAGAGGATGGAC
GCATGTGTCAAGATGTAGACGAGTGTGCAGAAGATCTTCATAACTGTGACTCCAGAGGAATG
GAATGTAGCAACCTAATTGGCACATTTATGTGTGTTTGTCCGGCCGGTATGATCCGCAGGATG
AGTGATGAGGCCTGTCAAGATGAAAATGAATGCTTGACTCAGCCTGGTGTTTGTGAAAATGGC
CGTTGTGTGAACACTGTTGGCAGCTACACTTGTGAATGTGGTGTTGGGTTCAAAACGGACTCA
TCAGCCACACAATGTCTTGATTACAGGAAAGGCTTCTGTTTCACTGAAGTTCTGCACACCATG
TGTCAGATGTCGTCCAGCAGTCGTGTTCCTGTCAGCAGGTCTCAGTGCTGCTGTAATGGAGGT
CATGGGTGGGGGGATCAGTGTGAGCTCTGCCCTCTGCCTGCCACTGCCAACTACAAAAAACTC
TGTCCATATGGTCATGGATACGCCATAGACGGAACAGATATAGATGAGTGTAAACTAATTCCA
GATGTCTGTGCCAATGGCGCTTGTATCAACATGATGGGCTCTTACAGATGCCACTGCAAACCA
GGATACATAGCATCTACTGCAGGAACCGCATGTGTTGATGTCGATGAATGTGGTATGTCTCCA
AAACCCTGTAACTTCATATGTAAGAACACCGAGGGCAGCTATGCATGTTCCTGTCCCCGTGGT
TACACTCTGCAGAATGACAACAGGTCATGCAAAGATGTGGATGAATGTCAGAGCAGACGACA
CAACTGCCAGTTCTCGTGCATGAACACCATCGGTGGATTCACATGCAAGTGTCCAGCAGGTTT
CAGCCAGCATCACAGAGCTTGCAGAGATATTGATGAATGTTTGTCAGACCTAACACCGTGTGG
CCTGCAAGGAGCATGTCAGAATTCAGTGGGAAGCTTCAGCTGTGAGTGTCCCCAGGGCTTCAG
TCTGGACTCTCTCGGCCACAACTGTGATGATGTAGATGAGTGTGCACGGGATCACAGGTGTCA
GTTCGGTTGTCAGAATGTTGCTGGAGGTTTTCGCTGCAGCTGTCCACAGGGTTACACACAACA
CCAGCAGTGGAACCAGTGTGTGGATGACAATGAGTGCTTGAACGCAGACAACTGTGGTTCAG
CTTCCTGTTTCAACACTTTGGGCAGTTTCAAGTGTGGCTGCCCATCTGGCTTCACCTTTGATCC
TGCATCTACTAGCTGTGAGGATGTAGACGAGTGCGGGTCCTTCATGAACCCCTGCAGATACGG
CTGCTCTAACACACAGGGTGGATTTGCGTGCGGGTGCCCAGCTGGTTATTACAGAGCAGGACA
GGG

B)
MSSQGDLRCLFGFVALLGILTGKISGIHGKATVHIDGSQRRQKQESLRGPNVCGSRLQSFCCPGWK
TLPGGNQCVVPICRSDCGDGFCSRPNMCTCPGGQTATTCFTKSSKQCKIRCMNGGVCEDDYCQCP
KGYTGSFCGQPVCEKNCQNGGHCIGPNRCACGYGFTGPQCERDYRTGPCFIQVHSRKCAGQSSEF
VCSKALCCATVGQAWGHSCEQCPPISSPCTRGFIPNTRTGACQDVDECKVVPDLCKGGRCINTLGS
YQCTCPVGYQQHVSILKCEDVDECSTIERACEAGHCINSAGSFSCVCPSGYVLSADRTRCLDQHTG
ICFASVVNGRCAHEISGRFNKIQCCCDRGRCWSQRTTHEMCPVPGSDEYLRICLVGSALSGYNEED
PEMSPHHHSSFSVSPNDQILHPHNGNGQIKPQIRQTPQILQFPQIPQIPRHDNGFKPQRPVVSVNETV
NRCRLLPNLCLNGRCIPMESDYRCDCNTGFKEDNRGECSDVDECEFDPCANGNCINTPGSYYCRC
HTGFLRVTGKQTCIDIDECLQNGVLCKNGRCLNTEGSFQCICNSGFKLSPDGRNCVDHDECAATN
MCLNGMCINEDGSFKCVCKPGFTLNSSGRYCTEIDECRTPGVCMNGRCVNTQGSFRCECFAGLTV
GIDGRTCVDTHMRSTCYGAVKRGLCLRPFQRAVTKSQCCCANPDYAFGEPCHPCPAKHSAEFQVL
CASGVGFSADGKDINECALDPDICSNGVCENLRGNFRCICNIGYESDQSGRNCLDIDECVVNSLLC
DNGLCRNVPGSYSCTCPAGFIFRHDTETCEDVNECVSSPCVNGVCKNSAGSFYCECSQGSKLDSTG
LLCVDSVKGSCWLTLQDGRCEVNINGATLRSQCCATLGLAWGSPCEPCQTDLVCERGFARSRGAS
CEDVNECEVFPGVCHNGHCVNTRGSFKCQCPESLTLDVTGRLCVDVRSEPCFLTYEEDVCTQPVP
GRFRMDMCCCTVGLAWGKDCDLCPEPGTRQFDTLCPRGPGFANKGDVLTGRAVYKDINECKVF
QSICVHGKCRNTIGSFRCRCDSGFALDTNEKNCTDIDECMISPDVCGHGTCVNTLGSFQCDCFPGY
ESGIMMMKNCMDIDECERNLSLCNGGTCENTDGSYKCVCPPGHHLSVDGSACEDVNECDLSSTL
CPNGWCVNLVGTYQCSCNSGYQTAPDWKGCTDIDECTIENGGCELYCSNSEGSYSCSCGQGYSLT
PDQRTCSDVNECEEVLDICEGGQCTNVPGAYHCLCYEGFMASVDMKTCIDVNECELNDNICAFGE
CENTKGSFICHCDIGYAVKKGTSGCTDVNECEINSHNCDTHATCVNTPGHYHCSCGDGWFGDGV
KCADVDECANRTSVCSADAECVNTAGSYHCECSDGFIGDGVICSDLDECAEDVDLCENGQCLNVP
GSYRCECEMGFTHTSNRKTCRDIDECSFQNICVFGTCQNIPGMFRCICDEGYELDRTGGNCTDVDE
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CLDSLNCVNGHCENTAGSYQCNCPIDFELNPTGIGCVDTRVGNCFLEVAYHSKLACSAEIGFGVSR
SSCCCSLGRVWGYPCDHCPTLNTSEYNTLCPGGEGFKPNPVTIILEDIDECQELPGLCQGGNCVNTF
GSFQCECPAGFYLNTQSRICEDIDECVLSLGVCGPGTCYNTLGNYTCVCPQEYIQVNGGHRCMDM
RKSLCYRSYNGSACEHQLNFNITHRLCCCSYNVGKAWNKPCHACPIPGTDDYSSLCGSVTGFWINI
ATGKPKDIDECHEIPGVCAHGVCINHMGSFHCECPTGFLYNDLLLICEDIDECSSREPVCQRNADCI
NRPGGYQCECSDGYILTPNGDCNDRNECLETPSVCRHGDCVDIPGGYECMCHTGFTVTPNRRMCV
DVNECSPQPCGNGTCKNSVGSFNCICHHGFELATNNYCTDIDECAVFHSQLCRNGRCVNNVGSFQ
CLCREGYELTFDGKTCMDVNECTIIPGICAPGTCLNLDGSFRCVCPDGYIVQSDHCVDVNECSEEP
GICTYGTCFNSLGSFECVCKPGFVLSEDKRRCYDTRESFCFTRFENSKCSVPQAFNTTKAKCCCSIM
AKEGWGDPCELCPKEHDAFQDLCPFGHGIIPGVGDTRVDLNECVENPEICVNGRCINMDGSFRCEC
PAGYTLDYTGTHCDDIDECSVRNPCGNGTCSNVIGAFECLCEEGFEPGPMMSCEDVNECGQNPLL
CAFRCINTFGSYECSCPSGYTLREDGRMCQDVDECAEDLHNCDSRGMECSNLIGTFMCVCPAGMI
RRMSDEACQDENECLTQPGVCENGRCVNTVGSYTCECGVGFKTDSSATQCLDYRKGFCFTEVLH
TMCQMSSSSRVPVSRSQCCCNGGHGWGDQCELCPLPATANYKKLCPYGHGYAIDGTDIDECKLIP
DVCANGACINMMGSYRCHCKPGYIASTAGTACVDVDECGMSPKPCNFICKNTEGSYACSCPRGY
TLQNDNRSCKDVDECQSRRHNCQFSCMNTIGGFTCKCPAGFSQHHRACRDIDECLSDLTPCGLQG
ACQNSVGSFSCECPQGFSLDSLGHNCDDVDECARDHRCQFGCQNVAGGFRCSCPQGYTQHQQW
NQCVDDNECLNADNCGSASCFNTLGSFKCGCPSGFTFDPASTSCEDVDECGSFMNPCRYGCSNTQ
GGFACGCPAGYYRAGQG

Supplementary Figure 2
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RCACSEGFTGDGFTCSDVDECAENINLCENGQCLNVPGAYRCECEMGFTPASDSRSCQDI
RCSCKEGFNGDGFSCSDMDECADNVNLCENGQCLNAPGGYRCECEMGFTPTEDSKACQDI
-----------------------------------------------------------HCECSDGFIGDGVICSDLDECAEDVDLCENGQCLNVPGSYRCECEMGFTHTSNRKTCRDI
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DECSLPNICVFGTCHNLPGLFRCECEIGYELDRSGGNCTDVNECLDPTTCISGNCVNTPG
DECSFQNICVFGTCNNLPGMFHCICDDGYELDRTGGNCTDIDECADPINCVNGLCVNTPG
DECNFQNICVFGSCQNLPGMFRCVCDYGYELDRSGGNCTDINECFDPVNCINGVCVNLPG
-----------------------------------------------------------DECSFQNICVFGTCQNIPGMFRCICDEGYELDRTGGNCTDVDECLDSLNCVNGHCENTAG
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RYECNCPPDFQLNPTGVGCVDNRVGNCYLKFGPRGDGS-LSCNTEIGVGVSRSSCCCSLG
SYLCNCPPDFELNPSGVGCVDTRVGNCFLDTLDRGDGG-ISCSAEIGVGVTRASCCCSLG
-----------------------------------------------------------SYQCNCPIDFELNPTGIGCVDTRVGNCFLEVAYH---SKLACSAEIGFGVSRSSCCCSLG
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GAWGNPCELCPFVNSTEYKTLCPGGEGFRPNPITVILEDIDECQELPGLCQGGNCVNTFG
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CMDMRRSLCYRNYYADNQTCDGELLFNMTKKMCCCSYNIGRAWNKPCEQCPIPSTDEFAT
CMDMRKSFCYRSYNG--TTCENELPFNVTKRMCCCTYNVGKAWNKPCEPCPTPGTADFKT
CMDMRKSVCYRNFN---DTCENELSFNMTKKMCCCAYNVGKAWNRPCEACPTPATSEYQL
---------RRNYN---DTCENELSSNMTKKMCCCSYNIGKAWNKPCEPCPSPATPEYIF
CMDMRKSLCYRSYNG--SACEHQLNFNITHRLCCCSYNVGKAWNKPCHACPIPGTDDYSS
CMDMRKSVCFRHYN---GTCQNELAFNVTRKMCCCSYNIGQAWNRPCEACPTPISPDYQI
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ICGN-IPGFTFDIHTGKAVDIDECKEIPGICANGVCINQIGSFRCECPTGFSYNDLLLVC
LCGNQAPGFIIDIHTGKPIDIDECREIPGICANGVCINQIGSFRCECPMGFSYNNILLIC
LCGNQAPGFIIDIRTGKPMDIDECSEIPAICSNGVCINQIGTFRCECPMGFSYNNILLIC
LCGS-VTGFWINIATGKPKDIDECHEIPGVCAHGVCINHMGSFHCECPTGFLYNDLLLIC
LCGNQAPGFLTDIHTGKPLDIDECGEIPAICANGICINQIGSFRCECPAGFNYNSILLAC
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EDIDECQNG-PVCQRNAECINTAGSYRCDCKPGYRFTSTGQCNDRNECQEIPNICSHGQC
EDIDECSNGDNLCQRNADCINSPGSYRCECAAGFKLSPNGACVDRNECLEIPNVCSHGLC
EDIDECNSGDNLCQRNANCINIPGSYRCECSAGFKLSPSGACIDRNECQEIPNVCSHGEC
EDIDECSSGENLCQRNADCINIPGSYRCECSSGYKLSPSGACVGRNECQEIPNVCSHGTC
EDIDECSSREPVCQRNADCINRPGGYQCECSDGYILTPNGDCNDRNECLETPSVCRHGDC
EDVDECGSRESPCQQNADCINIPGSYRCKCTRGYKLSPGGACVGRNECREIPNVCSHGDC
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IDTVGSFYCLCHTGFKTNDDQTMCLDINECERDACGNGTCRNTIGSFNCRCNHGFILSHN
VDLQGSYQCICHNGFKASQDQTMCMDVDECERHPCGNGTCKNTVGSYNCLCYPGFELTHN
IDTQGSFRCLCHNGFKTTPDQTMCMDIDECDRQPCGNGTCKNTVGSYNCLCFPGFELTHN
MDTEGSYICVCHNGFKASGDQTMCMDIDECDRQPCGNGTCKNTVGSYNCLCFPGFELTHN
VDIPGGYECMCHTGFTVTPNRRMCVDVNECSPQPCGNGTCKNSVGSFNCICHHGFELATN
MDTEGSYMCLCHRGFQASADQTLCMDIDECDRQPCGNGTCKNIIGSYNCLCFPGFVVTHN
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NDCIDVDECASGNGNLCRNGQCINTVGSFQCQCNEGYEVAPDGRTCVDINECLLEPRKCA
NDCLDIDECSSFFGQVCRNGRCFNEIGSFKCLCNEGYELTPDGKNCIDTNECVALPGSCS
NDCMDIDECSVHASQVCRNGQCINNMGSFKCLCLDGYNLTPDGKNCVDINECVTLPGACQ
NDCMDIDECSSLVGQVCRNGQCINNVGSFQCLCQEGYEITPDGKNCMDINECTSLPATCS
NYCTDIDECAVFHSQLCRNGRCVNNVGSFQCLCREGYELTFDGKTCMDVNECTIIPGICA
GDCVDFDECTTLVGQVCRFGHCLNTAGSFHCLCQDGFELTADGKNCVDTNECLSLAGTCL
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PGTCQNLDGSYRCICPPGYSLQNEKCEDIDECVEEPEICALGTCSNTEGSFKCLCPEGFS
PGTCQNLEGSFRCICPPGYEVKSENCIDINECDEDPNICLFGSCTNTPGGFQCLCPPGFV
PGTCQNLDGSFRCICPPGYEVQNDKCVDINECNVEPNICQFGTCKNTPGSFQCICQPGFV
PGTCQNLEGSFRCICPPGFEVQNDNCIDINECDEEPNICLFGTCTNTPGSFQCVCPPGFV
PGTCLNLDGSFRCVCPDGYIVQSDHCVDVNECSEEPGICTYGTCFNSLGSFECVCKPGFV
PGTCQNLEGSFRCICPPGFQVQSDHCIDIDECSEEPNLCLFGTCTNSPGSFQCLCPPGFV
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LSDNGRRCFDTRQSFCFTNFENGKCSVPKAFNTTKAKCCCSKMPGEGWGDPCELCPKD-D
LSDNGRRCFDTRESFCFTRFEAGKCSVPKPRNTTKAKCCCSLLPGEGWGDPCELCPRDTE
LSDNGRRCFDTRQSFCFTRFDNGKCSVPKAFNTTKARCCCSKMPGEGWGDPCELCPQE-G
LSEDKRRCYDTRESFCFTRFENSKCSVPQAFNTTKAKCCCSIMAKEGWGDPCELCPKE-LSDNGHRCFDTRQSFCFTRFEAGKCSVPKAFNTTKTRCCCSKRPGEGWGDPCELCPQE-G
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DEAFRQICPYGSGIIVGPDDSAVDMDECKE-PDVCKHGQCINTDGSYRCECPFGYILAGN
EVAFQDLCPYGHGTVPSLHDTREDVNECLESPGICSNGQCINTDGSFRCECPMGYNLDYT
EAAFHTLCPYGHEAVP-KPEGREDMNECVENPEICGNGLCINTDGSFRCECPFGYNLDYT
SVAFQELCPYGHGSIPGMGDTREDVNECSESPGICVNGVCINTDGSFRCECPFGYNLDYT
HDAFQDLCPFGHGIIPGVGDTRVDLNECVENPEICVNGRCINMDGSFRCECPAGYTLDYT
SAAFQELCPFGHGAVPGPDDSREDVNECAENPGVCTNGVCVNTDGSFRCECPFGYSLDFT
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--ECVDTDECSVGNPCGNGTCKNVIGGFECTCEEGFEPGPMMTCEDINECAQNPLLCAFR
GVRCVDTDECSIGNPCGNGTCTNVIGSFECNCNEGFEPGPMMNCEDINECAQNPLLCAFR
GVNCVDTDECSIGNPCGNGTCSNVPGGFECSCQEGFEPGPMMTCEDINECAVNPLLCAFR
GVNCVDTDECSIGNPCGNGTCSNVVGGFECACDEGFEPGPMMTCEDINECTN-PLLCAFR
GTHCDDIDECSVRNPCGNGTCSNVIGAFECLCEEGFEPGPMMSCEDVNECGQNPLLCAFR
GINCVDTDECSVGHPCGQGTCTNVIGGFECACADGFEPGLMMTCEDIDECSLNPLLCAFR
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CVNTFGSYECMCPTGYVLRDDNRMCRDQDECAEGLDDCASRGMACKNQIGTFMCICPPGM
CINTYGSYECTCPSGYTLREDQRMCKDLDECAEGLHDCESRGMMCKNLIGTFMCICPPGL
CINTFGSYECSCPSGYTLREDGRMCQDVDECAEDLHNCDSRGMECSNLIGTFMCVCPAGM
CHNTEGSYLCTCPAGYTLREDGAMCRDVDECADGQQDCHARGMECKNLIGTFACVCPPGM
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IRRM-SDEACQDENECLTQPGVCENGRCVNTVGSYTCECGVGFKTDSSATQCLDYRKGFC
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FTEVLQTMCQQSSTNRNTVTKSECCCNGGRGWGSLCELCPLPGTIQYKKMCPLGPGYTTD
FTEVLQTMCQLSSTNRNMVTKSECCCNSGRGWGNQCEICPLPGTGAFKKMCPHGAGFSTD
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GRDINECEVMPNLCKNGQCINSVGSFRCHCNVGYTNDFTGTSCIDMDECSQSPKPCNFLC
GRDIDECKVLPNLCKNGQCINTIGSFRCHCKLGYTTDITGTTCVDLDECAQSPKPCNFIC
GTDIDECKLIPDVCANGACINMMGSYRCHCKPGYIASTAGTACVDVDECGMSPKPCNFIC
GRDVDECRMLAHLCAHGECINSLGSFRCHCQAGYTPDATATTCLDMDECSQVPKPCTFLC
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KNTEG-SYLCSCPRGYILQPDGKTCKDLDECSTKQHNCQFLCVNTIGGFTCKCPSGFTQH
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QTACIDNNECSNQPNICGSRASCLNSPGSFNCECQKGFSLDATGLNCDDVDECGGNHRCQ
QSSCIDNNECNAQPNLCGSRGTCQNNPGSFTCECQKGFSLDNSGSNCEDVDECDGNHRCQ
HRACRDIDECLSDLTPCGLQGACQNSVGSFSCECPQGFSLDSLGHNCDDVDECARDHRCQ
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HGCQNILGGYRCGCPQGYIQHYQWNQCVDENECS-NPNACGSASCYNTLGSYKCACPSGF
HGCQNMMGGYRCGCPQGYVQHYQWNQCVDENECT-GNQVCGSASCYNTLGSYKCVCPSGF
HGCQNVLGGFRCGCPQRYVQHYQWNQCVDENECA-SQSACGSASCYNTLGSFKCVCPSGF
FGCQNVAGGFRCSCPQGYTQHQQWNQCVDDNECL-NADNCGSASCFNTLGSFKCGCPSGF
HGCQNQLGGYRCSCPQGFTQHSQWAQCVDENECALSPPTCGSASCRNTLGGFRCVCPSGF
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DFEATAGGCQDVNECSMGN-NPCSYGCSNTDGGYLCGCPGGFYRAGQGHCINGVGF-QGQ
DFDQSFGGCQDVDECSSGGGNPCSYGCSNTDGGYLCGCPGGYFRAGQGHCVSGMGFGKGS
TFDPASTSCEDVDECGSFM-NPCRYGCSNTQGGFACGCPAGYYRAGQG-----------DFDQALGGCQEVDECAGRR-GPCSYSCANTPGGFLCGCPQGYFRAGQGHCVSGLGFSPGP
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YLSLDTEVDEENALSPEACYECKINGYSKKDSRQKRSIHEPDPT-------AVEQISLES
FGSEGG--DDEESLSPEACYECKINGDLGKKGRHRRNADDNE---------LKETVSMAS
YLQAPVEEDEENVLSPESCYECKINGYPKR-GRQRRNADDINGN-------EIQNVSLAS
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VDMDSPVNMKFNLSHLGSKEHILELRPAIQPLNNHIRYVISQGNDDSVFRIHQR-NGLSY
MDIQTSIPMNLSLAQLLNKEPLLELLPALEPLEHHVRYVITHGNQGEHFRILERRDGKSV
VDIDAPLNMTLNISDLANKQHIFEFIPALESLENRVRYIISHGNEGGIFHIHQR-DGISY
-----------------------------------------------------------LDSEALLTLGLNLSHLGRAERILELRPALEGLEGRIRYVIVRGNEQGFFRMHHL-RGVSS
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LHFTKKKPVAGTYSLQISSTPLYKKKELNQLEDKYDKDYLSGELGDNLKMKIQVLLH
LHTAKKKLMPGTYTLEITSIPLYKKKELKKLEESNEDDYLLGELGEALRMRLQIQLY
LRLGRRPPAPGLYRLEIASLRLFGPRKLQQMEDQHDSDYLLGEIGDALRIKLHIHLH
LHLGHKKVATGIYNLEIASVSLYRKKELQKLEDEKDHNYLSGEVGQTLKMKLHIHLY
--------------------------------------------------------LQLGRRRPGPGTYRLEVVSH-MAGPWGVQPEGQP-------GPWGQALRLKVQLQLL
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Essential role for the alpha 1 chain of type VIII collagen in zebrafish notochord formation
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Abstract
A number of zebrafish mutants identified in large-scale forward genetic screens exhibit
notochord distortion. We now report the cloning and further characterization of one such
mutant, gulliverm208 (gulm208). The notochord defect in gulm208 mutants is exacerbated
under conditions of copper depletion or lysyl oxidase cuproenzyme inhibition that are
without a notochord effect on wild-type embryos. The gulm208 phenotype results from a
missense mutation in the gene encoding Col8a1, a lysyl oxidase substrate, and
morpholino knockdown of col8a1 recapitulates the notochord distortion observed in
gulm208 mutants. Interestingly, the amino acid mutated in gulm208 Col8a1 is highly
conserved, and the equivalent substitution in a closely related human protein, COL10A1,
causes Schmid metaphyseal chondrodysplasia. Taken together, the data identify a new
protein essential for notochord morphogenesis, extend our understanding of gene-nutrient
interactions in early development, and suggest that human mutations in COL8A1 may
cause structural birth defects.
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Introduction
The notochord is a midline structure that functions both as an axial skeleton and as an
important signaling center to other tissues during embryogenesis (31). It is one of the
defining structures of the chordate phylum, and is the first organ to fully differentiate in
vertebrates (31). The notochord arises from the dorsal organiser and likely represents a
primitive form of cartilage, as indicated by its expression of type II collagen, type IX
collagen, sox9, aggrecan, and chondromodulin (16). In higher chordates, the notochord
plays a critical role in vertebral column formation and persists post-embryonically as the
nucleus pulposus of intervertebral discs (16).
In zebrafish, studies of notochord morphogenesis are facilitated by the genetic
tractability of this model organism and by the ease with which its notochord is visualized
throughout early development (16, 19, 20). During late notochord morphogenesis,
chordamesoderm differentiates into mature notochord, a transition that involves the
downregulation of specific marker genes and the inflation of notochord cell vacuoles
which exert turgor pressure on an extracellular matrix sheath (31). If sheath formation is
impaired, this turgor pressure results in notochord abnormalities that are readily
observed, permitting insight into the mechanisms of both notochord morphogenesis and
extracellular matrix formation. Indeed, a number of zebrafish notochord mutants have
already been identified during large-scale forward genetic screens (17, 18), and early
studies of these mutants established the importance of laminins and coatomer proteins in
notochord differentiation and sheath formation (19, 20). Since notochord abnormalities
and extracellular matrix defects have both been implicated in the development of
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structural birth defects (11, 15, 134), elucidating the mechanisms of notochord formation
will not only permit a greater understanding of the biology of this important organ, but
may also allow for the therapeutic intervention or prevention of structural birth defects,
which are a major cause of morbidity and mortality in children (135).
Previous work in our laboratory has demonstrated that copper deficiency causes
notochord distortion in zebrafish embryos and that this distortion results from the
inhibition of specific lysyl oxidase cuproenzymes, which crosslink collagens in the
notochord sheath (14, 80). In addition, we have recently conducted a forward genetic
screen for zebrafish mutants that exhibit increased notochord distortion after partial lysyl
oxidase inhibition, identifying one such mutant (136). These studies raised the intriguing
possibility that notochord mutants previously identified in large-scale forward genetic
screens (17, 18) could provide insight into the molecular mechanisms of copperdependent notochord formation. We now report the mapping and further characterization
of one such recessive lethal mutant, gulliverm208 (17). The analysis presented here
demonstrates a role for the alpha 1 chain of type VIII collagen in zebrafish notochord
formation and an interaction with lysyl oxidase cuproenzymes.
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Materials and methods
Zebrafish maintenance
Gulliverm208 was obtained from the Zebrafish International Resource Center (Eugene,
OR). Zebrafish were reared under standard conditions at 28.5C (33) and staged as
described (34). Synchronous, in vitro fertilized embryos were obtained for all
experiments, which were carried out in accordance with Washington University‟s
Division of Comparative Medicine guidelines. In Figs. 1, 2, and the first two lanes of 5B,
“wild-type” refers to either +/+ or +/- embryos.
Microscopy
Live embryos were anesthetized in tricaine, mounted in 2% methylcellulose, and imaged
using an Olympus SZX12 zoom stereomicroscope fitted with an Olympus DP70 camera.
Electron microscopy was carried out as previously described (80) except that negatives
were directly scanned using a Canon Canoscan 8400F. For the electron microscopy,
sections from two wild-type and two mutant embryos were examined.
Pharmacologic treatment and yolk sac extension measurements
Pharmacologic compounds were purchased from Sigma (St. Louis, MO).aminopropionitrile (A3134) and neocuproine (N1501) were prepared as 100 mM stocks
in egg water (33) and dimethyl sulfoxide, respectively, and diluted in egg water.
Tunicamycin (T7765) was prepared as a 1 mg/mL stock in DMSO and used at a
concentration of 2 g/mL. 4-Phenylbutyric acid (P21005) was prepared as a 2 M stock in
DMSO and used at a concentration of 5 mM in buffered egg water adjusted to a pH of 6.9
(137). In all cases, embryos were placed in compound between 6 and 10 hpf. Lengths of
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individual yolk sac extensions were measured from photographs of 10 mutant and 10
wild-type embryos per pharmacologic treatment using ImageJ software (47). Values are
reported in arbitrary units, with standard deviations noted.
Meiotic mapping
Gulliverm208 was mapcrossed to the polymorphic WIK strain and the progeny (AB*/WIK)
raised to adulthood. The gulm208 mutation was assigned to chromosome 9 by centromeric
linkage analysis (26, 93) using simple sequence length polymorphism (SSLP) markers
(94) and DNA from early pressure gynogenetic diploids. For fine mapping, 1295 mutant
embryos from AB*/WIK females crossed to AB*/AB males were collected and assessed
for recombination along chromosome 9 by SSLP analysis. Embryos were incubated in 2
M neocuproine to accentuate the mutant phenotype and facilitate rapid mutant
identification. When necessary, candidate marker primer pairs for BAC sequences were
generated using the Zebrafish SSR search website of the Massachusetts General Hospital
(http://danio.mgh.harvard.edu/markers/ssr.html). Primers for the BAC markers used in
Fig. 3 are: zC81J7 – forward 5‟-TTGTTCTGCAAATTTTGTTGG-3‟ and reverse 5‟GGGGCAACCCCTCTAAAGT-3‟; zK46K9 – forward 5‟AACACAAGCTGGGACTGGAC-3‟ and reverse 5‟GATGTCTAACACAAACACATTGG-3‟; zC206L17 – forward 5‟GAGTATCACCTCTGACAGATGGG-3‟ and reverse 5‟GCAGCATTGACGGTGAAGGTCAC-3‟; zK229B18 – forward 5‟TGATTAATACAACATGGGCA-3‟ and reverse 5‟-CGCACTGTGAAATAACATGA3‟; zC184M13 – forward 5‟-GGAAGTGTGTGTGTGCGTTT-3‟ and reverse 5‟-
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GGCCACAAGAACCATGACA-3‟ (descendents of one WIK grandparent) and also
forward 5‟-TGGTGTAGGGGGCTAACAAG-3‟ and reverse 5‟TGAACTGAACTGGCATGAACA-3‟ (descendents of the other WIK grandparent).
DNA from wild-type and heterozygote embryos as well as WIK and AB grandparents
was used to ensure polymorphism between AB and WIK.
Cloning and annotation
Full-length col8a1 was amplified from wild-type and mutant cDNA and cloned into pCRXL-TOPO (Invitrogen). cDNA for these reactions was generated with Superscript III
reverse transcriptase (Invitrogen) and PCR carried out using Phusion DNA polymerase
and high-fidelity buffer (Finnzymes). The primers used for PCR were: forward primer 5‟GAGTGAGCCCACCAATCCTTG-3‟ and reverse primer 5‟CCTTCAAATTCTTACTTATTCTTGC-3‟. The full-length zebrafish col8a1 coding
sequence is available at Genbank (accession number EU781032). The protein sequence
alignment of zebrafish Col8a1 with orthologues from other species was created using
ClustalW2 (96). Signal peptides were predicted using SignalP 3.0 (39).
Trimerization assay
Wild-type and mutant col8a1 sequences were subcloned into pCS2+ and in vitro
transcribed and translated in the presence of TRAN35S-LABEL (MP Biomedicals) using
the SP6 TNT Coupled Reticulocyte Lysate System (Promega) essentially as described
(138, 139). 5 µl of each 25 µl reaction was mixed with an equal volume of 2X sample
buffer containing 250 mM Tris pH 6.8, 4 M urea, 4% sodium dodecyl sulfate (SDS), 24
mM dithiothreitol, and a small amount of bromophenol blue. Samples were heated at
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50C for 5 minutes and subjected to SDS-PAGE on a 1 mm gel with 3.5% stacking and
7.5% resolving layers. The gel was fixed for 30 minutes in a mixture of 20% methanol
and 10% glacial acetic acid, washed in water for 5 minutes, and vacuum dried at 80 C
for 2 hours before exposure of a low-energy phosphor screen (Amersham) and image
acquisition using a Storm imaging system (Amersham).
Whole-mount in situ hybridization and frozen sections
Embryos were manually dechorionated at the indicated developmental stages, fixed in
4% paraformaldehyde-PBS overnight at 4C, and dehydrated by methanol series. The
probe construct was generated by cloning the 5‟ end of zebrafish col8a1 into pCRII
(Invitrogen). The primers used for the PCR amplification reaction were: forward primer
5‟-GAGTGAGCCCACCAATCCTTG-3‟ and reverse primer 5‟CTCCTGGACTTCCAATACCC-3‟. DIG-labeled antisense RNA probes were
synthesized using a DIG-labeling kit (Roche), and whole-mount in situ hybridization was
performed as previously described (14, 45).
Reverse transcriptase-polymerase chain reaction (RT-PCR)
RNA was obtained from pooled embryos or unfertilized eggs using Trizol reagent
(Invitrogen). For Figs. 4J and 5B, cDNA was prepared from 500 ng of RNA using an
oligo dT primer and Superscript III reverse transcriptase (Invitrogen). PCR amplification
over 35 cycles was subsequently performed using 1 L of cDNA and GoTaq polymerase
(Promega) in a final volume 25 L. The annealing temperature was 57C and the
extension time 1 minute. Primers to col8a1 were: forward primer 5‟GAGTGAGCCCACCAATCCTTG-3‟ and reverse primer 5‟-
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CCTCTGGGAATGGTCTCACC-3‟. Primers to xbp1 were: forward primer 5‟GTTCAGGTACTGGAGTCCGC-„3 (140) and reverse primer 5‟GGATGTCCAGAATACCAAGCAGG-3‟. Primers to ampka1 and spt (also known as
tbx16) have been reported previously (141). For Fig. 6C, cDNA was prepared from 1 g
of RNA and the annealing temperature was 55C. The forward primer to col8a1 was as
noted above, but the reverse primer was 5‟- GACATTCCTGGCTTACCAATTCC-3‟.
Band quantitation was performed using ImageJ software (47). For Fig. 4J, band
quantitation of col8a1 was calculated using a different exposure of the same gel where
the bands were not saturated.
Morpholino and mRNA injections
Morpholino oligonucleotides (27) targeting start and splice sites in col8a1 were
resuspended in Danieau buffer (start MO) or water (splice MO), diluted to include 0.05%
phenol red, and injected into 1-cell embryos. Standard control morpholino (Gene Tools,
LLC) was resuspended in Danieau buffer and likewise injected. Morpholino sequences
were: 5‟-CCGTAGGAGAAGATAATCTCAAGGA-3‟ (start MO) and 5‟TAAAGTGTATCTCCTTACCTTTCCT-3‟ (splice MO). The start MO was used at doses
of 2.4 ng and 7.2 ng. Capped, polyadenylated mRNA for rescue experiments was
generated from wild-type or mutant full-length clones of zebrafish col8a1 using the
mMESSAGE mMACHINE kit (Ambion). Individual embryos from gulm208/+ intercrosses
were injected with either 200 or 800 pg of mRNA.
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Results
gulm208 mutants are sensitized to lysyl oxidase inhibition
Gulliverm208 (gulm208) mutants exhibit notochord distortion similar to what is obtained
under conditions of copper deficiency or direct pharmacologic lysyl oxidase
cuproenzyme inhibition (14, 17, 74, 80). However, the distortion observed in gulm208
mutants is less robust, and we therefore tested these mutants for sensitivity to lysyl
oxidase inhibition (Fig. 1). Clutches from gulm208/+ intercrosses were incubated in vehicle
(Fig. 1A, B) or in a dose of the copper chelator neocuproine (Fig. 1C, D) that does not
cause notochord distortion in wild-type embryos (Fig. 1C and Gansner et. al, 2007).
Under such copper-limiting conditions, gulm208 mutants exhibited increased notochord
distortion (Fig. 1D vs. Fig. 1B, arrowheads), presumably due to the partial inhibition of
lysyl oxidase activity (80). This hypothesis was confirmed by incubating clutches from
gulm208/+ intercrosses in a dose of the irreversible lysyl oxidase inhibitor aminopropionitrile that does not cause notochord distortion in wild-type embryos (Fig.
1E). Under these conditions, increased notochord distortion in gulm208 mutants was again
observed (Fig. 1F vs. Fig. 1B, arrowheads).
Interestingly, the notochord distortion observed in gulm208 mutants is accompanied
by a decrease in the length of the yolk sac extension (wild-type length = 3.23 0.09 vs.
mutant length = 2.64 0.18 in vehicle), and the increased notochord distortion observed
after neocuproine or -aminopropionitrile treatment is associated with a further
shortening of this structure in mutant but not wild-type embryos (wild-type length = 3.33
0.15 vs. mutant length = 2.31 0.09 in neocuproine; wild-type length = 3.22  0.12 vs.
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mutant length = 2.13  0.16 in-aminopropionitrile) (Fig. 1). These data suggest that
force generation in the notochord is impaired in gulm208 mutants and confirms a synergy
between the gulm208 locus and both copper chelation and lysyl oxidase inhibition.
Electron microscopy reveals notochord abnormalities in gulm208 mutants
To determine if a defect in notochord sheath formation could explain the notochord
phenotype of gulm208 mutants, we imaged truncal cross-sections from gulm208 mutant and
wild-type embryos by transmission electron microscopy. This revealed abnormalities in
both the vacuolated notochord cells and notochord sheath of gulm208 mutants at 24 hpf
(Fig. 2). In the vacuolated notochord cells of gulm208 mutants, the rough endoplasmic
reticulum exhibits striking areas of engorgement compared to wild-type embryos,
presumably due to retention of protein that fails to be secreted and instead forms large
circular aggregates (Fig. 2B vs. Fig. 2A, arrows). These aggregates are also observed in
the hypochord, which is closely apposed to the ventral aspect of the notochord (Fig. 2C,
red arrows) and plays a critical role in the formation of the dorsal aorta (57, 58). While
the inner (i), medial (m), and outer (o) layers of the notochord sheath are present in both
wild-type embryos and gulm208 mutants, the fibrillar medial layer appears disordered in
gulm208 mutants (Fig. 2E vs. Fig. 2D).
The gulm208 mutation disrupts the zebrafish col8a1 gene
To determine the molecular basis of the gulm208 phenotype, we meiotically mapped the
gulm208 locus to a centromeric region of chromosome 9 (Fig. 3A). This region contains
twenty-six genes (S. Fig. 1) one of which encodes the alpha 1 chain of type VIII collagen
(Col8a1), a known lysyl oxidase substrate (67). Cloning and sequencing of zebrafish
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col8a1 revealed a missense mutation in gulm208 mutants that is absent in wild-type
embryos (Fig. 3B). This mutation results in the substitution of histidine for tyrosine in the
C1q-like domain of Col8a1 (Y628H) (Fig. 3C). Protein sequence alignment demonstrates
that the tyrosine mutated in gulm208 fish is highly conserved (Fig. 3D; see also the
Discussion), and that zebrafish Col8a1 is similar to homologues in other species (S. Fig.
2). Sequencing of other genes located in the region between our flanking markers did not
identify any additional mutations capable of causing the gulm208 phenotype (S. Fig. 1).
The expression of col8a1 is consistent with the gulm208 phenotype
To determine the spatio-temporal expression of zebrafish col8a1, we performed wholemount in situ hybridization on wild-type embryos at various stages of development (Fig.
4). Consistent with the hypothesis that the Y628H substitution disrupts notochord
morphogenesis, col8a1 is robustly expressed in the notochord at the 5-, 10-, 15-, and 20somite stages (Fig. 4A-D, arrows). Starting at the 10-somite stage and continuing through
24-30 hpf, expression is also observed in the prechordal plate region (Fig. 4B-E, asterix),
floorplate (Fig. 4B-E, G, black arrowhead), and hypochord (Fig. 4B-E, G, white
arrowhead). At 24 hpf, notochord staining is diminished (Fig. 4E) and col8a1 is
expressed in the caudal somites (Fig. 4F, arrowheads). By 48 hpf, col8a1 expression is
restricted to the forming jaw cartilages (Fig. 4H, I, arrows). A difference in staining
intensity was not detected between gulm208 mutant and wild-type embryos processed in
the same basket (data not shown), suggesting that mutant col8a1 transcripts are not
degraded or overexpressed.
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To precisely map the onset of col8a1 expression, we employed a more sensitive
method for transcript detection, reverse transcriptase-polymerase chain reaction (RTPCR). This revealed that col8a1 is expressed at very low levels maternally and is
upregulated between 9 hpf and the 3-somite stage (Fig. 4J). Importantly, a PCR product
was not obtained if the reactions were performed in the absence of cDNA (Fig. 4J).
The Y628H substitution prevents Col8a1 trimerization but does not activate the
unfolded protein response
Since C1q-like domains are important for oligomerization (142), we tested whether the
Y628H substitution impairs zebrafish Col8a1 trimer formation using an in vitro assay
previously validated in studies of a closely-related collagen, collagen X (138, 139, 143).
While transcription and translation from either wild-type or mutant plasmid contructs
results in the production of Col8a1 monomers (Fig. 5A, lanes 1 and 2), only wild-type
zebrafish Col8a1 is able to trimerize (Fig. 5A, lane 1). Co-transcription and translation of
half the amounts of wild-type and mutant Col8a1 together did not prevent trimerization
(Fig. 5A, lane 3), consistent with loss of function of mutant Col8a1. Bands migrating
faster than monomer may represent late initiation products, as they were not present in a
negative control lane and were not cleaved in reactions supplemented with canine
pancreatic microsomes, which facilitate proteolytic processing of the Col8a1 signal
peptide (data not shown).
We also considered whether the gulm208 phenotype could result from a toxic effect
of mutant Col8a1 aggregates, which are observed in the endoplasmic reticulum of gulm208
mutants at 24 hpf (Fig. 2B, E). These aggregates could lead to endoplasmic reticulum
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stress, which results in the processing of x-box binding protein-1 (xbp1) mRNA to a
splice form encoding an activator of the unfolded protein response (144). However, xbp1
splicing is not observed in wild-type embryos or gulm208 mutants at 24 hpf (Fig. 5B).
Furthermore, incubation of wild-type embryos in tunicamycin, an inhibitor of Nglycosylation that causes endoplasmic reticulum stress, results in xbp1 splicing (Fig. 5B)
but does not cause the gulm208 phenotype (data not shown). Finally, 4-phenylbutyric acid,
a chemical chaperone that reduces endoplasmic reticulum stress (145, 146), does not
rescue the gulm208 phenotype (data not shown). These data suggest that the Y628H
substitution causes notochord distortion through insufficient Col8a1 deposition in the
notochord sheath rather than through activation of the unfolded protein response.
Morpholino knockdown of col8a1 recapitulates the gulm208 phenotype
To determine if loss of col8a1 recapitulates the notochord phenotype observed in gulm208
mutants, we designed morpholinos to knock down col8a1 in zebrafish. While injection of
standard control morpholino into wild-type embryos did not result in any visible
phenotypic effect (Fig. 6A and Table 1), injection of a splice morpholino targeting col8a1
caused notochord distortion indistinguishable from what is observed in gulm208 mutants
(Fig. 6B and Table 1). Importantly, this splice morpholino also caused a dose-dependent
reduction in col8a1 transcript, as detected by RT-PCR (Fig. 6C). Injection of a second,
distinct morpholino targeting the start site of col8a1 gave identical phenotypic results
when used at a dose of 2.4 ng (data not shown), confirming that the gulm208 phenotype
results from loss of Col8a1. Interestingly, injection of either the start or splice
morpholinos at higher doses resulted in more robust notochord distortion (Fig. 6D and
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data not shown). Neither morpholino altered melanin pigment formation (data not
shown).
Injection of 200 pg of mRNA encoding full-length col8a1 into clutches from
gulm208/+ intercrosses did not rescue the gulm208 phenotype (data not shown), whereas
injection of 800 pg of mRNA caused dysmorphism during epiboly and at 26 hpf (data not
shown). This suggests that col8a1 expression must be restricted to specific cell types
during early development in order for rescue to be successful.
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Discussion
These data reveal a previously unappreciated role for the alpha 1 chain of type VIII
collagen (Col8a1) in zebrafish notochord formation. Type VIII collagen is formed
through homopolymerization of either alpha 1 or alpha 2 polypeptide chains (147) and is
a member of the short-chain collagen family that includes type X collagen. The
experiments with neocuproine (Fig. 1C, D) reveal a gene-nutrient interaction between
copper and col8a1 that significantly alters notochord morphogenesis. The notochord
sensitivity of gulm208 mutants to lysyl oxidase inhibition (Fig. 1D, F) suggests that some
mutant Col8a1 may be able to fold in vivo, and residual Col8a1 function could explain
the enhanced notochord distortion observed with higher doses of col8a1 morpholino (Fig.
6D). Importantly, the mechanism by which morpholinos decrease specific gene
transcription precludes the accumulation of protein aggregates in the rough endoplasmic
reticulum, arguing that mutant Col8a1 aggregates do not cause the gulm208 phenotype. In
addition, no mutant Col8a1 is present in the morpholino-injected wild-type embryos, and
thus mutant protein cannot be interfering with normal collagen assembly in the
extracellular space. Taken together, the data presented here strongly suggest that the
Y628H substitution causes notochord distortion through insufficient Col8a1 deposition in
the notochord sheath.
Implications for other notochord mutants
Our results advance the possibility that published late notochord mutants such as crash
test dummy, zickzack, wavy tail, quasimodo, and kinks (17, 18) may encode mutations in
lysyl oxidases, proteins required for lysyl oxidase activity, or lysyl oxidase substrates. In
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some cases, additional phenotypes may help to identify the mutant gene. For instance,
quasimodo exhibits defects in both notochord and melanin pigment formation (18),
suggesting a mutation in a protein required for global copper homeostasis. The lesion in
quasimodo has been mapped to a region near the atp7a locus (148), and may thus be
allelic to calamity (14).
Our data also suggest that force generation in the notochord can be indirectly
measured by quantitating the length of the yolk sac extension, which is simple to do and
could prove useful in studies of other notochord mutants. Since col8a1 is not expressed in
the yolk sac extension (Fig. 4), the reduction in the length of this structure in gulm208
mutants, both before and after pharmacologic treatment (Fig. 1), provides evidence for
impaired force generation in the notochord, and implicates Col8a1, copper, and lysyl
oxidases in this force generation process.
Conservation of amino acid Y628
The Y628H substitution identified in gulm208 mutants is located within the C1q-like
domain of Col8a1 (Fig. 3C). This domain is present in a number of other proteins,
including the structurally similar collagen paralogues COL8A2 and COL10A1 (Fig. 3D)
(143, 149, 150). Alignment of all 31 human C1q-like domain-containing proteins reveals
only eight invariant residues, including the tyrosine corresponding to Y628 in zebrafish
Col8a1 (151). Furthermore, this tyrosine is conserved in all predicted 52 zebrafish C1qlike domain-containing proteins (152). In view of such notable evolutionary conservation,
it is not surprising that the Y628H substitution present in gulm208 mutants could be
deleterious. Indeed, an identical substitution at the equivalent position in human
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COL10A1 (Y597H) causes Schmid metaphyseal chondrodysplasia, an autosomal
dominant skeletal disorder (153). The Y597H mutation is predicted to prevent proper
folding of the COL10A1 C-terminal noncollagenous domain (NC1) in the endoplasmic
reticulum and to cause disease by haploinsufficiency (149). This mechanism may also
account for the gulm208 phenotype since the crystal structures of the COL10A1 and
COL8A1 NC1 domains are very similar and in each case the histidine would destabilise
the hydrophobic core of the protein (149, 150).
Our data support the hypothesis that the Y628H substitution inhibits proper
folding of individual Col8a1 chains. First, the large circular aggregates visualized by
electron microscopy are consistent with unfolded Col8a1 monomer that is retained in the
rough endoplasmic reticulum (Fig. 2B, E, arrows). Similar aggregates resulting from
protein retention in the endoplasmic reticulum are observed in three zebrafish coatomer
mutants, although the cause of retention is different in these mutants and leads to a more
severe phenotype (19). Second, the in vitro trimerization assay directly demonstrates a
defect in mutant Col8a1 trimerization (Fig. 5A, lane 2 vs. lane 1). This presumably
results from a primary defect in NC1 domain folding rather than a defect in inter-chain
assembly because the mutated tyrosine is buried in the NC1 domain (150). We propose
that the Y628H substitution in Col8a1 inhibits monomer folding in gulm208 mutants. Since
the NC1 domain nucleates trimer formation (154-156), this unfolded Col8a1 monomer
would subsequently fail to trimerize and form higher-order assemblies (Fig. 7).
Comparative expression of type VIII collagen
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Zebrafish col8a1 expression is restricted to a few tissues during early development (Fig.
4), and the absence of col8a1 expression in zebrafish eye was initially puzzling because
Type VIII collagen is a major component of Descemet‟s membrane in other vertebrates
(157-160). However, zebrafish encode a paralogue of col8a1 located on chromosome 22
(BAC CR956626), and an EST encoding part of this paralogue (DN898414) has been
isolated from zebrafish eye, specifically from the anterior segment where Descemet‟s
membrane is located. Thus, it appears that partitioning of tissue-specific patterns of
expression has occurred (56), and type VIII collagen distribution in zebrafish is expected
to be broader than what is predicted from the expression data presented here (Fig.4).
Previous work demonstrates that type VIII collagen is distributed in the cartilage
matrix and perichondrium of fetal calf tissues (161). The zebrafish notochord is most
closely related to cartilage as a tissue (16), and expression of col8a1 in notochord and jaw
cartilages (Fig. 4A-D, H, I) suggests an association between cartilage and type VIII
collagen deposition that is evolutionarily conserved during early development. This
association is supported by the similar spatio-temporal expression profiles of col8a1 and
cartilage-expressed col2a1 in zebrafish embryos (compare Fig. 4 with Fig. 3 of Yan et al.,
1995) (44). Importantly, loss of wild-type col8a1 expression in jaw cartilages likely
causes the severe head malformation noted in gulm208 mutants by 72 hpf (17) and thus the
two principal phenotypes of gulm208 mutants (notochord distortion and head
malformation) involve the major cartilage and cartilage-related tissues of zebrafish during
early embryogenesis. Mice lacking both alpha 1 and alpha 2 chains of type VIII collagen
exhibit anterior segment abnormalities in the eye but are not noted to have notochord or
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jaw malformations (162). The reasons for these differences are presently unknown,
though Col8a1 is expressed in at least some cartilages of newborn mice (163).
Short-chain collagens in human disease
Col8a1 belongs to a small group of highly-related short-chain collagens, and the gulm208
mutant zebrafish may provide insight into the mechanism by which specific types of
point mutations in these collagens cause disease. Indeed, our findings may be relevant to
the molecular pathogenesis of Schmid metaphyseal chondrodysplasia, which is currently
debated. Schmid metaphyseal chondrodysplasia results from mutations at multiple sites
in COL10A1, and functional haploinsufficiency due to nonsense-mediated decay of
mutant message appears to cause this disorder (164, 165). However, an effect of
misfolded protein on chondrocyte differentiation secondary to activation of the unfolded
protein response has also been invoked (166, 167). The determination of whether a
missense mutation causes disease through loss of function or endoplasmic reticulum
stress is potentially critical because treatment options may differ. 4-Phenylbutyric acid
has been shown to reduce endoplasmic reticulum stress and restore glucose homeostasis
in a mouse model of type 2 diabetes (145) and is already approved by the U.S. Food and
Drug Administration for the chronic management of certain urea-cycle disorders (168).
Thus, a disease caused by endoplasmic reticulum stress may be amenable to treatment
with this chemical chaperone. Our data suggest that mutations affecting monomer folding
(Fig. 7) cannot be rescued by 4-phenylbutyric acid (Fig. 5B and data not shown).
To date, no human disease has been shown to result from mutations in COL8A1.
While COL8A1 has been evaluated as a candidate gene for certain eye disorders due to
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the presence of type VIII collagen in Descemet‟s membrane and to the fact that mutations
in COL8A2 cause corneal dystrophies (169-171), the data presented here suggest that a
role for COL8A1 in cartilage development should now be considered. Indeed, the
expression pattern of col8a1 in zebrafish (Fig. 4) and the notochord and head phenotypes
of gulm208 mutants (17) suggest that mutations in COL8A1 could result in
chondrodysplasias. A number of different mutations in COL10A1 cause Schmid
metaphyseal chondrodysplasia (172), but not all patients with this disease have an
identifiable mutation in COL10A1 and additional unknown loci are implicated in its
pathogenesis (153, 173-175). COL8A1 may thus be a candidate gene for Schmid
metaphyseal chondrodysplasia or another chondrodysplasia.

160

Acknowledgments
We thank Marilyn Levy for the electron microscopy and Stephen Johnson for help with
meiotic mapping. We also thank Stephen Johnson, Erik Madsen, and Robert Mecham for
careful review of the manuscript. This work was supported by NIH Medical Scientist
Training Program grant T32 GM07200 (J.M.G.) and by NIH grant DK44464 (J.D.G.).

161

Figure legends
Fig. 1. gulm208 mutants are sensitized to lysyl oxidase inhibition. Clutches from
gulm208/+ intercrosses were incubated in vehicle (A, B), the copper chelator neocuproine
(2 M) (C, D), or the lysyl oxidase inhibitor -aminopropionitrile (1 mM) (E, F). The
notochord is normal in wild-type embryos treated with vehicle, neocuproine, or aminopropionitrile (A, C, E). Notochords of gulm208 mutants incubated in neocuproine
and -aminopropionitrile (D, F, arrowheads) are substantially more distorted than
mutants incubated in vehicle (B, arrowheads). Insets show notochord at higher
magnification. Embryos were treated with PTU to inhibit melanin pigmentation and
photographed at 30 hpf.
Fig. 2. Electron microscopy reveals notochord abnormalities in gulm208 mutants. (AE) Transmission electron micrographs of truncal cross-sections from embryos at 24 hpf.
(A) Notochord sheath and vacuolated notochord cell of a wild-type embryo, with small
areas of protein accumulation visible in the rough endoplasmic reticulum (arrow). (B)
Notochord sheath and vacuolated notochord cell of a gulm208 mutant with large circular
aggregates of protein in the rough endoplasmic reticulum (arrow). (C) Notochord and
hypochord of a gulm208 mutant with large circular aggregrates of protein in the hypochord
(red arrows) and notochord (yellow arrow). (D) Notochord sheath of a wild-type embryo
with inner (i), medial (m), and outer (o) layers indicated. Small areas of protein
accumulation are visible in the rough endoplasmic reticulum (red arrow). (E) Notochord
sheath of a gulm208 mutant where the collagen fibrils in the medial (m) layer appear
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disorganized. A large circular aggregate of protein is visible in the rough endoplasmic
reticulum (red arrow). Not = vacuolated notochord cell; Hyp = hypochord.
Fig. 3. The gulm208 mutation disrupts the col8a1 gene. (A) The gulm208 lesion was
meiotically mapped to a centromeric region of chromosome 9 bounded by markers
zK46K9 and zK229B18. The number of recombinants at each marker is noted. According
to the physical genome assembly (Zv7), 26 genes are located within the critical region,
including the alpha 1 chain of type VIII collagen (col8a1). (B) Sequencing of wild-type
and gulm208 mutant cDNAs revealed a missense mutation in gulm208 mutant col8a1 that
changes a tyrosine to a histidine. (C) Structure of the predicted 711-amino acid zebrafish
Col8a1 protein. NC1 and NC2 are two non-collagenous domains. The Y628H
substitution present in gulm208 mutants (arrow) is located within the C1q-like domain
(grey) of NC1. (D) Protein sequence alignment of N-terminal portions of select C1q-like
domains. Conserved residues, including Y628 (arrow), are shaded yellow. Sequence
numbering refers to the zebrafish Col8a1 sequence (DrCol8a1).
Fig. 4. col8a1 expression is consistent with the gulm208 phenotype.
(A-I) Whole-mount in situ hybridization for col8a1 was performed on wild-type embryos
at various developmental stages. (A) Lateral view of a 5-somite embryo with col8a1
expression in the vacuolated notochord cells (arrow). (B-D) Lateral views of 10- (B), 15(C), or 20- (D) somite embryos with col8a1 expression in the notochord (arrow),
floorplate (black arrowhead), hypochord (white arrowhead), and prechordal plate region
(asterix). (E) Lateral view of an embryo at 24 hpf with col8a1 expression in the floorplate
(black arrowhead), hypochord (white arrowhead), and prechordal plate region (asterix).
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(F) Dorsal view of an embryo at 24 hpf with col8a1 expression in the caudal somites
(arrowheads). (G) Lateral view of an embryo at 30 hpf with col8a1 expression in the
floorplate (black arrowhead) and hypochord (white arrowhead). (H) Dorsal view of an
embryo at 48 hpf with col8a1 expression in jaw cartilages (arrows). (I) Lateral view of an
embryo at 48 hpf with col8a1 expression in jaw cartilages (arrows). (J) RT-PCR for
col8a1 at the indicated developmental stages. As controls, maternally-expressed 5'-AMPactivated protein kinase catalytic subunit alpha-1 (ampka1) and zygotically-expressed
spadetail (spt) were amplified in parallel (104, 176). The fold induction of col8a1 relative
to ampka1 is noted. Unfert. = unfertilized; NA = not applicable.
Fig. 5. The Y628H substitution prevents Col8a1 trimerization. (A) Constructs
encoding wild-type (lane 1) or gulm208 mutant (lane 2) Col8a1 were transcribed and
translated in the presence of radiolabelled methionine, and the products analyzed as
described under Experimental Procedures. Col8a1 monomers and trimers are indicated.
Co-transcription and translation of half the amounts of wild-type and mutant construct
together does not prevent trimerization (lane 3). The approximate location of molecular
weight markers (kDa) is noted. (B) RT-PCR to assess the splice status of xbp1 in wildtype embryos and gulm208 mutants at 24 hpf. Splicing of xbp1 is not observed in gulm208
mutants but occurs after incubation of wild-type embryos in tunicamycin. U = unspliced;
S = spliced. Amplification of the gene spt was performed in parallel to confirm that equal
amounts of cDNA were used for each condition.
Fig. 6. Morpholino knockdown of col8a1 recapitulates the gulm208 phenotype.
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(A) Wild-type embryos injected with 12 ng of control morpholino exhibit normal
morphology. (B) Embryos injected with 2.4 ng of a splice morpholino targeting col8a1
develop notochord distortion (arrowheads) characteristic of gulm208 mutants. (C) RT-PCR
at 24 hpf demonstrating a dose-dependent reduction in col8a1 transcript after morpholino
injection. (D) Embryos injected with 12 ng of a splice morpholino targeting col8a1
develop notochord distortion (arrowheads) that is worse than in gulm208 mutants. Insets
show notochord at higher magnification. All embryos were treated with PTU to inhibit
melanin pigmentation and photographed at 30 hpf.
Fig. 7. Model of Col8a1 assembly in wild-type and gulm208 mutant embryos. Col8a1
monomer containing the Y628H mutation is unable to fold, preventing trimer formation
and higher-order assembly that occurs in the absence of the mutation. The Y628H
mutation is located within the NC1 domain of Col8a1 (asterisk).
Table 1. Morpholino knockdown of col8a1 recapitulates the notochord distortion
observed in gulm208 mutants. Wild-type embryos were injected with morpholino and
live embryos sorted to new dishes at 10 hpf; these embryos were scored for notochord
distortion at 30 hpf. Data shown are the pooled results of three independent experiments.
S. Fig. 1. (A) Ordered list of the genes located between markers zK46K9 and
zK229B18. Marker zC206L17 is included for reference. A single asterisk indicates the
gene where most of the coding sequence was cloned from gulliver mutant cDNA. Double
asterisks indicate genes where the entire coding sequence was cloned from gulliver
mutant cDNA. (B) Nucleotide coding sequence of genes cloned from gulliver mutant
cDNA. Primers used for PCR are indicated. Notes are included detailing why any
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alterations to the predicted amino acid sequence are not expected to cause the gulm208
phenotype.
S. Fig. 2. Protein sequence alignment of zebrafish Col8a1 with orthologues from
other species. Predicted signal peptides are in bold and the conserved tyrosine at position
628 is in blue. The C1q-like domain is in grey.

166

Figure 1

167

Figure 2

168

Figure 3

169

Figure 4

170

Figure 5

171

Figure 6

172

Specific
Morpholino
Control
col8a1 (splice)

Dose of
morpholino (ng)
12
2.4

Embryos
scored (#)
186
170

Dead or dysmorphic
embryos (#)
10
2

Table 1
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Notochord distortion
+
172 (98%)
4 (2%)
2 (1%)
166 (99%)
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A)
Marker zK46K9 (1 recombinant)
Q6GML5_DANRE = PHD finger protein 11 (PHF11)
c13orf1 = Chronic lymphocytic leukemia deletion region gene 6 protein
zgc:56602 = Ribonuclease H2 subunit B (RNASEH2B)
zgc:152866 = X-linked interleukin-1 receptor accessory protein-like 1 precursor
(IL1RAPL1)
Marker zKC206L17 (0 recombinants)
**zgc:101814 = C3orf26
**zgc:63472 = transmembrane protein 30A (TMEM30A)
*zgc:158743 = Discoidin, CUB and LCCL domain-containing protein 2 precursor
(DCBLD2)
col8a1– annotated only on BAC (BX322575)
zgc:101070 = jagunal homolog 1 (JAGN1)
**tfg = TRK-fused gene
LOC100006853 = Target of Nesh-SH3 precursor (ABI3BP)
LOC558093 = interphotoreceptor matrix proteoglycan 2 (IMPG2)
tlr20f = Toll-like receptor 20f
A3KPA1_DANRE = Sentrin-specific protease 7 (SENP7)
g12 = Mid1-interacting protein 1 (MID1IP1)
LOC794667 = Ornithine carbamoyltransferase (OTC)
RPGR = X-linked retinitis pigmentosa GTPase regulator
zgc:110822 = Sushi repeat-containing protein SRPX precursor (SRPX)
SYTL5 = Synaptotagmin-like protein 5
asb11 = Ankyrin repeat and SOCS box protein 11
zgc:56589 = Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (PIGA)
zgc:113314 (novel protein)
LOC795718 = Gap junction alpha-8 protein (GJA8)
cx45.6 = Gap junction alpha-5 protein (GJA5)
LOC558758 = Lysophosphatidic acid phosphatase type 6 precursor (ACP6)
chaf1b = Chromatin assembly factor 1 subunit B
Marker zK229B18 (1 recombinant)
B)
>Sequence for zgc:101814. Forward 5‟-GCGATTGCGGTTTGAGACATG-3‟ and
reverse 5‟-GGCATTAAAGTACACAACAATCTCTC-3‟.
ATGGCTGATGATTTAGGAGACGAGTGGTGGACCCAGGGCGATAATTCAGATG
TGCCTGAGGTAGAGGAGGAAACAGAGCCTGCAGAAGAAAAACAACCGATTA
AATCTACACCTAAGAAAAGGAAGGTTGAAAAACAGATTCCAGATGCCACAA
AGAAAAAGAAGAAGGCAACAGTTAAGAAAGAATGTTTCATCACGCAAGAGA
GATCAGAGGAAAAGCCTGATAACGAGTCTAACAAAAACAAGAAAAGAAGAA
AGAAGAAGAAAACCATCACAGATGTCCTGACAAGCTCTAAGCCTGTGCCCGG
CTCTCCAGTTGACCTTGTGAGCCTTCTGAAGACTTACCACAGCCAGACCCGCT
CTGTTATTGAGCAGGAGGAACTGACGTTACAAGATTCTTGTTTCCTCAGCTGT
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AATGACCTCACACACAGCTTGTCTTCCTACCTCAAAGAAGTTTGTCCAAAGTG
GGCTAAAATGCAGAAACAGCACACCCAGACCAGCTCAGTGGTTTTGCTAATT
GTTTGTGGATCTGCTTTAAGAACCATTGATCTCATTAAGCAGCTGGTGACATT
CAAAGGACAAGCTAAAGTGCTGAAGCTGTTTGCAAAACACATCAAAGTGGA
AGAACAGATAAAGTCATTGAGTAAAGGTGTGACCCATATTGCTGTTGGAACT
CCTGGGAGAATTTGCGCGCTGTTAGAGAAAGAGGGATTGACTGTGCAAGGAC
TACGTTATCTGGTGCTGGACTGGAACTACAGAGACCAGAAGCAAAGGAGGAT
GGTGGATGTACCAGAGGTGAAAGGAGACTTACTAAAAATGATGGACCAAGG
TCTAATCCAGAGCTGCAGAGAAGGAACGGTTAAAATAGGACTCTTCTGA
NOTES: H27P and insertion of K before ATVKKEC vs. zgc:101814 (BC083291), but
BAC BX957250 agrees in both cases with the above sequence.
>Sequence for zgc:63472. Forward 5‟- GAAAACTTCCTTCGGTGGCAG-3‟ and
reverse 5‟- GCTTGTTTTCAGTGATTCTGGG-3‟.
ATGGCCAAGAAGGCAGTAGGTTTAGGGCCACTGTCGAGGCGTCCAGATAACT
CGGCGTTTAAACAGCAGAGATTACCAGCCTGGTCTCCATCTCTCACGGCACA
GACCGTCCTGCCAATCTTCTACATCCTAGCTGTCGTGTGCCTGCTGCTGGGCA
TCTGGCTCCTCATCACTGTCCAGAACACACACCAACTGAAGGTGGACTACAC
CGATGCTGGAACATGTGAACAGTGCTTCGAGCTTCATGCCAACAACACCAGA
ACGGTCTGCACATGTTCAGTCAACTTCTACGTTCCAAGACCCTTTCCGGGCGA
CGTGTTCTTCTACTACGGTCTGAGGAACTTTCATCAGAACCTGCGGAGGTACA
TGGACTCCCGCGATGATGCACAGATGGTGGGGAGGAAGAACAACCTGAAGG
CACCGAGTTCATACTGCGCTCCGTTTCATTACGATGCAAACGGGGTACCCATC
GCCCCCTGCGGTGCCGTGGCCAACAGCATGTTCAACGACTCATTTACACTGAT
GTATCATCAAGCTAATGGGGCAGAAGTGCAAGTTCCTCTCTATAGGAAGGGC
ATTGCTTGGTACACAGACAAAAATGTCAAGTTCCGCAACCCTCCGACCAACA
ACACATTTTCCCTTCGACAAGCCTTTGAAGGCACGACTCGGCCCTTATACTGG
CAGCACTCGGTTTATGAGCTGGATGACACAGACTCCAACAACAATGGTTTCA
TAAATGACGACCTGATTGTCTGGATGAGAGAGGCAGCCTTCCCTAATTTCAA
AAAGCTTTATGGGGTTCTCAATCGTGCTCAAGAGCCTTTCACTGAAGGCCTGC
CCGCCGGCAACTACAACATCTCTATAGATTACAATTTTCCTGTTGAGCCCTTC
AGAGGTCGAAAGGAGCTGGTGATCTCAATGGTGACCTGGTTTGGTGGGCAGA
ATTACTTTCTGCCCATTGCGTATCTGGTGACCAGTGGGCTAATCCTGGTGACT
GCTGTCGTTCTCACAACAGTGTTTGTCAAATTTGGCAAAAATGGCAAGAACA
TGGAGGAATAA
Notes: 1) R77Q vs. zgc:63472 (NM_200596) but EST EB861052 agrees with the above
sequence. 2) K136N, but EST AL920832 agrees with the above sequence. 3) P268L, but
EST CR929675 agrees with the above sequence.
>Sequence for tfg. Forward 5‟-GATTGACACGTCCAAAACACCAGC-3‟ and reverse
5‟-GAGGGAAGTTATAGTGAGGTGCTG-3‟.
ATGAATGGACAGCTGGACCTGAGTGGGAAGCTGATCATCAAAGCTCAGCTGG
GTGATGATATTCGTCGTATTCCTATCCACAATGAAGACATCACCTACGACGAG
CTCCTGCTGATGATGCAGAGAGTTTTTCGTGGCCAGTTACAGAGCAGCGATG
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AAGTCACCATCAAATACAAGGACGAAGATGACGACCTTATCACCATCTTTGA
CAGTTCTGATTTGTCCTTTGCGATCCAGTGCAGTAGAATATTAAAGCTCACTC
TTTTTGTGAATGGGCAGCCTCGGCCACTGGAGTCATCTCAGGTGAAGCACCTG
CGCAGAGAACTGATCCATTTGAGGAATAAAGTCAACAGCCTGCTGGACAGCC
TGGAGCCACCCTTAGAGTCTGTCCCAGAAAGCACCAACCCAGAAACTGAATG
TGTAAATGATGCAGTAGACTCCACAATGAGGCATGCTCCTCCTGTCAGTGCTG
CCAGCATGTCTGCTTTTGACCCACTGAAGAACCAGGAAGAGGTCAACAAGAA
TGTCATTTCTGCATTTGGTTTAACTGAGGAACCTGCCCCAGTTCCAGCTGTAG
CTGCCACCGCTGCTGCAGAGGAGCGCTCTGCTACTCCAGACAGTATTGCCTCT
TCATCCTCTGCAGCGCCCCCTGCTGCTGTGGCTCCACAGGCCCCCCCACCTTA
TTCAGGGGTCCAGCAACCCCCCTCTACTACTATGGATGGTCAGATGTATCAGC
AGTATCAGGCTCCAGGTGGATATCCTCCACCAGCTGGACCGCAGCAGCAGTA
TGGCATGCAGTACCCTGCTGGTTATACTCCTCAATCTGGTGTTCCTCAGGCTC
CGCCTCCTCAACAGCAGTTCCAGAATTACCCCACCCCTACTTCTCAGGCTGCT
GGCGCTCCTGGCTCCGCCCCTGGCTTTTCTGGCCAATCACAGCCTCCTGCTCC
CCAAGCACCTGCTCAGTATCCACCCGGAGCCTTTCCGCCTCAAAACTACACAT
CCCAGGCCTCTCAGCAGCCCGCAAACTACAGCCTGCCTCCAACCTCGCAGGC
CACAGCCGGTTACCAGCCCCGTCCCGGATACACCCCACCACCAGGTGCCACC
CCTCCACCCGGGGGTGCCAATCCCTATGCCCGAAACCGCCCGCCTTACGGCC
AGGGCTACACCCAACCAGGTCCTGGCTATCGGTAA
NOTES: 100% nucleotide agreement with CT726943 and CT700332 (full coverage
when both are aligned).
>Sequence for zgc:158743. Forward 5‟-CGGCTGATCGGGACACTTTAGC-3‟ and
reverse 5‟-AGGCTCGGGGAGAGATTTCC-3‟.
ATGGACGCGTCGGTAATGGTGGGCAGAGGAACCGGAGGGGCTGCGCTCTTCA
TCCTGATCGTCTTCATCGTACTACTAGGTGCCAGAAGCTCACGGGCGCAGAA
GGGGGACGGCTGTGGACACACAGTGCTAGGTGTGGGCAGCGGGAGCCTGGC
GTCTCTGGGTTATCCTCAGTCTTATCCTTCACAGTCTGTGTGTGAGTGGGAGA
TCAGCGTGACCGCTGGGCACAAAGTCCTTGTGCGCATCGCAGATCTTGACATT
GATACAAACAATTGCCAGGTGTCTTACCTGCGACTCTATAATGGGATCGGAC
CGGGACGAACAGAAATTGTGAAGTTTTGTGGCAGTAAAGAATGGAAAGAATT
GGTTATAAAGTCTGAGGGCCATCAGGTCACAGTGCAGTTCATGAGTGGACCA
CACCACAACGGCCGTGGCCTTTTCCTCTCCTACACCAACAGTCAGCACACTGA
CCTCATCACCTGTCTGGAGAAAGGAGAGCACTTCAGTGAAGCAGAGTTCAGT
AAATTCTGTCCTGCTGGATGCCTGATTGATTTCGGAGAGGTTTCGGGAACCAT
ACCGCATGGATACAGAGATTCTTCTCCTCTGTGCCTGGCCGGCATTCATGCGG
GTGTGCTGTCCAACACTCTGGGGGGGCAGATCAGTGTGGTCAGCAGCAAAGG
CATCCCACACTACGAAAGCTCACTGGCTAACAATGTGACATCTGTGCCTGGA
AATCTCTCCCCGAGCCT
NOTES: Fragment. D28A (in signal peptide) vs. zgc:158743 (NM_001080171) but this
change is present in CO922572. Larger fragment was also cloned – sequence below.
>Additional sequence for zgc:158743. Forward 5‟-GGGACACTTTAGCATTATGC-3‟
and reverse 5‟-GAGTGCCTCCTGATAGGTGG-3‟.
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GGGACACTTTAGCATTATGCATTCGGACTGCAGGCTGCTGGGATGGACGCGT
CGGTAATGGTGGGCAGAGGAACCGGAGGGGCTGCGCTCTTCATCCTGATCGT
CTTCATCGTACTACTAGGTGCCAGAAGCTCACGGGCGCAGAAGGGGGACGGC
TGTGGACACACAGTGCTAGGTGTGGGCAGCGGGAGCCTGGCGTCTCTGGGTT
ATCCTCAGTCTTATCCTTCACAGTCTGTGTGTGAGTGGGAGATCAGCGTGACC
GCTGGGCACAAAGTCCTTGTGCGCATCGCAGATCTTGACATTGATACAAACA
ATTGCCAGGTGTCTTACCTGCGACTCTATAATGGGATCGGACCGGGACGAAC
AGAAATTGTGAAGTTTTGTGGCAGTAAAGAATGGAAAGAATTGGTTATAAAG
TCTGAGGGCCATCAGGTCACAGTGCAGTTCATGAGTGGACCACACCACAACG
GCCGTGGCCTTTTCCTCTCCTACACCAACAGTCAGCACACTGACCTCATCACC
TGTCTGGAGAAAGGAGAGCACTTCAGTGAAGCAGAGTTCAGTAAATTCTGTC
CTGCTGGATGCCTGATTGATTTCGGAGAGGTTTCGGGAACCATACCGCATGG
ATACAGAGATTCTTCTCCTCTGTGCCTGGCCGGCATTCATGCGGGTGTGCTGT
CCAACACTCTGGGGGGGCAGATCAGTGTGGTCAGCAGCAAAGGCATCCCACA
CTACGAAAGCTCACTGGCTAACAATGTGACATCTGTGCCTGGAAATCTCTCCC
CGAGCCTTTTTACTTTCAAGACCAGCGGTTGCTATGGTACTTTGGGTTTGGAG
TCGGGGGTGGTGAGCGACTCTCAGATCACGGCCTCGTCCGAGTGGGAATGGG
GCGGTCATGGAAAACAGCCCACCGTCTGGGGCCCTACGGGGGCCCGCCTCAA
AACTCCAGGACGTCCGTGGGCTGCAGCCAACAGCGACACCAAAGAATGGATT
CAAGTGGACCTAAAGAAAGAGAAAAAAATAACAGGCATTACCACCACTGGC
TCCACACTCCCAGAGTATCAGTTTTACGTTTCAGCCTATGAGGTGTTATATAG
CCATGATGGACAGCAGTGGAAAACCTATCAAGAAGTGGGATCAGATAAAAA
CAAGATTTTCCAAGGTAACACCCACTATCTGCAGGAGGTGCGAAACAACTTT
ATTCCTCCAATTGAGGCACGCTTTCTCCGAATATGTCCCTTACAGTGGCACCA
GAGGATCGCCCTTAAAATGGAACTGCTGGGCTGCCAACCACATGCAGCGAGG
CCCAGAATCTTCCACCCAGGCCCTGCACCTCCTCGCAGGAAGAGCACAACAC
CGCCAGCGCAGGACAGGACCACACACACACCCAACATCCGAAACTCCACCAT
GCCTCCACACTCCCATGACGAGGTGGCTCTGGTAGCAGTGTTGGTTCCTGTAT
TGGTGGTGGTTCTGACGACACCAGTTCTGGTGATGGTGTGCTCATGGCTGTGG
AAGAACAGAAAAAGCCCTGAGGTGACGTATGACCTTCCACACTGGGAGCGC
ACGGTGTGGTGGAAGAGTATGAAACAGTTGTTGCCCTCTAAGCTGGATGGAG
AAGACTGTGTTCGCTATAGCTCTACGGCGCGAGTGGACCACCAGAGACCCCG
GGTGGAGCCTGCAGAATACGCCCAACCGCTGGTCACAGGAAACATGGCCTCT
CTTGGACAACGGTCGACATTTAAACCCGAAGAGGCCGATGTTCCCGAATACG
ATGCACCTATTCCTCCAGAACATTACCATGCTTATGCTGAGCCCCTTCCTGCT
TCTGGCACTGAATACGCCATGCCGATCATGATTGACAGGGCTAACCACCTAT
CAGGAGGCACTC
NOTES: Longer than zgc:158743 (NM_001080171). Compare with cds for CAQ14992
– agrees for all amino acids except E121D and L122V, both of which are conservative
changes. Missing sequence for the terminal 45 amino acids compared to cds for
CAQ14992. Smaller fragment was also cloned – see above.
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BtCOL8A1
GgCOL8A1
OcCOL8A1
MmCOL8A1
HsCOL8A1
DrCol8a1

MAGPPSPLQLLGVLLTLSVGSIRLIHAGAYYGIKPLPPQIPAQIPPQIPQYQPLGQQVPH
MAVQPGPPQLLQVLLTISLGSIRLIQAGAYYGIKPLPPQIPPQMPPQIPQYQPLGQQVPH
MAVPPGPPQLLQVLLTISLGSIRLIQAGAYYGIKPLPPQIPPQMPPQIPQYQPLGQQVPH
MAVPPRPLQLLGILFIISLNSVRLIQAGAYYGIKPLPPQIPPQIPPQIPQYQPLGQQVPH
MAVLPGPLQLLGVLLTISLSSIRLIQAGAYYGIKPLPPQIPPQMPPQIPQYQPLGQQVPH
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MPLAKDGLTMGKEMPHAQYGKEYPHLPQYMKEVQPVPRMGKEAVPKKGK-EIPLASLRGE
MPLAKDGLTMGKEMPHAQYGKEYPHLPQYMKEVQPVPRMGKEAVPKKGK-EIPLASLRGE
MPLGKDGLSMGKEMPHMQYGKEYPHLPQYMKEIPPVPRMGKEVVPKKGKGEVPLASLRGE
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QGPRGEPGPRGPPGPPGLPGQGIPGVKGKPGPQGYPGIGKPGMPGMPGKPGAMGMPGAKG
QGPRGEPGPRGPPGPPGLPGQGIPGIKGKPGPQGYPGVGKPGMPGMPGKPGAMGMPGAKG
QGPRGEPGPRGPPGPPGLPGQGIPGIKGKPGPQGYPGVGKPGMPGMPGKPGAMGMPGAKG
QGPRGEPGPRGPPGPPGLPGHGMPGIKGKPGPQGYPGIGKPGMPGMPGKPGAMGMPGAKG
QGPRGEPGPRGPPGPPGLPGHGIPGIKGKPGPQGYPGVGKPGMPGMPGKPGAMGMPGAKG
QGPVGPPGPQGPPGPQGNGIQGPPGKPGPPGPPGYPGIGKPGMSGMPGKAGDPGQPGQPG
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BtCOL8A1
GgCOL8A1
OcCOL8A1
MmCOL8A1
HsCOL8A1
DrCol8a1

EIGPKGEIGPMGIPGPQGPPGPHGLPGIGKPGGPGLPGQPGAKGERGPKGPPGPPGLQGP
EIGPKGEIGPMGIPGPQGPPGPHGLPGIGKPGGPGLPGQPGAKGDRGPKGPPGPPGLQGP
EIGPKGEIGPMGIPGPQGPPGPHGLPGIGKPGGPGLPGQPGAKGDRGPKGPPGPPGLQGP
EIGPKGEIGPMGIPGPQGPPGPHGLPGIGKPGGPGLPGQPGAKGERGPKGPPGPPGLQGP
EIGQKGEIGPMGIPGPQGPPGPHGLPGIGKPGGPGLPGQPGPKGDRGPKGLPGPQGLRGP
EQGPRGEDGQPGIAGPPGPPGPSGLPGIGKPGGQGLPGQPGNKGEPGHKGFPGLPGLPGP
* * :** * **.** ***** ********** ******* **: * ** ** ** **
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BtCOL8A1
GgCOL8A1
OcCOL8A1
MmCOL8A1
HsCOL8A1
DrCol8a1

KGEKGFGMPGLPGLKGPPGMHGPPGPVGLPGVGKPGVTGFPGPQGPLGKPGPPGEPGPQG
KGEKGFGMPGLPGLKGPPGMHGPPGPVGLPGVGKPGVTGFPGPQGPLGKPGPPGEPGPQG
KGEKGFGMPGLPGLKGPPGMHGPPGPVGLPGVGKPGVTGFPGPQGPLGKPGPPGEPGPQG
KGEKGFGMPGLPGLKGPPGMHGPPGPVGLPGVGKPGVTGFPGPQGPLGKPGPPGEPGPQG
KGDKGFGMPGAPGVKGPPGMHGPPGPVGLPGVGKPGVTGFPGPQGPLGKPGAPGEPGPQG
KGDRGIGLPGPQGPKGPVGPPGLRGPAGLPGVGKTGLPGIPGPAGVPGKPGEPGEPGPEG
**::*:*:** * *** * * **.*******.*:.*:*** * **** ******:*
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PIGVPGVQGPPGIPGIGKPGQDGIPGQPGFPGGKGEQGLPGLPGPPGLPGVGKPGFPGPK
PIGVPGVQGPPGLPGVGKPGQDGIPGQPGFPGGKGEQGLPGLPGPPGLPGVGKPGFPGPK
PIGVPGVQGPPGLPGVGKPGQDGIPGQPGFPGGKGEQGLPGLPGPPGLPGVGKPGFPGPK
LIGVPGVQGPPGMPGVGKPGQDGIPGQPGFPGGKGEQGLPGLPGPPGLPGVGKPGFPGPK
PIGVPGVQGPPGIPGIGKPGQDGIPGQPGFPGGKGEQGLPGLPGPPGLPGIGKPGFPGPK
PPGEKGPQGPQGAPGIGSPGEKGLPGQPGTPGHKGLHGPPGLPGKPGLPGFGKPGYPGPK
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BtCOL8A1
GgCOL8A1
OcCOL8A1
MmCOL8A1
HsCOL8A1
DrCol8a1

GDRGVGGLPGPLGPRGEKGPVGAPGLGGPPGEPGLPGIPGPMGPPGAIGFPGPKGEGGVV
GDRGIGGVPGALGPRGEKGPVGAPGMGGPPGEPGLPGIPGPMGPPGAIGFPGPKGEGGIV
GDRGIGGVPGALGPRGEKGPVGAPGMGGPPGEPGLPGIPGPMGPPGAIGFPGPKGEGGIV
GDRGIGGVPGVLGPRGEKGPIGAPGMGGPPGEPGLPGIPGPMGPPGAIGFPGPKGEGGVV
GDRGMGGVPGALGPRGEKGPIGAPGIGGPPGEPGLPGIPGPMGPPGAIGFPGPKGEGGIV
GDRGMGGLPGPQGPKGEKGHMGQPGMMGPPGQTGLPGPSGPIGAPGEVGSPGLKGEGGAG
****:**:** **:**** :* **: ****:.**** .**:*.** :* ** *****

419
419
419
420
419
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BtCOL8A1
GgCOL8A1
OcCOL8A1
MmCOL8A1
HsCOL8A1
DrCol8a1

GPQGPPGPKGEPGLQGFPGKPGFLGEVGPPGMRGLPGPIGPKGEAGLKGLPGLPGAPGLL
GPQGPPGPKGEPGLQGFPGKPGFLGEVGPPGIRGLPGPIGPKGEAGHKGLPGLPGVPGLL
GPQGPPGPKGEPGLQGFPGKPGFLGEVGPPGIRGLPGPIGPKGEAGHKGLPGLPGVPGLL
GPQGPPGPKGEPGLQGFPGKPGFLGEVGPPGMRGLPGPIGPKGEGGHKGLPGLPGVPGLL
GPQGPPGPKGEPGLQGFPGKPGFLGEVGPPGMRGLPGPIGPKGEAGQKGVPGLPGVPGLL
GAKGDPGPIGLTGPPGIPGQPGQPGEDGEPGPRGPQGPIGPKGEGGSNGLPGPPGQSGLP
*.:* *** * .* *:**:** ** * ** ** ********.* :*:** ** .**

479
479
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BtCOL8A1
GgCOL8A1
OcCOL8A1
MmCOL8A1
HsCOL8A1
DrCol8a1

GPKGEPGIPGEQGLQGPPGIPGISGPSGPIGPPGIPGPKGEPGLPGPPGFPGVGKPGVAG
GPKGEPGIPGDQGLQGPPGIPGITGPSGPIGPPGIPGPKGEPGLPGPPGFPGVGKPGVAG
GPKGEPGIPGDQGLQGPPGIPGITGPSGPIGPPGIPGPKGEPGLPGPPGFPGVGKPGVAG
GPKGEPGIPGDQGLQGPPGIPGIVGPSGPIGPPGIPGPKGEPGLPGPPGFPGVGKPGVAG
GPKGEPGIPGDQGLQGPPGIPGIGGPSGPIGPPGIPGPKGEPGLPGPPGFPGIGKPGVAG
GLKGETGPPGPEGPRGPTGIPGLAGPGGLLGPPGPPGPKGEVGPPGQAGQPGEGSPGIQG
* ***.* ** :* :**.****: **.* :**** ****** * ** .* ** *.**: *
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BtCOL8A1
GgCOL8A1
OcCOL8A1
MmCOL8A1
HsCOL8A1
DrCol8a1

LHGPPGKPGALGPQGQPGLPGPPGPPGPPGPPAVMPPTPPPHGEYLPDMGLGIEGAKPPH
LHGPPGKPGALGPQGQPGLPGPPGPPGPPGPPAVMPPTPAPQGEYLPDMGLGIDGVKTPH
LHGPPGKPGALGPQGQPGLPGPPGPPGPPGPPAVMPPTPAPQGEYLPDMGLGIDGVKTPH
LHGPPGKPGALGPQGQPGLPGPPGPPGPPGPPAVMP-TPSPQGEYLPDMGLGIDGVKPPH
LHGPPGKPGALGPQGQPGLPGPPGPPGPPGPPAVMPPTPPPQGEYLPDMGLGIDGVKPPH
PVGPPGPPGPNGSPGQPGIQGPPGPPGPPGP----APSPDLMG-VLPEMGPALDGVKAGY
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AYG--AKKGKNGGGPAYEMPAFTAELTAPFPPVGAPVKFDKLLYNGRQNYNPQTGIFTCE
AYA--AKKGKNGG-PAYEMPAFTAELTAPFPPVGAPIKFDRLLYNGRQNYNPQTGIFTCE
AYA--AKKGKNGG-PAYEMPAFTAELTAPFPPVGAPIKFDRLLYNGRQNYNPQTGIFTCE
AYA--GKKGKHGG-PAYEMPAFTAELTVPFPPVGAPVKFDKLLYNGRQNYNPQTGIFTCE
AYG--AKKGKNGG-PAYEMPAFTAELTAPFPPVGAPVKFNKLLYNGRQNYNPQTGIFTCE
KKGKYAGEGDMMGANGLEMPAFTAKLTAPFPPVGTPIVLDKLLYNGRQNYNPQTGVFTCD
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BtCOL8A1
GgCOL8A1
OcCOL8A1
MmCOL8A1
HsCOL8A1
DrCol8a1

VPGVYYFVYHVHCKGGNVWVALFKNNEPVMYTYDEYKKGFLDQASGSAVLLLRPGDRVFL
VPGVYYFAYHVHCKGGNVWVALFKNNEPVMYTYDEYKKGFLDQASGSAVLLLRPGDRVFL
VPGVYYFAYHVHCKGGNVWVALFKNNEPVMYTYDEYKKGFLDQASGSAVLLLRPGDRVFL
VPGVYYFAYHVHCKGGNVWVALFKNNEPMMYTYDEYKKGFLDQASGSAVLLLRPGDQVFL
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Discussion: Summary and Future Directions
This thesis originated in the observation that the pleiotropic phenotype of copper
deficiency in zebrafish embryos includes a strikingly distorted notochord. The work that
followed has elucidated a number of genes essential for notochord morphogenesis in
zebrafish and has contributed to an understanding of the gene-nutrient interactions critical
for notochord development. Importantly, though our studies focused on a single nutrient
involved in the formation of a single organ system, the results are broadly generalizable
to other nutrients and organ systems.
Cloning of the lysyl oxidase gene family in zebrafish (Chapter 2) sets the stage for
more detailed study of the role of individual family members in early development. Our
work concentrated on the notochord-expressed lysyl oxidases, revealing overlapping
roles for loxl1 and loxl5b in notochord formation as well as interactions between these
genes, the gene encoding collagen II, and copper. However, the embryonic functions of
other lysyl oxidase family members, including Lox, Loxl2a, Loxl3a, and Loxl5a are yet
to be determined. Studies of these family members will be facilitated by the optical
clarity and genetic tractability of the zebrafish.
Our data suggest that studies of notochord formation may be relevant to
understanding the etiology of congenital birth defects of the axial skeleton (Chapters 2, 4,
and 5). For instance, mutations in human lysyl oxidases may contribute to the
development of idiopathic scoliosis, a hypothesis now testable using a candidate gene
approach based on our findings in zebrafish. The data may also have implications for
certain diseases prevalent in adults. Single nucleotide polymorphisms in the human
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LOXL1 gene have recently been associated with pseudoexfoliation syndrome, a late-onset
systemic disorder of altered extracellular matrix homeostasis that can lead to glaucoma
and blindness (177-186). Interestingly, many carriers of the high-risk polymorphisms do
not develop pseudoexfoliation syndrome, and therefore additional environmental or
genetic factors must strongly influence the phenotypic expression of the syndrome (180182). The gene-nutrient interaction demonstrated between copper and zebrafish loxl1 in
notochord formation (Chapter 2) suggests that suboptimal copper nutrition or
polymorphisms in genes affecting the delivery of copper to LOXL1 may play a role in
the pathogenesis of this disorder.
The identification of a novel lysyl oxidase inhibitor, 2-mercaptopyridine-N-oxide,
provided an important tool for use in our forward genetic sensitivity screen. 2mercaptopyridine-N-oxide reduces amine oxidase activity in adult zebrafish extracts
(Chapter 3), and the kinetics of lysyl oxidase inhibition by 2-mercaptopyridine-N-oxide
should now be determined using precise radioactive assays and recombinant or purified
lysyl oxidases. This potent compound may provide a basis for pharmacologic
optimization by medicinal chemists with the goal of creating an inhibitor that is familymember specific. In light of the role of LOX in hypoxia-dependent cancer metastasis
(54), such a drug could be important as a chemotherapeutic agent. It would also facilitate
studies aimed at delineating the function of individual lysyl oxidases in early
development.
Using 2-mercaptopyridine-N-oxide, we conducted a forward genetic screen for
mutants that exhibit increased notochord distortion after partial lysyl oxidase inhibition.
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This screen yielded a mutant in fibrillin-2 with defects in notochord and vascular
morphogenesis and provided insight into the pathogenesis of congenital contractural
arachnodactyly (Chapter 4). Future screens should focus on mutants that appear wild-type
before pharmacologic inhibition and manifest a mutant phenotype only after exposure to
2-mercaptopyridine-N-oxide. This approach will identify “nonessential” genes that are
actually essential under stress, as elegant work has recently demonstrated in yeast (107).
It will also identify hypomorphic alleles of “essential” genes that may not be lethal,
permitting studies into the role of these genes in adult fish. Cloning of each mutant locus
will provide structure-function information about the affected protein and will further
elucidate the molecular mechanisms of notochord formation.
Studies of the notochord mutant gulliver demonstrated a gene-nutrient interaction
between copper and the gene encoding the alpha 1 chain of type VIII collagen (Chapter
5). This finding reiterates the need to interpret the nutritional status of an organism within
the context of its specific genotype. The biological relevance of COL8A1 is poorly
defined, and the gulliver mutant zebrafish may permit important studies into various
aspects of COL8A1 function in the extracellular matrix. The observation that inhibition
of lysyl oxidases (Chapter 2), disruption of fibrillin-2 (Chapter 4), or disruption of
collagen VIII (Chapter 5) results in notochord distortion underscores the utility of the
notochord as a model for understanding extracellular matrix formation.
The gene-gene and gene-nutrient interactions elucidated in this thesis (Chapters 2,
4, and 5) are particularly relevant in the era of personalized medicine that is now upon us.
Sequencing individual human genomes has become a reality, with dramatic reductions in
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cost and increases in speed (187). Indeed, the sequencing of James Watson‟s genome was
recently completed in less than 2 months at a cost of under $1 million (188, 189). While
the goal of the $1000 genome (190) is still out of reach, it will soon become a reality.
Even today, single nucleotide polymorphism typing is being commercially exploited to
provide interested parties with information regarding their putative health risks,
determined mainly on the basis of genome-wide association studies. However, the
interpretation of the polymorphisms and other quirks of individual genomes remains a
largely unsolved challenge. For the full potential of this information to be realized, the
functions and interactions of genetic and environmental networks involved in
development and disease must be clarified. This represents one of the greatest challenges
now facing science.
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